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Abstract
It has been well established that omega-3 (n-3) polyunsaturated fatty acids (PUFA)
(found in fish oil) have beneficial effects on the cardiovascular system including a
reduction in ischaemia induced cardiac arrhythmia and increased threshold required
to induce electrically ventricular fibrillation. In heart, membrane phospholipid
composition reflects dietary fat content. In particular regular fish consumption in
humans has been shown to reduce the incidence of “new heart attacks”, while in rats
n-3 PUFA is associated with improved oxygen efficiency and maintained function.
In skeletal muscle, membrane composition also reflects dietary fat content. Increased
dietary n-3 PUFA has significant effects on skeletal muscle insulin sensitivity and
substrate preference amongst a number of other functional changes. The direct
effects of n-3 PUFA on skeletal muscle oxygen consumption has not been
investigated and may have a significant role in maintaining contractile performance
and reducing fatigue. The aim of this thesis was to study the possible direct effects of
dietary n-3 PUFA on skeletal muscle oxygen consumption and function in rats.

Male Wistar rats (12 weeks old) were fed, ad lib, one of three diets (SF: saturated fat;
n-6 PUFA: safflower oil; n-3 PUFA: tuna fish oil) for a period of 8 weeks. The total
fat content of the diets was 10% by weight and the level of polyunsaturation in the n6 and n-3 groups was controlled using a mixture of the test oil and monounsaturated
olive oil. After 8 weeks, skeletal muscle oxygen consumption, function and fatigue
were assessed using the rat auto-perfused contracting hindlimb developed in this
thesis and membrane fatty acids were analysed. The hindlimb auto-perfusion enabled
control of blood flow to the animal’s hindlimb in resting and contracting conditions
with simultaneous measurement of oxygen consumption and skeletal muscle twitch
XIV

tension. The auto-perfusion achieved close to physiologically relevant oxygen
consumption and perfusion pressure with a hindlimb flow rate that was reflective of
in vivo conditions compared to previously used rat hindlimb perfusion systems.

The skeletal muscle membrane composition was reflective of the fat content in the
diets. Animals fed n-3 PUFA compared to SF and n-6 PUFA significantly increased
total n-3 PUFA, mostly through increased levels of the long chain fat
docosahexaenoic acid (DHA) in the membranes. This significantly altered the n-3/n6 ratio in the membranes. The change in membrane fatty acid composition was very
close to previously established changes in the heart after similar dietary
interventions, particularly DHA content.

The collective results of this thesis support the role of the long chain n-3 PUFA
DHA in membranes, as a requirement for optimal skeletal muscle function. In the
rat auto-perfused contracting hindlimb, during brief (10minutes) and prolonged
(30minutes) bouts of stimulation, in recovery after bouts of stimulation and during
hypoxic conditions, n-3 PUFA feeding was associated with enhanced muscle
contractile function and indicative of reduced fatigue. Specifically, reduced fatigue
in the n-3 PUFA group during normoxic conditions was associated with
maintenance of isometric twitch rise time, fall time, contraction duration and
maximum rate of tension development and relaxation. The effect of diet on these
twitch characteristics provide information that may explain the measured
differences in fatigue, such as sarcoplasmic reticulum calcium release. Supportive
of the possible changes in skeletal muscle calcium handling was the greater
recovery of tension from the fatigued state in n-3 PUFA animals when caffeine was
administered.

Of particular interest in regard to the hypothesis of this thesis,
XV

reduced fatigue in the n-3 PUFA group was associated with modulated oxygen
consumption during contraction and recovery. These results complement earlier
findings in heart and establish n-3 PUFA DHA in skeletal muscle as an essential
membrane fatty acid for optimal function. If human applications of these results are
successful, it is most likely that dietary n-3 PUFA may have significant impact on
dysfunctional skeletal muscle and improve quality of life. This encompasses muscle
function in combination with sedentary life style, diabetes, heart failure, or
muscular dystrophy.
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Chapter 1
Introduction

1

1.1 The influence of dietary component on skeletal muscle fatigue
The complexity of skeletal muscle fatigue processes has, and will continue to
intrigue a collective of scientific, medical and sporting bodies. A review by (Fitts and
Metzger, 1993) indicated that the cause and degree of skeletal muscle fatigue is
multi-factorial, clearly dependent on the duration, intensity and the type of exercise,
the fibre type composition of the muscle, individual level of habitual activity, and
environmental factors.

Dietary carbohydrate intake has been shown to influence whole body performance.
(Christiansen and Hansen, 1939) suggested that endurance performance was strongly
determined by the amount of dietary carbohydrate ingested. However, not until the
1960’s was the direct relationship between pre-exercise muscle glycogen content,
resulting from carbohydrate ingestion, and exercise performance discovered
(Bergstrom et al., 1967). To date, the importance of carbohydrate ingestion prior to,
during and following exercise bouts has been confirmed and formed the basis of
dietary approaches to delay skeletal muscle fatigue (Costill and Hargreaves, 1992).
The importance of dietary carbohydrate in a practical sense of delaying fatigue has
resulted mostly in dietary fat and protein simply making up the remainder of the
prescribed diet. Specifically, if dietary fat has any influence on muscular
performance, the high levels of ingested carbohydrate may have compromised this in
the past.

There are three possible outcomes for dietary fats once ingested. They can be directly
metabolised to provide energy, stored for later use, or incorporated into membranes
or other sub-cellular components such as lipoprotein. Studies involving dietary fat
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manipulation have focused on enhancing fat oxidation during exercise and
attenuating the rate of glycogen utilisation (Helge et al., 2001a). Work done with
animal models demonstrates that a diet high in fat, with little or no carbohydrate,
positively effect endurance performance (Miller et al., 1984; Simi et al., 1991;
Lapachet et al., 1996). This is not always the case in studies involving humans.
Methods currently used in humans to increase the level of fatty acids available for
oxidation include, acute ingestion (Costill et al., 1977; Jeukendrup et al., 1995;
Jeukendrup et al., 1996; Jeukendrup et al., 1998; Hawley et al., 2000), intra-venous
infusion of intralipid (Ravussin et al., 1986; Hargreaves et al., 1991), short (Starling
et al., 1997; Pitsiladis and Maughan, 1999) and long term feeding of high fat, low
carbohydrate diet (Pruett, 1970; Phinney et al., 1983; Lambert et al., 1994; Muoio et
al., 1994; Helge et al., 1996a; Helge et al., 1998; Helge et al., 2001a) and finally fat
adaptation with carbohydrate restoration (Burke et al., 2000; Carey et al., 2001;
Lambert et al., 2001; Burke et al., 2002).

Acute ingestion has focused on both medium (Jeukendrup et al., 1995; Jeukendrup et
al., 1996; Jeukendrup et al., 1998) and long chain triglycerides (Costill et al., 1977;
Hawley et al., 2000). There has been little evidence that medium chain triglyceride
ingestion will effect either substrate utilisation or performance. On the other hand,
ingestion of long chain triglyceride certainly has resulted in some difference in
oxidation rates yet they still do not translate into enhanced performance (Costill et
al., 1977; Hawley et al., 2000).

Intra-venous lipid infusion will also shift substrate preference toward fatty acid
oxidation, however despite reductions in muscle glycogen use (traditionally
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associated with performance enhancement) there has been no evidence to support
employing this method to delay fatigue (Ravussin et al., 1986; Hargreaves et al.,
1991).

Both short term (<7days) (Starling et al., 1997; Pitsiladis and Maughan, 1999) and
long term (>7days) (Pruett, 1970; Phinney et al., 1983; Lambert et al., 1994; Muoio
et al., 1994; Helge et al., 1996a; Helge et al., 1998) high fat, low carbohydrate
dietary feeding programs will result in marked increases of fatty acid oxidation,
particularly during endurance and ultra-endurance performance. However, initially
low muscle (Phinney et al., 1983) and liver (Hultman and Nilsson, 1971) glycogen
levels are not conducive to improved performance and result in significantly greater
catecholamine and heart rate responses (Helge et al., 1996b). Even when
carbohydrate restoration takes place, on most occasions no clear difference in
performance is seen (Burke et al., 2000; Carey et al., 2001; Burke et al., 2002).
Conflicting information limits the consensus of the influence of dietary fat on muscle
fatigue and it has become evident that there maybe responders and non-responders as
previously demonstrated by (Phinney et al., 1983) and recently referred to in a
review by (Helge, 2002).

Most often, the high levels of ingested fat have been in the form of either saturated or
monounsaturated fatty acids with little emphasis placed on specific fats. It is now
recognised that individual dietary fats, specifically the long chain derivatives, may
have individual roles in the regulation of skeletal muscle fatigue, given that specific
fats are oxidised at different rates (Leyton et al., 1987) and have different end results
as precursors and second messengers (Abeywardena et al., 1993). Additionally,
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improvement in performance has focussed on endurance in athletes. Alternatively,
the role of specific dietary fats may have greater impact on dysfunctional skeletal
muscle and improve quality of life. This may include muscle function in combination
with diabetes (Cameron et al., 1990), heart failure (Lunde et al., 1998), or Duchenne
muscular dystrophy (Gillis, 1996).

Only a few studies have considered the role of specific fatty acids in skeletal muscle
contractile function (Ayre and Hulbert, 1996b) and exercise performance (Leaf and
Rauch, 1988a; Ayre and Hulbert, 1997; Oostenburg et al., 1997; Raastad et al., 1997)
with conflicting results. It was likely that the results from these studies were
influenced by the methodology, including the definition of endurance and time
period of supplementation. Therefore, further research into how specific fatty acids
can influence fatigue is warranted and unlike studies involving short or long term
“fat loading” in athletes, the current thesis will focus on maintaining levels in the diet
that are attainable in the animal and human diet and shown to have direct
physiological effects (McLennan, 2001).

1.2 Identifying the primary sites of skeletal muscle fatigue
One of the most demonstrable and consequently accepted observations in muscle
physiology is that a repetitively contracting muscle progressively loses the ability to
generate a target force. Therefore, skeletal muscle fatigue is often defined as an
inability to generate the required or expected force (Edwards, 1981). However, this
does not recognise that muscle fatigue commences at the initiation of muscle
contraction. Maximum force is the absolute amount that can ever be achieved and
declines from the onset of activity. The definition of fatigue as a reduction in the
maximum generating force capacity may be more appropriate.
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The reduction or decline in force is often obvious, however the specific levels and
sites at which physiological dysfunction is occurring may not be so evident. Skeletal
muscle fatigue originates from either the central nervous system and neuromuscular
junction activity or peripherally at the level of the skeletal muscle activity. At both
these levels, major sites of fatigue were recognised by (Bigland-Ritchie and Woods,
1984). The first four sites can be classified as central and include, i) excitatory input
to higher motor centres, ii) excitatory drive to lower motor neurons, iii) motor neuron
excitability and iv) neuromuscular transmission. From this point, the level of fatigue
is peripheral, and includes the remaining four sites of i) sarcolemma activity, ii)
excitation contraction coupling, iii) contractile mechanism, and iv) metabolic energy
supply and metabolite accumulation.

The evidence accumulated to date suggests that the primary sites of fatigue lie
peripherally within the contracting muscle (Edwards, 1981; Fitts et al., 1981).
Although failure in neuromuscular transmission has been demonstrated to occur with
high frequency stimulation, these levels can be regarded as non-physiological.
Furthermore, any reduced neural drive occurring in response to high intensity
exercise is thought to actually protect the activated muscle against development of
fatigue (Bigland-Ritchie et al., 1979; Bigland-Ritchie et al., 1986).

Fatigue resulting from repeated tetanic or low frequency stimulation is closely
associated with sites beyond the neuromuscular junction and involves a much wider
variety of mechanisms. There are seven reported sites within excitation contraction
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coupling that contribute to muscle fatigue. Figure 1.1 schematically shows these sites
(Fitts and Metzger, 1993). More specifically, tension decline with repeat tetanic
stimulation is linked to a combination of reduced Ca2+ release, reduced Ca2+
sensitivity of the myofibrils and reduced maximum Ca2+ activated tension
(Westerblad et al., 1991). Failure of the sarcoplasmic reticulum release has been
additionally associated with elevated intra-cellular calcium levels and / or changes in
the metabolism within the triad space including glycogen, ATP, lactate, Mg2+ and
reactive oxygen species (see review (Favero, 1999)).

Figure 1.1: A diagrammatic representation of the major components of a muscle cell involved
in excitation contraction (EC) coupling. The numbers indicate the possible sites of muscle
fatigue during heavy exercise and include: (1) surface membrane; (2) t-tubular charge
movement; (3) unknown mechanism coupling t-tubular charge movement with SR Ca2+
release; (4) SR Ca2+ release; (5) SR Ca2+ reuptake; (6) Ca2+ binding to troponin; (7)
actomyosin hydrolysis of ATP and cross-bridge force development and cycling rate (Fitts and
Metzger, 1993).
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1.3 Omega-3 polyunsaturated fatty acids (PUFA) derived from fish consumption
Epidemiological studies have attributed positive cardiovascular health effects to fish
oil consumption. (Nelson, 1972) demonstrated clearly that eating fish can be of great
benefit to patients with advanced cases of coronary disease by increasing survival
time. A much larger epidemiological study by (Kromhout et al., 1985) displayed an
inverse relationship between fish consumption and deaths resulting from coronary
heart disease during 20 years follow up. The authors concluded that even a diet of
one to two fish meals per week would be beneficial to prevent death from coronary
heart disease. Further studies have also arrived at these conclusions (Shekelle et al.,
1985; Norell et al., 1986). A major finding of Kromhout and co-workers (1985)
related to the relatively small initial amount of fish consumed on average across all
groups (20g/day). In comparison, the well documented low cardiovascular disease in
Greenland Eskimos is associated with consumption of fish up to 400g/day (Bang and
Dyerberg, 1972).

It is now well established that omega-3 PUFA (referred to as n-3 PUFA) are
associated with potential antiatheromatous effects on the cardiovascular system both
in the human model and the animal model (Wiener et al., 1986; Davis et al., 1987),
affect eicosanoid metabolism and function (Fischer et al., 1986), lower blood
pressure (Lorenz et al., 1983), and reduce endogenous fibrotic activity (Barcelli et
al., 1985), reduce the amount of serum triglycerides, very low density lipoproteins
and increase the levels of high density lipoproteins (Dyerberg et al., 1975; Phillipson
et al., 1985).
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Oils extracted from fish are rich sources of n-3 PUFA. N-3 PUFA are essential
components of mammalian cells, providing structural components of cell membranes
and biologically active metabolites. They are also essential components of the diet since
mammals cannot synthesise them de novo. Of the two principal families of
polyunsaturated fatty acids, omega-6 PUFA (referred to as n-6 PUFA) are usually
readily available in the diet in the form of the 18 carbon parent, linoleic acid (18:2n-6).
While some of the short chain n-3 PUFA, -linolenic acid (18:3n-3), is obtained in the
diet, its conversion to longer chain derivatives is quite poor due to competition with the
vast excess of linoleic acid. Therefore, n-3 PUFA are best derived directly from the diet.

Biologically, the most important long chain n-3 PUFA are the 20 and 22 carbon
derivatives, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA,
22:6n-3). While fish oils contain both EPA and DHA, commercial fish oil preparations
commonly derived from northern hemisphere fish catches have traditionally been richer
in EPA. On the basis of its prevalence in those oils it has largely been assumed, without
proper validation, that EPA is the active component. However, analysis of a wide
variety of tissues indicates that as a structural component of cell membranes, DHA is
often most prevalent (Charnock et al., 1992), even after feeding purified EPA
(McLennan et al., 1996). Even in man where levels of DHA (without supplementation)
are as low as in n-6 PUFA supplemented animals (Charnock et al., 1992), myocardium
has higher levels of n-3 PUFA than serum or adipose tissue and DHA predominates
over EPA (Sexton et al., 1995). Laboratory studies have demonstrated that dietary
supplementation with DHA has a variety of physiological effects on the cardiovascular
system, either with a higher efficacy than EPA or not shared by EPA (McLennan et al.,
1996).
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1.4 The direct effect of fish oil on the heart
Fish oil consumption by marmoset monkey or rat has also resulted in reduced
severity of ischaemia induced cardiac arrhythmia (McLennan et al., 1988; McLennan
et al., 1992; Pepe and McLennan, 1996). Furthermore, fish oil fed animals develop
an increase in the threshold required to electrically induce ventricular fibrillation
during ischaemia (McLennan et al., 1992; Pepe and McLennan, 1996). Observations
that suggest potential mechanisms include changes in the n-3 and n-6 derived
eicosanoid production leading to reduced ventricular fibrillation (Abeywardena et al.,
1993) and modification of cardiac muscle cell membrane phospholipids occurring
with fish oil feeding. The marmoset monkey and rat animal models demonstrate the
direct antiarrhythmic effect that fish oil has on the animal myocardium subsequently
revealed as an antiarrhythmic effect in humans (Siscovick et al., 1995).

The direct effect of fish oil on the myocardium is also reported by (Burr et al., 1989)
during the ‘Diet and re-infarction trial’ (DART) and (Marchioli and Investigators,
1999) in the GISSI Prevenzione Trial. Men who had recovered from a myocardial
infarction either received or did not receive advice on dietary increase in fatty fish
intake (Burr et al., 1989) or received one capsule of fish oil per day (Marchioli and
Investigators, 1999). No significant differences in classical risk factors (cholesterol,
blood pressure etc) were attributable to dietary fish or fish oil nor was there any
reduction in new ‘heart attack’ events. However, reduced mortality from coronary
heart disease associated with increase in the dietary fish or fish oil consumption
suggests the direct anti-arrhythmic effect of fish oil on the heart. Moreover, the
direct anti-arrhythmic effects of n-3 PUFA rely on the incorporation of DHA into the
myocardial cell membranes (McLennan, 2004).
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Additionally, the n-3 PUFA may act directly on the cardiovascular system through
the ability to increase the overall efficiency of oxygen utilisation. This efficiency of
oxygen utilisation has been shown to occur in the heart (Pepe and McLennan, 2002).
Isolated hearts of rats fed a diet high in fish oil had reduced oxygen consumption
without a loss of performance. Pepe and McLennan (2002) using the isolated
working heart model demonstrated that rats supplemented with n-3 PUFA increased
pumping efficiency. There was no difference in the cardiac output or myocardial
external work of the isolated working heart under control conditions. However, the
isolated working hearts of fish oil fed animals had significantly lower myocardial
oxygen consumption than a reference group and a saturated fat supplemented group.
The authors attributed the low coronary flow seen in the isolated working hearts of
the fish oil group to the low oxygen demand of the cardiac muscle.

1.5 Dietary modulation of skeletal muscle fatigue processes
There is evidence to suggest that intake of n-3 PUFA is less than optimal in
developed nations (Leaf and Weber, 1988b). The very high sensitivity of heart
membranes to changes in n-3 PUFA intake, coupled with the observations that fish
oil feeding or deficiency produces fundamental changes in cardiac rhythm stability
(Pepe and McLennan, 1996) and oxygen consumption in isolated rat hearts
(Grynberg et al., 1997; Pepe and McLennan, 2002) is the stimulus for this study.
Cardiac tissue avidly accumulates n-3 PUFA, particularly DHA, well above the
circulating levels and shares this property with skeletal muscle. Recent studies have
shown that the dietary fatty acid profile influences the composition of skeletal
muscle phospholipids (Ayre and Hulbert, 1996a), even to the extent where the
uptake of n-3 PUFA may be fibre type specific (Kriketos et al., 1995). Coupled
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with the high levels of DHA found in the mammalian brain and retina (Weisinger et
al., 1995; Jeffery et al., 2001; Salem et al., 2001), the available evidence suggests an
important role of DHA in the function of excitable cells. The precise role or roles of
DHA in skeletal muscle and other cell membranes are unknown. It is the premise of
this thesis that the long chain fatty acid DHA, when provided in the diet, will
influence the membrane composition of skeletal muscle and in turn will directly
affect the use of oxygen in skeletal muscle as previously seen in the heart. This may
have beneficial effects on function including improved twitch contractile
performance.

1.6 Studies of skeletal muscle function using the auto-perfused rat hindlimb
The main criteria for the initial stage of this project was to focus on the development
of specific experimental protocols that allow for monitoring of skeletal muscle twitch
tension fatigue. Metabolic studies using the isolated skeletal muscle organ bath
preparation were not considered appropriate. In fact, previous work by (Ayre and
Hulbert, 1996b) investigating the effect of n-3 PUFA on fatigue resistance used this
model and found conflicting results to later studies using running rats (Ayre and
Hulbert, 1997). The in vitro models have been important as initial building blocks
however the organelle of interest may be substantially disrupted by the preparation.
The in vitro models are appropriate to studies of a pharmacological nature where
skeletal muscle response, that is, either excitation or inhibition is the key interest.
To adapt this model to metabolic studies and expect in vivo responses is nonphysiological and simplistic. That is i) there is no longer any blood supply to either
the resting or contracting muscle and ii) simple processes of oxygen diffusion may
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be altered to the extent where certain parts of the deeper tissue are not adequately
supplied.
The thesis has established a new technique to study the effects of dietary lipids on
skeletal muscle twitch function using the rat auto-perfused hindlimb. A similar
method of auto-perfusion was previously used in dogs (Hogan and Welch, 1986). An
auto-perfused hindlimb involves the controlled perfusion of the back leg or legs
using the animal’s own blood and allows for sampling of both arterial and venous
blood. It is believed that this model is the best possible method to provide optimal
tissue oxygenation and to study dietary effects on twitch tension fatigue under close
to in vivo conditions.

Previously, rat hindlimb metabolic studies have used an in situ muscle preparation,
with perfused flow protocol based upon (Ruderman et al., 1971) and then further
adapted (Rennie and Holloszy, 1977; Spriet et al., 1985; Colquhoun et al., 1988;
McDermott et al., 1989). This method has been found to be cumbersome and time
consuming and does not make use of the animal’s own blood. Perfusates have
included cell free (Colquhoun et al., 1988; Colquhoun et al., 1990; Ye et al., 1990),
human (Ruderman et al., 1971; Rennie and Holloszy, 1977; Gorski et al., 1986;
Hood et al., 1986) and bovine erythrocyte (Spriet et al., 1985; Rolfe et al., 1999),
and fluorocarbon emulsions (Kubo and Foley, 1989). All types of perfusate
demonstrate non-physiological responses, including low oxygen consumption and
low perfusion pressure. Most of these studies have been conducted in resting state
with no muscle contraction. It is not surprising that when the hindlimb has been
stimulated to isometrically contract, the ability of the muscle to perform over a long
duration is diminished.
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The importance of using blood in perfusion when investigating oxygen
consumption, tissue function and metabolic response is clearly demonstrated in
earlier work involving heart (Topping and Trimble, 1985; Pepe and McLennan,
1993) and liver (Storer et al., 1980) perfusion systems. The direct comparison to
buffer perfusion systems in the heart, demonstrate long term stability and
maintenance of function (Duvelleroy et al., 1976; Olders et al., 1990; Pepe and
McLennan, 1993) when using perfusates containing red blood cells. Similarly, in
the liver, insulin sensitivity is maintained with physiological blood perfusate (Storer
et al., 1980).

This thesis has significantly adapted the rat hindlimb model first described by
(Ruderman et al., 1971) by using an extra-corporal loop to allow the isometrically
twitching skeletal muscle to be perfused with the animal’s own blood. A similar
technique has been successfully used in the lager canine for investigation involving
blood flow regulation and oxygen consumption of the isometrically contracting
muscle (Hogan and Welch, 1986). In the current thesis, the stimulation parameters
used to isometrically twitch the hindlimb skeletal muscle are reported elsewhere
(Fitts and Holloszy, 1976; Hood et al., 1986; Metzger and Fitts, 1987; Hogan et al.,
1996; Ameredes et al., 1998). The canine model has provided background for our
method to be validated against before investigating the role of fish oil fatty acid in
skeletal muscle twitch function and oxygen consumption.
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1.7 Primary hypotheses of this thesis:
On the basis of the reviewed literature, the doctoral thesis will test the hypotheses,
i) That n-3 PUFA are an essential component of the membranes of excitable
cells in skeletal muscle for optimum energy efficiency, and
ii) That n-3 PUFA will modulate twitch tension fatigue of skeletal muscle in
the auto-perfused rat hindlimb under near physiological conditions.

Specifically, this project aims to:
•

Develop hindlimb twitch tension fatigue and auto-perfused blood flow
protocols in anaesthetised rats that can be used for dietary investigations
(Chapter 2).

•

Investigate the influence of dietary modulation on skeletal muscle
membrane fatty acid composition and establish whether observations of
fundamental alterations to oxygen use by cardiac muscle are applicable to
skeletal muscle (Chapter 3).

•

Investigate the essential nature of n-3 PUFA in mammalian skeletal muscle
membranes and their ability to modulate twitch tension fatigue under
various conditions (normoxia and hypoxia) with reference to possible
mechanisms involved in oxygen modulation (Chapter 4 and 5).

•

Discuss overall the findings of the experimental studies, interpret their
significance and propose the direction for further investigation (Chapter 6).
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Chapter 2
General methods and development of a
contracting, auto-perfused hindlimb using the
laboratory rat for the study of skeletal muscle
fatigue
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2.1 Introduction
Muscle performance and metabolic processes are highly dependent on blood flow and
oxygen delivery to the active tissue (Reis et al., 1967; Horstman et al., 1976). It is a
crucial part of this investigation into the direct effect n-3 PUFA on skeletal muscle
function and twitch tension fatigue that as near as possible, the in vivo physiological
conditions of the skeletal muscle are achieved. These include stimulation of the muscle,
oxygen and substrate delivery and removal of waste products. Previous methods used
extensively to investigate muscle metabolism (in vitro organ bath and in situ rat
hindlimb), although appropriate for some purposes (e.g. pharmacological responses), do
not seem to provide the resting and especially contracting muscle with adequate oxygen
to examine physiology and metabolism in relation to in vivo conditions. The autoperfused rat hindlimb developed in this present investigation, is based upon autoperfused canine hindlimbs used to investigate the interaction of oxygen supply and
contractile response (Hogan and Welch, 1986; Hogan et al., 1994; Hogan et al., 1996;
Hogan et al., 1998; Hogan et al., 1999). The importance of in vivo physiological
conditions and using the animals own blood during perfusion are recognised in
studies of both heart (Topping and Trimble, 1985; Pepe and McLennan, 1993) and
liver metabolism (Storer et al., 1980). The direct comparison to buffer perfusion
systems in the heart, demonstrate long term stability and maintenance of function
(Duvelleroy et al., 1976; Pepe and McLennan, 1993) when using whole blood. This
is in direct support of the current method development study. In addition, by
extending the auto-perfused canine model into the rat, long term dietary investigations
and their impact on muscle fatigue and oxygen use are possible. The first stage of
development was to investigate the blood flow and ventilation requirements of the
hindlimbs during rest and proposed stimulation protocols simultaneously.
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2.1.1 In vitro preparation of skeletal muscle in studies of fatigue
Studies using the isolated skeletal muscle organ bath preparation are very popular in
the field of muscle metabolism. In fact, previous work by (Ayre and Hulbert, 1996b)
investigating the effect of n-3 PUFA on fatigue resistance has already used the in
vitro model. The in vitro models have been important as initial building blocks
however the organelle of interest maybe substantially disrupted by the preparation.
The model relies completely on oxygenation of the tissue via diffusion pathways as
the muscle of interest is dissected and placed in an incubation medium. The in vitro
models are appropriate to studies of a pharmacological nature where skeletal muscle
response, i.e. either excitation or inhibition, is the key interest. To adapt this model
to metabolic studies and expect in vivo responses is non-physiological and simplistic.
That is i) there is no longer any blood supply to either the resting or contracting
muscle and ii) simple processes of oxygen diffusion may be altered to the extent
where certain parts of the deeper tissue are not adequately supplied and iii) there is
an effect of time delay between excising the muscle and oxygenating it in vitro that
will result in muscle hypoxia and excessive glycogenolysis.

Critical thickness of the muscle or muscle strip, incubating temperature used in the
preparation and final oxygen consumption are reported in review by (Bonen et al.,
1994). These results clearly indicate that the model is both highly temperature
dependant and limited by critical thickness of the muscle. It is suggested that when
the in vitro model is used, the interpretation must take into consideration its
limitations, based on incubating temperatures, thickness of the muscle, as well as
levels of phosphocreatine, ATP, and glycogen and / or lactate production. It is not in
the interest of the present investigation to use this system
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2.1.2 In situ preparation of rat hindlimb in studies of fatigue
Previously, rat hindlimb metabolic studies have largely used an in situ muscle
preparation, with blood flow protocol based upon (Ruderman et al., 1971) and then
further adapted (Rennie and Holloszy, 1977; Spriet et al., 1985; Colquhoun et al.,
1988; McDermott et al., 1989). The model traditionally makes use of one of three
types of perfusion medium: fluorocarbon emulsions; cell free perfusate; or the
bovine/human erythrocyte perfusate. As is the case of the in vitro preparation, the
perfusate can be tightly controlled over the course of the hindlimb perfusion,
namely haemoglobin, blood gas, acid-base status, and electrolytes. The in situ rat
hindlimb also carries the added advantages that the muscle receives exogenous
substrates through normal vascular channels and normal bone, muscle and nerve
relationships are maintained. However, the model does have its drawbacks. Flow
rates of less than 6ml/min result in cyanotic discolouration of the feet, lactate
production was deemed problematic and there is high incidence of hindlimb
oedema (Ruderman et al., 1971). Additionally, there is concern that the flow rates
used are non-physiological when compared to true in vivo measure of rat hindlimb
flow (Sapirstein et al., 1960). The volume of perfusate used and the time period
which these studies are carried over, it is estimated that re-circulation occurs 12
times (Ruderman et al., 1971) and even up to 18 times (Rolfe et al., 1999).

Re-

circulation in large quantities can eventually lead to loss of perfusate volume to the
systemic circulation. The rat possess a vertebral venous plexus that is not exclude
from the operative procedure and since this plexus eventually joins the systemic
circulation a certain amount of blood is shown to escape the hindlimb. Moreover
this model potentially does not allow for the clearance of metabolic wastes products
such as blood lactate. This is evident after prolonged stimulation and perfusion up
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to 125 minutes. Blood lactate values increased by 10 fold as the oxygen
consumption increased by 2-4 fold. Increases in blood glucose utilisation could only
account for 35% of the increased blood lactate levels. Although muscle glycogen
contributes significantly to blood lactate production, the levels obtained during
steady state contractions suggest that clearance of wastes were effected (Ruderman
et al., 1971). One method of overcoming the problems of re-circulation is to set up
one-pass perfusion systems. This type of system cancels the need for repeated
perfusate gassing and also allows for the separation of red blood cell and hindlimb
metabolism. There is still the chance of perfusate loss and oedema. In addition, the
natural physiological changes to the blood, as occur in heavy exercise, are not
permitted to occur as all the delivered blood is fresh perfusate. Overall, both the recirculating and the one-pass systems may result in unphysiological metabolic
responses to stimulation. It is not in the interest of the present investigation to use
this system.

The nature of the in situ preparation is such that all direct neurological innervation to
the hindlimb vasculature is lost, resulting in abolition of sympathetic tone and mass
vasodilation of the vascular bed. As a consequence very high perfusion flow rates are
used to sustain the pressure within the physiological range. Flow rates ranging from
6-20ml/minute have been needed to establish perfusion pressures of 80mmHg or
more (table 2.1) compared with the reported in vivo rat hindlimb blood flow of 0.752ml/minute (Sapirstein et al., 1960). These high perfusion rates would also contribute
to the reported oedema (Bonen et al., 1994). Table 2.1 is a summary of the studies
that used the in situ preparation under both resting and contracting conditions. It
becomes clear that there is a large variation in parameters (perfusate, flow,
stimulation) used by investigators, many of them far from the physiological ranges,
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that impact on the findings of each study and their interpretation. Table 2.1 provides
an important summary for comparison with the results of this method development
section.
Table 2.1: A comparison of hindlimb flow rates, pressure and oxygen consumption
responses from varying models based upon Ruderman et al., (1971).
Authors

Perfusate

Condition

Flow

Pressure

O2 consumption

Ruderman et al., 1971

Human RBC

Rest

8

80

0.33

Contract

12

110

0.66

Rennie et al., 1977

Human RBC

Rest

7

70-80

0.45

Spreit et al., 1985

Bovine RBC

Rest

6

82

0.5

Contract

18

200-220

2.6

Rest

8.5

not reported

0.38

Contract

14.3

not reported

1.8-1.9

Rest

2

17

0.25

5

46

0.3

7

57

0.35

11

69

0.35

20

80-90

0.15

2

22

0.08

4

34

0.14

8

61

0.21

Hood et al., 1986

Gorski et al., 1986

Human RBC

Human RBC

Shiota et al., 1986

Cell Free

Colquhoun et al., 1988

Cell Free

Rest

Kubo et al., 1989

Fluorocarbon

Rest

8

not reported

0.37

McDermott et al., 1989

Cell Free

Rest

15

70-80

0.18

Ye et al., 1990

Cell Free

Rest

5.4

30

0.12

Colquhoun et al., 1990

Cell Free

Rest

4.1

29

0.1

Ye et al., 1990

Cell Free

Rest

18.5

70-80

0.5

Ye et al., 1998

Cell Free

Rest

5

37

0.13

Rolfe, et al., 1999

Bovine RBC

Contract

8

not reported

0.35

This table represents a range of studies that have used variations in the rat hindlimb perfusion method.
It is by no means completely comprehensive. Condition:

Rest indicates no hindlimb muscle

stimulation took place, Contract indicates a level of hindlimb stimulation took place (varying). Flow:
Hindlimb flow expressed as ml/minute. Pressure: Hindlimb perfusion pressure expressed as mmHg.
O2 consumption: Hindlimb oxygen consumption expressed as mol/gram/minute.
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2.1.3 Auto-perfused preparation of canine hindlimb in studies of fatigue
For the investigation of n-3 PUFA and direct effects on skeletal muscle oxygen use
and muscle fatigue it is imperative that oxygen delivery to the resting and contracting
muscle is as near to physiological conditions as possible. Importantly, oxygenation
should be achieved with physiologically relevant hindlimb blood flow and vascular
tone. The importance of in vivo physiological conditions during perfusion have also
been recognised in the study of both heart (Topping and Trimble, 1985; Pepe and
McLennan, 1993) and liver metabolism (Storer et al., 1980). The direct comparison
of blood to buffer perfusion systems, demonstrate long term stability and
maintenance of function (Duvelleroy et al., 1976; Pepe and McLennan, 1993). The
auto-perfusion of canine hindlimb has become common practice in studies of oxygen
delivery and uptake in combination with skeletal muscle function (Hogan and Welch,
1986). An auto-perfused hindlimb involves the controlled perfusion of the back leg
or legs using the animal’s own blood. There are several options for creating an extracorporal loop and controlling flow to the hindlimb under investigation. The present
study will use the femoral artery of the non-investigated limb for the oxygenated
supply of blood and return the de-oxygenated venous blood to the central body via
the jugular vein. At this point the blood from the hindlimb will re-join the blood from
other parts of the animal and be re-oxygenated at the lungs.

The auto-perfusion model is highly regarded for the provision of optimal tissue
oxygenation and to study nearly in vivo conditions while still being able to control
and modulate various parameters such as hindlimb flow (Hogan and Welch, 1986;
Hogan et al., 1994; Hogan et al., 1996; Hogan et al., 1998; Hogan et al., 1999). While
dog would be ideal for ease of use, it is less suitable than the rat for long term dietary
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studies where a range of relevant data is established (Pepe and McLennan, 2002). To
our knowledge there has been no validation or application of the auto-perfused
method in the rat hindlimb. This will be particularly important for future studies that
wish to investigate long term dietary effects on oxygen use of the skeletal muscle.

It is the premise of this study that the auto-perfused model used by Hogan and coworkers (1986), when adapted for the rat hindlimb, compared to the in situ hindlimb
perfusion first established by (Ruderman et al., 1971) will; (i) improve oxygen
delivery, (ii) provide physiological relevant levels of substrate, (iii) improve
metabolic waste clearance, iv) improve vascular responses, (v) minimise hindlimb
swelling, (vi) improve long term muscle developed isometric twitch tension and
muscle performance and (vii) have more stability in overall performance

2.2 Aims and Hypothesis
Specifically, this part of the project aims to set up and evaluate a new method of
metabolic study in the contracting rat hindlimb, concentrating on,
•

the best rate and volume of ventilation to sustain arterial blood oxygen
levels at rest and during contraction.

•

the normal rate of blood flow through the hindlimbs at rest and when the
muscles are being stimulated.

•

the most appropriate stimulus settings for short and long-term twitch
contractions and which muscle bundles can best be used for twitch
contraction measurement.

23

It is hypothesised that this new method of rat hindlimb auto-perfusion when
compared to previously established rat models, will result in:
•

lower hindlimb flow rates required for adequate oxygen delivery and
physiologically relevant hindlimb perfusion pressures;

•

greater oxygen uptake in resting and contracting tissue;

•

greater contracting performance of the hindlimb muscle bundle;

•

true physiological representation of skeletal muscle function and
metabolism.
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2.3 General Methods
2.3.1 Animals
Experiments were approved by the Animal Ethics Committee from the University
of Wollongong. Experimental animals (Wistar rats) were obtained from Gore Hill
Animal Research Laboratory (Royal North Shore Hospital) and housed in the
University of Wollongong’s Animal facility. Environmental conditions where the
animals were controlled with room temperature maintained at 23oC-25oC and 12
hour light cycle.

2.3.2 Animal anaesthesia
Rats were anaesthetised throughout all the procedures. Briefly, anaesthetic was
induced by sodium pentobarbital (6mg/100g i.p.) and was maintained by
supplementary injections (2mg/100g i.p.) as required during the procedure.
Experiments were performed with the rat and perfusion system in a heated perspex
chamber and animal body temperature was maintained with the aid of a heating lamp
placed above the rat.

2.3.3 Surgical preparation for muscle stimulation, ventilation and blood flow.
Figure 2.1 illustrates the set up of the animal for pressure measurement, nerve
stimulation, and muscle tension recording as described below.

Ventilation and Systemic Blood Pressure
The animal was shaved across both hindlimbs, abdominal region and anterior neck. A
polyethylene tube was placed into the trachea for the animal’s breathing to be
maintained by constant volume artificial ventilation. This was done in order to
ensure that the level of oxygen in the arterial blood remained high and constant
during each experiment.
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A rodent ventilator (7025, Ugo Basile, Italy) was used and a constant volume was set
according to animal body weight (1ml/200g). A cannula was inserted into the left
carotid artery and connected to a pressure transducer for direct measurement of
systemic blood pressure. All cannulae (Dural Plastics Internal Diameter 0.58mm
Outside Diameter 0.96mm) were fluid filled with saline containing 6% Dextran (w/v)
and 5000 IU Heparin / 100ml.

Nerve and muscle isolation
The rat was turned onto its right side and a small incision was made in the skin, 1cm
below the iliac crest. The gluteal muscles were separated to expose the sciatic nerve
trunk. A bipolar electrode (Grass Instrument Division, USA) was placed under the
nerves for direct electrical stimulation of the trunk supplying the muscles of the
gastrocnemius-plantaris-soleus muscle bundle. Saline-soaked gauze was placed over
the incision to prevent the nerve from drying.

The animal was then turned onto its back and the left leg was clamped to the staging
at the knee and foot to prevent movement during stimulation. The gastrocnemiusplantaris-soleus muscle group tendons were tied with non-stretch silk and connected
to a force transducer in the line of contraction (FT03C, Grass Instrument Division,
USA). Saline-soaked gauze was placed over the muscles to prevent them from drying.

Arterial blood flow
A cannula was inserted into the right femoral artery (non-perfused leg) towards the
heart for direct access to oxygenated arterial blood from the descending aorta. The
cannula was connected to a re-sealing flexi-tube, passed through a peristaltic roller
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pump (Gilson Minipuls 3) and connected to a cannula that was inserted into the left
femoral artery (perfused leg) towards the foot. The cannula was passed well down
the femoral artery to close off unwanted side branches and restrict perfusion to the
muscle beds of interest. Other side branches were ligated. A T-junction inserted in
the blood flow line on the perfused hindlimb side of the pump was connected to a
pressure transducer (Argon CDXIII, Maxim Medical, USA) for measurement of
hindlimb perfusion pressure. A Windkessel pressure dampener was inserted into the
blood flow line to alleviate large pulsatile changes in pressure such as when the
pump was started.

Venous blood flow
A cannula was inserted into the left femoral vein of the perfused leg for passive
venous return to the heart and lungs for re-oxygenation via a cannula inserted in the
right jugular vein. Blood could be sampled from the arterial and venous lines
through in-line, thick walled, self-sealing silicone tubing.

When all cannulae were in place, passive re-flow was allowed from the right
femoral artery of the control hindlimb to the left femoral artery of the perfused
hindlimb. When all tubes had filled with the animal’s own blood (1minute) the
pump was engaged to provide a constant flow rate of 1ml/minute through the
hindlimb vasculature. During these setting up procedures the perfused hindlimb was
hypoxic for less than 2 minutes.
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Figure 2.1: Surgical cannulations redirect and via a pump, regulate arterial blood flow in the rat
s
from the control to the perfused hindlimb. Venous blood flow is returned passively to the heart via
the jugular vein for re-oxygenation by the lungs. Stimulator attached to electrode on sciatic nerve.
Gastrocnemius-plantaris-soleus muscle bundle attached to the force transducer.
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2.3.4 Calibration of Equipment
Pressure and force transducers were calibrated immediately prior to each muscle
perfusion.

Pressure

transducers

were

calibrated

against

a

mercury

sphygmomanometer in the range of 0-300mmHg. The force transducer was
calibrated using standard calibration weights in the range of 0-500g (HB Selby and
Co Ltd. Sydney. A multi-meter (Testmate 308) was used to read voltage output for
calibration of computer data acquisition.

2.3.5 Collection of blood pressure and twitch force
Data was referenced to ground and amplified (Onspot Australia). The data
acquisition software, Labview for Windows (National Instruments) was used to
collect both pressure and twitch force simultaneously during the perfusion trials at a
sampling rate of 200Hz. The data was displayed in real time and stored on computer
for later analysis.

2.3.6 Collection of blood samples and muscle tissue
Blood
Arterial and venous blood samples (400l) were collected via the re-sealing silicone
sections of the cannulae located on either side of the hindlimb. Of the 400l blood
sampled, 80-240l was presented to the laboratory blood gas and electrolyte
machine (BGElectrolytes, Instrumentation Laboratory, USA or ABL77 Radiometer,
Copenhagen) machines for measurement of PO2, PCO2, Na+, K+, pH and
haemoglobin. The remaining 150-200l was spun down on a bench top micro
centrifuge (Millipore Ltd), the plasma removed and frozen for later analysis of
metabolites. Erythrocytes from the plasma collections were re-suspended in an
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equal volume of saline and re-injected into the venous side of the perfusion. This
maintained haemoglobin levels above 12.5 g/100ml whole blood. Procurement of
the ABL77 allowed much smaller (~80l) and hence more frequent sampling to be
taken in subsequent experiments.

Muscle sampling
With the left limb perfused using the blood from the contralateral limb, skeletal
muscle in the right limb is left without any blood supply. Control muscle samples
(gastrocnemius, plantaris and soleus) were therefore taken from the right leg
immediately prior to the right femoral artery cannulation, to be used as within-animal
control tissue. The muscles were rapidly freeze-clamped using liquid nitrogen-cooled
tongs and stored for later analysis. At the completion of each experiment and while
the blood was still flowing, left leg (perfused) muscle samples (gastrocnemius,
plantaris, soleus) were rapidly extracted, freeze-clamped and stored for later analysis.
Additional muscle (deep posterior tibial, extensor digitorum longus, tibialis anterior)
from the perfused hindlimb were collected to establish total weight of the muscle
involved in the perfusion.

2.3.7 Biochemical Assays
Lactate
Previously stored plasma samples (50l aliquot) were allowed to thaw on ice. The
samples were analysed for lactate using a Lactate Kit purchased from Sigma
Diagnostics (Australia). The method was adapted to allow samples to be analysed on
the Cobas Mira (Roche Diagnostics, Australia). Absorbance was read at 340nm
wavelength and compared to prepared controls (Sigma Diagnostics, Australia).
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Pyruvate
If plasma pyruvate levels were required, the samples were analysed using a Pyruvate
Kit purchased from Sigma Diagnostics (Australia). The method was adapted to allow
samples to be analysed on the Cobas Mira (Roche Diagnostics, Australia).
Absorbance was read at 340nm wavelength and compared to prepared controls
(Sigma Diagnostics, Australia).

Glucose
Plasma samples were thawed and kept on ice. A duplicate aliquot (10l) of each
sample was placed in a micro-plate. Pre-made glucose standards were also included
on the plate at increasing concentrations of 1.25, 2.5, 5 10 and 20mM. 200l glucose
assay mixture (Roche Diagnostics, Australia) was added to each duplicate sample
and the colourimetric reaction allowed to proceed for 45minutes at room
temperature. The micro-plate was immediately read at A510nm. All samples were
compared to the standard curve.

Muscle Glycogen
The muscle samples were cut into approximately 100g sections. The exact weight
was recorded, and the sample placed immediately into poly-propylene tubes
containing 2ml potassium hydroxide (1M). The samples were then heated in a water
bath for 30minutes at 70°C to enhance digestion. The digested samples were allowed
to cool and 100l duplicate aliquot placed onto Whatman 3mm chromatography
paper (2cm x 2cm). Glycogen standard (2mg/ml) (Sigma Diagnostics, Australia) in
0, 20, 40, 60, 80, 100l aliquot were also placed onto Whatman 3mm
chromatography paper at this time. When the paper had dried, each sample
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(including standards) was placed into a clean tube and washed with 2 x 2ml ethanol
to remove free glucose. The remaining glycogen was then set to the paper with 1ml
acetate, which evaporated over a few hours.

Amyloglucosidase and 2ml glucose assay mixture (Roche Diagnostics, Australia)
were added to each duplicate sample and the colour-metric reaction allowed to
proceed for 45minutes at room temperature. The reaction was stopped when 200l
was taken out of the tubes and placed in a micro-plate to be read at A510nm. All
samples were compared to the standard curve.

2.3.8 General calculations
The following calculations were used in both this initial methods development
section and following experiments. Additional calculations are detailed as required.
Oxygen consumption
Oxygen consumption was assessed according to the Fick equation.
Oxygen consumption = (a – v O2 ) x ( hindlimb flow rate)
Weight of perfused muscle
Where:
•

O2 consumption is expressed in mol/gram/minute

•

(a – v)O2 is the arterial – venous oxygen difference expressed in mol.

•

Hindlimb flow rate is in ml/minute.

•

Weight of perfused muscle is in grams (wet weight).

Arterial and venous oxygen content (ml/100ml) were calculated using
Oxygen content = (1.39 x Hb x RBC saturation(%))+(0.003 x PO2)
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Where:
•

1.39 = millilitres oxygen bound to 1gram haemoglobin.

•

Hb is the blood haemoglobin concentration expressed in grams/100ml.

•

RBC saturation(%) is the percentage of the haemoglobin that is saturated with
oxygen calculated using measured PO2, PCO2 and pH for blood specific P50.

•

PO2 is the partial pressure of oxygen in whole blood expressed in mmHg

•

0.003 = constant for dissolved oxygen in plasma at 38oC.

Efficiency Index
For the purposes of this study, an index was derived to express the efficiency of
conversion of oxygen into contractile force and reported as grams twitch tension /
gram muscle tissue / mol oxygen consumed / minute.

2.3.9 Statistical Analysis
Results are expressed as meanSEM. All statistics were performed using Statistix
for Windows (USA). Data was analysed using either one-way or two-way ANOVA.
Comparison of means was performed post-hoc using Bonferroni’s Test. Alpha was
set as p<0.05.

2.3.10 Chemicals
Saline was made up in stock solution (0.9% NaCl) and used at room temperature.
Dextran (Sigma Diagnostics) was dissolved in the prepared saline (6% by weight) at
room temperature 24 hours prior to use. Potassium hydroxide (1M) (Fluka: Riedel-de
Haen) was dissolved in the prepared saline, analytical grade ethanol and acetate used
for the muscle glycogen assay were pre-purchased (Fluka: Riedel-de Haen) and
stored appropriately.
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2.4 Study design for assessment and validation of the auto-perfused rat hindlimb.
Two separate studies were conducted to assess and validate the method of hindlimb
auto-perfusion in the rat as a novel model for studying skeletal muscle oxygen
consumption and fatigue.
•

Study 1: Conducted to determine appropriate flow rates in the autoperfused rat hindlimb under conditions of rest.

•

Study 2: Conducted to determine flow rates required in the autoperfused rat hindlimb under conditions of muscle twitch contraction.

2.4.1 Study 1: Long term stability under resting conditions
Aims:
•

To assess the optimal flow rate required during resting conditions in the
auto-perfused rat hindlimb for optimal oxygen consumption and
perfusion pressure.

•

To establish optimal ventilation rates that result in controlled and stable
arterial oxygen levels for up 120minutes.

•

To assess regional blood distribution in the hindlimb for calculation of
muscle mass involved in perfusion and contraction.

Hypotheses:
•

Both oxygen consumption and hindlimb pressure will be a function of flow
rate.

•

The method will allow a majority of the controlled blood flow to perfuse the
lower hind limb especially the gastrocnemius-plantaris-soleus bundle used
for the study of muscle twitch contraction.
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•

Adequate oxygen delivery can be achieved at physiological (near in vivo)
flow rates.

•

Near in vivo perfusion pressures can be achieved with the near physiological
flow rates.

•

Ventilation will impact on the oxygen uptake in the hindlimb.

Eighteen male Wistar rats, 12-14 weeks old, were used to assess and validate
conditions of hindlimb auto-perfusion. Animals were prepared as outlined in the
general methodology section. All animals were perfused at a predetermined
hindlimb flow rate of 1ml/minute for 30minutes. This flow rate was based on
previous data that measured rat hindlimb blood flow in vivo under resting and
contracting conditions (Sapirstein et al., 1960). Baseline arterial and venous blood
samples (400l) were collected at the completion of the 30minutes perfusion. Of the
400l blood sampled, 240l was presented to the BGE for analysis of PO 2, PCO2,
Na+, K+, Cl-, pH and haemoglobin. The remaining 160l were spun down on a
bench top micro spinner, the plasma removed and frozen for later analysis of lactate
and pyruvate. The animals were then randomly allocated to three different groups
and perfused at one of three constant flow rates (1ml/minute (Group 1),
1.5ml/minute (Group 2) or 2ml/minute (Group 3) (n=6 per group)) for the
remaining 120minutes of perfusion. Flow rate was adjusted over a period of
3minutes to achieve the desired flow. Arterial and venous blood samples (400l)
were collected at 30 minutes intervals and analysed as for the baseline samples.
Hindlimb perfusion pressure and whole animal systemic blood pressure were
collected continually during the 120minutes (200Hz) using Labview Software.
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At the completion of the perfusion, foot volume was estimated based on water
displacement when emersed, skeletal muscles from the perfused hindlimb were
collected, freeze clamped and stored in marked aluminium foil at -80oC until further
analysis of muscle glycogen. Six animals were randomly selected from amongst the
three different groups for investigation of blood distribution within the hindlimb. At
the completion of the perfusion trial, prior to muscle being collected, 1ml of
concentrated Evan’s Blue dye was injected into the arterial perfusion line. The flow
was allowed to continue for a further 60sec. Once the pump was stopped, the
muscles of the entire hindlimb were extracted and carefully separated into stained
(perfused) and unstained (non-perfused) sections. These sections were weighed to
quantify the hindlimb blood flow distribution and mass of muscle tissue consuming
oxygen.

To determine the effects of inappropriate ventilation, a separate group of animals
(n=4), were evaluated during two 60minutes periods of constant resting perfusion at
different ventilation rates. In the first period, lung ventilation and hindlimb flow
were maintained at control levels and arterial and venous samples were collected
every 15 minutes. After 60minutes, ventilation rate was increased to 85 breaths /
minute for a further 60minutes while the breathing depth and hindlimb flow was
kept constant. Arterial and venous blood samples (240l) were collected every 15
minutes for analysis of PO2, PCO2, Na+, K+, Cl-, pH and haemoglobin.
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2.4.2 Study 2: Long term stability with skeletal muscle twitch contractions
Aims:
•

To assess the flow rate required during twitch contracting conditions in
the auto-perfused rat hindlimb for optimal oxygen consumption and
perfusion pressure.

•

To establish controlled and stable arterial oxygen levels for the period of
120minutes during bouts of twitch contraction

Hypotheses:
•

Both oxygen consumption and hindlimb pressure will be a function of flow rate

•

Fatigue rate of the stimulated muscle group will be a function of flow rate and
oxygen delivery

Six male Wistar rats, 12-14 weeks old, were used to validate and assess conditions
of hindlimb auto-perfusion over a time period of 120 minutes with three 10minute
bouts of stimulation. Animals were prepared as outlined in the general methodology
section (2.3.2-2.3.3) including preparation of the sciatic nerve for stimulation of the
gastrocnemius-plantaris-soleus muscle group. The hindlimbs of all animals were
perfused initially at the hindlimb flow rate of 1ml/minute. Baseline arterial and
venous blood samples (400l) were collected after 30minutes of control perfusion.
From the 400l blood sampled, 240l was used for analysis of PO2, PCO2, Na+, K+,
Cl-, pH and haemoglobin. The remaining 160l were spun down on a bench top
microcentrifuge, the plasma removed and frozen for later analysis of lactate and
pyruvate.
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Optimal muscle length and stimulation voltage
Optimal length for each muscle was defined as the muscle length at which the highest
isometric twitch force could be generated in response to an electrical stimulus at
supramaximal voltage (0.05ms duration, optimal voltage 6-15V) applied to the sciatic
nerve. Initially the muscle group was held at low tension, stimulated via the sciatic
nerve in 2volt increments and the force recorded. The length of the muscle group was
then gradually increased using micrometer adjustments and stimulated at each length
until the maximum twitch force was generated. This was carried out after the
30minutes of baseline perfusion. A recovery period of 2 minutes was allowed between
twitch contractions.

Twitch contractions of the gastrocnemius-plantaris-soleus muscle group were
investigated at 3 different flow rates in each animal (1ml/min, 1.5ml/min and
2ml/min). These flow rates were studied in random order. A recovery period of
30minutes was allowed between stimulation bouts. Flow rate was re-set at 1ml/min
during this recovery period. Repetitive stimulation (1Hz, 0.05ms) was delivered to
the sciatic nerve for 10minutes at the pre-determined optimal voltage. This pattern of
stimulation resulted in six hundred isometric twitch contractions over 10minutes.

Arterial and venous blood samples were taken at the end of each 30minute rest period
and then during the 10minutes stimulation bout, just prior to its completion. Hindlimb
perfusion pressure and twitch tension of the gastrocnemius-plantaris-soleus muscle
bundle were recorded continuously during the 10minute stimulation bouts using
Labview Software.
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From the twitch tension recorded (figure 2.2) the following analyses were made
•

Maximum twitch tension (PTmax) during the stimulation period

•

Peak twitch tension (PT) for one single twitch

•

Rise Time (Rt) (time from 10% peak tension to 90% peak tension)

•

Fall Time (Ft) (time from 90% peak tension to 10% peak tension)

•

Contraction Duration (time between 50% )

•

Peak rate of tension development and decline (± dT/dt max)

A
B

C

D

Figure 2.2: Sample trace of a twitch contraction. A: Peak twitch tension (PT). B:
Rise time from 10-90% PT (Rt) (ms). C: Fall time from 10-90% PT (Ft) ms. D:
Contraction duration at 50% PT (CD) (ms).

Immediately following the three stimulation protocols each animal was released from
the artificial ventilator and euthanised by rapid exsanguination. This process took
10-15 seconds.
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2.5 Results
2.5.1 Study 1
There was no significant difference for body weight between groups at the time of
the experiment (Table 2.2).

2.5.1.1 Blood flow distribution within the perfused hindlimb
The staining of muscles by Evans Blue dye clearly demonstrated the distribution of
blood through the hindlimb (figure 2.3). The muscles of the upper hindlimb
(quadriceps and hamstring groups) had minimal staining while all muscles in the
lower hindlimb (soleus, plantaris, gastrocnemius, deep tibial, tibialis anterior and
extensor digitorum longus) had a high proportion of staining (>85%).

2.5.1.2 Baseline
Table 2.2 details the spontaneous respiration rates and all the measurements taken
following 30minutes of perfusion at 1ml/min. For the majority of the data collected,
there was no significant difference between groups as described below. In addition
the table 2.2 combines all groups (n=18) to provide overall baseline conditions for
the autoperfused method of the rat hindlimb. Although there was some variation in
both the mean arterial blood pressure of the entire animal and hindlimb blood
pressure of the perfused leg, there were no significant differences either between
groups or within groups.

Minute ventilation was significantly higher in Group 3 during baseline collections.
Using a rodent ventilator, respiration was controlled by adjusting breathing rate and
depth. Breathing depth was simply a function of animal body weight (0.5ml/100g).
Consequently, Group 3 animals with the largest body weights had significantly
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higher minute ventilation compared to Group 1 and 2. There was no difference in
breathing rate.

The target for PaO2 (~100mmHg) and percentage saturation of red blood cells
(Group 1: 98.2 ± 0.4 Group 2: 97.3 ± 0.3 Group 3: 97.9 ± 0.4) was met in all groups
(table 2.2) The high level of binding combined with the haemoglobin levels resulted
in all groups achieving arterial oxygen content (CaO2) of greater than 20ml/100ml
whole blood.

Table 2.2 also lists the PaCO2, [HCO3-], and pH levels recorded after the 30minutes
of baseline flow. PaCO2 levels were a little more variable than PaO2 and resulted in
some slight difference in pH. Group 2 had a significantly lower pH compared to
Group 1 or 3 but all groups were in a satisfactory arterial range.

There were no significant differences between groups at baseline for any of the
measured venous blood gas or electrolytes. A significant drop in pH and PvO2 and
ultimately CvO2 resulted from the uptake of oxygen across the resting hindlimb.
The (a-v) O2 difference expressed in ml/100ml whole blood was 22% of the initial
CaO2. The calculated oxygen consumption using the Fick method is reported in
table 2.2. There was no significant difference between any of the groups relative to
the muscle mass perfused. Basal oxygen consumption was accompanied by
increased PvCO2, CvO2 , and lower venous pH compared to the arterial pH (table
2.2). There were no significant differences between groups for the arterial or venous
electrolytes sodium (mM) or potassium (mM).
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Table 2.2: Baseline conditions and measures for all groups taken after 30minutes
perfusion at a constant a flow rate of 1ml/minute prior to changes in flow rate.

Variable

Group 1

Group 2

Group 3

Mean

639 ± 42

637 ± 34

668 ± 16

667±17

Cabinet Temperature ( C)

32.3 ± 0.5

31.6 ± 0.3

32.6 ± 0.6

32.2±0.3

Rectal Temperature (oC)

36.1 ± 0.6

36.8 ± 0.5

37.0 ± 0.7

36.6±0.3

Mean Art. Pressure (mmHg)

106 ± 9

101 ± 2

93 ± 9

99±4

Hindlimb Perfusion Pressure (mmHg)

92 ± 10

108 ± 7

107 ± 6

102±5

Respiratory Rate (spontaneous)

65 ± 3

60 ± 3

60 ± 2

62±2

Respiratory Rate (Set) (b/min)

61 ± 2

58 ± 2

61 ± 2

60±1

Respiratory Depth (Set) (ml)

2.87 ± 0.23

3.04 ± 0.11

3.16 ± 0.12

3.02±0.1

Minute Ventilation (ml/min)

176 ± 20 b

176 ± 9b

193 ± 10 a

182±8

pH

7.44 ± 0.02b

7.39 ± 0.01a

7.44 ± 0.03b

7.42±0.01

PaO2 (mmHg)

102 ± 4

96 ± 5

103 ± 6

100±3

PaCO2 (mmHg)

28 ± 3a

36 ± 2b

33 ± 2b

33±1

Hb (grams/100ml)

15.3 ± 0.5

15.7 ± 0.5

15.3 ± 0.2

15.4±0.2

CaO2 (ml/100ml)

22.6 ± 0.7

22.9 ± 0.4

22.4 ± 0.3

22.6±0.3

[HCO3 ] mM

18.8 ± 1.4

22.1 ± 1.2

21.6 ± 1.5

20.8±0.8

Na+ (mM)

132 ± 2

133 ± 1

134 ± 1

133±1

K+ (mM)

5.5 ± 0.2

5.2 ± 0.5

5.2 ± 0.2

5.3±0.2

pH

7.28 ± 0.03

7.28 ± 0.03

7.32 ± 0.01

7.30±0.02

PvO2 (mmHg)

47 ± 2

49 ± 3

45 ± 4

47±2

PvCO2 (mmHg)

48 ± 5

53 ± 3

51 ± 4

51±2

Hb (grams/100ml)

16.3 ± 0.5

16.7 ± 0.3

16.2 ± 0.2

16.4±0.2

CvO2 (ml/100ml)

18.1 ± 0.5

17.8 ± 1.4

17.4 ± 1.0

17.2±0.3

[HCO3-] mM

22.7 ± 1.3

22.6 ± 3.2

26.6 ± 1.2

24.3±1.2

Na+ (mM)

137 ± 1

138 ± 1

138 ± 1

137±1

6.0 ± 0.3

6.0 ± 0.6

5.4 ± 0.2

5.5±0.2

Body Weight
o

Blood Pressure

Ventilation

Arterial Blood Gas and Electrolyte

-

Venous Blood Gas and Electrolyte

+

K (mM)
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Table 2.2 (cont): Baseline conditions and measures for all groups taken after
30minutes perfusion at a constant a flow rate of 1ml/minute prior to changes in flow
rate.
Variable

Group 1

Group 2

Group 3

Mean

(a-v) O2 (ml/100ml)

4.46 ± 0.55

5.08 ± 1.29

5.0 ± 1.05

4.8±0.5

VO2 (mol /min /gram)

0.29 ± 0.05

0.31 ± 0.07

0.33 ± 0.07

0.31±0.03

Arterial Lactate (mM)

1.7 ± 0.3

1.8 ± 0.3

1.8 ± 0.1

1.77±0.13

Venous Lactate (mM)

2.1 ± 0.1b

1.8 ± 0.1a

2.2 ± 0.1b

2.02±0.08

Arterial Pyruvate (mM)

0.16 ± 0.02

0.16 ± 0.02

0.15 ± 0.0

20.16±0.01

Venous Pyruvate (mM)

0.16 ± 0.01

0.18 ± 0.02

0.17 ± 0.01

0.17±0.01

Arterial Lactate / Pyruvate

10.5 ± 1.5

11.8 ± 2.8

12.9 ± 1.1

11.8±1.0

Venous Lactate / Pyruvate

13.4 ± 1.5

11.5 ± 2.7

12.9 ± 0.9

12.5±0.9

Oxygen Consumption

Blood Metabolites

Values displayed as Mean ± SEM. Values sharing a common letter a,b,c are not significantly
different (p<0.05). n=6. Mean column represents all animals n=18 per group

% of Muscle Stained

100

50

0

Sol Pl Gas DT TA EDL HS

Q LHL HL

Muscle Group
Figure 2.3: Hindlimb muscle groups stained with Evans Blue dye after 2 hours
perfusion. Evan’s Blue Dye was allowed to flow through the hindlimb for 60seconds
before the muscles were extracted. Sol: Soleus, Pl: Plantaris, Gas: Gastrocnemius, DT:
Deep Tibial, TA: Tibialis Anterior, EDL: Extensor Digitorum Longus, HS:
Hamstrings, Q: Quadriceps, LHL: Lower Hindlimb, HL: Hindlimb. n=6. Mean  SEM.
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2.5.1.3 Perfusion rates
The mean hindlimb perfusion pressure did not deviate from baseline pressure
during 120minutes of 1ml/minute blood flow (Group 1). In Group 2, increasing
flow rate (1.5ml/min) significantly increased the mean hindlimb perfusion pressure
compared to baseline and Group 1 (1ml/min) over the period 30-120minutes. In
Group 3 when the flow rate was increased to 2ml/min the mean hindlimb perfusion
pressure sustained over the period 30-120minutes was significantly higher than in
hindlimbs perfused at either 1ml/minute or 1.5ml/minute (figure 2.4). There was no
significant change in hindlimb (foot) volume after 120minutes perfusion with any
flow rate (figure 2.5).

Haemoglobin was maintained above 12g /100ml whole blood and oxygen carrying
capacity was sustained throughout the perfusion (figure 2.6A).The volume of blood
progressively sampled (12 x 400l) from the system and replaced by saline with resuspended red blood cells resulted in a corresponding fall in haemoglobin. Over 120
minutes, haemoglobin levels fell progressively and significantly independent of
flow rate from the start of perfusion (p<0.05).

Arterial PO2 (figure 2.6B) and red blood cell oxygen saturation were sustained
independently of hindlimb perfusion flow. As a result, all groups had satisfactory
CaO2 for the 120minutes. The venous PO2 (figure 2.6B) and red blood cell
saturation, together with the (a-v)O2 difference (figure 2.7A), and oxygen
consumption (figure 2.7B) remained constant over 120 minutes when blood flow
was kept at 1ml/minute. At higher hindlimb flow rates the venous PO2 (figure
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2.6A) and red blood cell saturation was higher resulting in a lower (a-v)O2
difference (figure 2.7A) and lower oxygen consumption (figure 2.7B).

Pressure (mmHg)

300

200

*

1ml/min
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Figure 2.4: Hindlimb perfusion pressure at baseline (1ml/min) and then at three
experimental flow rates (1, 1.5 and 2ml/minute) for 120minutes perfusion. * indicates
significant difference over the period 30-120minutes Group 3(2ml/min) v Group
2(1.5ml/min) p<0.05. ** indicates significant difference over the period 30-120minutes
group 3(2ml/min) v Group 1 (1ml/min) p<0.05 . 2-way ANOVA with Bonferroni correction
for comparison of individual group means differences. N= 6 per group. Mean  SEM.
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Figure 2.5: Foot volumes (ml of displaced water) of control hindlimb and
perfused hindlimb (pre and post) for the three experimental flow rates (1, 1.5
and 2ml/minute). N = 6 per group. Mean  SEM.
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Figure 2.6: A: Haemoglobin (grams / 100ml whole blood) and B: Arterial and venous
blood PO2 at baseline (1ml/min) and then at three experimental flow rates (1, 1.5 and
2ml/minute) for the remaining 120minutes perfusion. * p<0.05 120mins v baseline
(independent of flow) 1-way ANOVA. **p<0.05 Group 3 (2ml/min) v Group 1
(1ml/min) over the period 30-120mins. 2-way ANOVA. (Bonferroni correction for
comparison of group means. N = 6 per group. Mean  SEM.
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Figure 2.7: A: (Arterial – venous) oxygen difference (ml/100ml) and B: Oxygen
consumption (mol / gram / minute) at baseline (1ml/min) and then at three
experimental flow rates (1, 1.5 and 2ml/minute) for the remaining 120minutes
perfusion. * p<0.05 Group 1 (1ml/min) v Groups 2 (1.5ml/min) and Group 3
(2ml/min) over the period 30-120mins. 2-wayANOVA (Bonferroni correction for
comparison of individual group means). N = 6 per group. Mean  SEM.
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Blood lactate levels in arterial and venous blood did not exceed 2.5mM at any stage
of the 120 minutes perfusion period in any group. Additionally, there was no
significant difference in the concentration of arterial or venous blood pyruvate
between groups during the perfusion period (table 2.3). A common measurement of
adequate oxygen delivery is the ratio between blood lactate and pyruvate (Bonen et
al., 1994). In all groups, across 120minutes of perfusion, both arterial and venous
lactate / pyruvate ratios were maintained in the range 10-12 (figure 2.8A and B).

Muscle glycogen depletion in the gastrocnemius-plantaris-soleus group of muscles
was a function of flow (figure 2.9). The highest loss occurred at 2ml/min. This
corresponded to the lowest consumption of oxygen and the highest absolute venous
lactate efflux. No difference was seen in the blood concentration of sodium or
potassium over the 120 minutes of perfusion.

2.5.1.4 Hyperventilation
Figure 2.10A shows that PaO2 was maintained above 100mmHg under both normal
ventilation and hyperventilation conditions. However, the higher ventilation in the
second 60 minutes of resting perfusion significantly dropped the PaCO2 and PvCO2
(figure 2.10B). PvO2 did not fall below 50mmHg (figure 2.10A) and the red blood
cells maintained >80% saturation of oxygen in the venous blood. The significant
(p<0.05) impact on the oxygen consumption is shown in figure 2.11.
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Table 2.3: Arterial and venous blood lactate (mM), pyruvate (mM), Na+ (mM),
K+(mM), samples taken at baseline (1ml/min) and then at 30minutes intervals for a
further 120minutes of resting perfusion (1, 1.5, 2ml/min)
Time

Variable

Group 1

Group 2

Group 3

30 minutes

Arterial lactate

1.69 ± 0.33

1.78 ± 0.27

1.84 ± 0.08

pyruvate

0.16 ± 0.02

0.16 ± 0.02

0.15 ± 0.02

Na+

132 ± 2

133 ± 1

134 ± 1

K+

5.5 ± 0.2

5.2 ± 0.5

5.2 ±0.2

2.07 ± 0.11

1.78 ± 0.12

2.22 ± 0.14

pyruvate

0.16 ± 0.01

0.17 ± 0.02

0.17 ± 0.01

Na+

137 ± 1

136 ± 1

137 ± 1

K+

5.4 ± 0.4a

4.1 ± 0.3b

4.8 ±0.5ab

1.71 ± 0.29

1.45 ± 0.07

2.12 ± 0.35

pyruvate

0.16 ± 0.02

0.16 ± 0.02

0.16 ± 0.01

Na+

132 ± 2

134 ± 1

135 ± 1

K+

5.2 ± 0.2a

4.2 ± 0.3b

4.4 ± 0.1b

1.95 ± 0.2

1.66 ± 0.09

2.0 ± 0.25

pyruvate

0.19 ± 0.02

0.18 ± 0.02

0.21 ± 0.02

Na+

137 ± 1

136 ± 2

136 ± 1

K+

4.3 ± 0.2

3.9 ± 0.2

4.4 ± 0.4

1.67 ± 0.22

1.59 ± 0.11

2.03 ± 0.34

pyruvate

0.15 ± 0.02

0.16 ± 0.01

0.16 ± 0.01

Na+

135 ± 1

135 ± 1

136 ± 2

K+

4.8 ± 0.2 a

4.1 ± 0.2b

4.8 ± 0.3a

1.94 ± 0.12

1.64 ± 0.11

2.16 ± 0.39

pyruvate

0.17 ± 0.01

0.19 ± 0.03

0.20 ±0.01

Na+

137 ± 1

135 ± 1

135 ± 3

K+

4.5 ± 0.3

3.9 ± 0.3

4.6 ± 0.5

1.86 ± 0.27

1.58 ± 0.11

2.39 ± 0.41

pyruvate

0.15 ± 0.02

0.15 ± 0.02

0.16 ± 0.01

Na+

136 ± 1

137 ± 1

136 ± 2

K+

4.8 ± 0.3

4.2 ± 0.2

4.9 ± 0.7

2.16 ± 0.2

1.73 ± 0.13

2.5 ± 0.42

pyruvate

0.16 ± 0.01

0.16 ± 0.03

0.2 ± 0.02

Na+

138 ± 1

136 ± 1

137 ± 2

K+

4.7 ± 0.1a

4.0 ± 0.2b

4.8 ± 0.7ab

Venous lactate

60 minutes

Arterial lactate

Venous lactate

90 minutes

Arterial lactate

Venous lactate

120 minutes

Arterial lactate

Venous lactate

Values displayed as Mean ± SEM. Common letter a,b,c are not significantly different (p<0.05) .
N = 6 per group
49

Arterial Lactate /
Pyruvate

20
18
16
14
12
10
8
6
4
2
0

1ml/min
1.5ml/min
2ml/min

Baseline

30

60

90

120

Venous Lactate /
Pyruvate

Time (minutes)
20
18
16
14
12
10
8
6
4
2
0

1ml/min
1.5ml/min
2ml/min

Baseline

30

60

90

120

Time (minutes)
Figure 2.8: A: Arterial and B: Venous lactate / pyruvate ratio at baseline (1ml/min)
and then at three experimental flow rates (1, 1.5 and 2ml/minute) for the remaining
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120minutes perfusion. N = 6 per group. Mean  SEM.

150

1ml/min
1.5ml/min
2ml/min

*

100

*
*
50

0

Sol (Con)

Sol (P)

Pl (Con)

Pl (P)

Muscle Groups
Figure 2.9: Muscle glycogen concentration (mg/g(w.w)) in the soleus (Sol) and plantaris
(Pl) muscles of the control (Con) and perfused (P) hindlimb. * p<0.05 1-way ANOVA
within muscles (Bonferroni correction for comparison of means), control v perfused. N =
6 per group. Mean  SEM.
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Figure 2.10: A: Arterial and venous PO2 and B: PCO2 levels under conditions of
normal ventilation (Norm) and hyperventilation (Hyper). * p<0.05 1-way ANOVA for
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each time point. N=4 per group. Mean  SEM.
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Figure 2.11: Oxygen consumption (mol/gram/minute) of rat autoperfused hindlimb
under conditions of normal ventilation (Norm) and hyperventilation (Hyper). *
p>0.05 1-way ANOVA for each time point. . N=4 per group. Mean  SEM.
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2.5.2 Study 2
2.5.2.1 Baseline
As for the resting conditions in study 1, baseline recordings were collected after
30minutes of perfusion (1ml/minute). Table 2.4 shows ventilation was adequate to
successfully maintain PaO2, PaCO2, red blood cell saturation (98.8±0.2%) and CaO2.
The resulting (a-v) O2 (ml/100ml) and oxygen consumption (mol/ gram / minute)
were in the desired range for these conditions. Additionally, the mean perfusion
pressure at 1ml/min was in the normal physiological range (10314 mmHg).

2.5.2.2 Twitch contraction
Hindlimb perfusion pressure was a function of flow, independent of stimulation.
That is, at 1ml/minute there was no difference in mean hindlimb pressure with or
without muscle contraction (figure 2.12). However, as in resting metabolism,
hindlimb pressure increased significantly with higher flow rates. There was no
significant difference in the mean pressure during stimulation compared with the
same flow determined in experiment 1 at rest with no muscle contraction.
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c
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b
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Rest Flow
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Figure 2.12: Hindlimb perfusion pressure at 1, 1.5 and 2ml/minute (from study 1) and during
stimulation at the same three experimental flow rates (1, 1.5 and 2ml/minute). Different letters a,b
indicate p<0.05. 1-way ANOVA (Bonferroni correction for comparison of group means). N=6 per
group. Mean  SEM.
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Table 2.4: Baseline conditions taken after 30minutes perfusion and subsequent
recovery measures at a constant flow rate of 1ml/minute.
Variable

Baseline

Recovery1

Recovery2

103 ± 14

101 ± 13

131 ± 16

Respiratory Rate (spontaneous)

62 ±1

60 ±1

60 ±1

Respiratory Rate (Set) (b/min)

61 ±1

71 ± 4

74 ± 5

Respiratory Depth (Set) (ml)

2.55 ± 0.05

2.75 ± 0.13

2.75 ± 0.13

Minute Ventilation (ml/min)

155 ± 4a

197 ± 19b

203 ± 19b

pH

7.49 ± 0.03

7.47 ± 0.04

7.44 ± 0.05

PaO2 (mmHg)

91 ± 3

93 ± 5

94 ± 5

PaCO2 (mmHg)

29 ± 2

31 ± 3

30 ± 4

Hb (grams/100ml)

15.1 ± 0.3

13.9 ± 0.4

13.6 ± 0.5

CaO2 (ml/100ml)

19.87 ± 0.94

19.82 ± 0.53

18.19 ± 0.18

25.0 ± 1.71

22.3 ± 1.73

18.7 ± 2.66

pH

7.41 ± 0.03

7.39 ± 0.04

7.34 ± 0.06

PvO2 (mmHg)

41 ± 4

36 ± 2

38 ± 2

PvCO2 (mmHg)

44 ± 2

45 ± 3

42 ± 6

Hb (grams/100ml)

14.4 ± 0.7

14.4 ± 0.3

13.2 ± 0.1

CvO2 (ml/100ml)

15.32 ± 1.19a

13.38 ±0.87ab

12.86 ±0.21b

[HCO3-] mM

28.3 ± 2.9

25.3 ± 2.0

22.1 ± 2.9

(a-v)O2 (ml/100ml)

4.55 ± 0.82

6.54 ± 0.87

5.37 ± 0.15

VO2 (mol /min /gram)

0.36 ± 0.07a

0.53 ± 0.09b

0.42 ± 0.02ab

Blood Pressure
Hindlimb Pressure (mmHg)
Ventilation

Arterial Blood Gas and Electrolyte

-

[HCO3 ] mM
Venous Blood Gas and Electrolyte

Oxygen Consumption

Values displayed as Mean ± SEM. a, b, c indicate p<0.05 between baseline, recovery 1 and
recovery 2. N=6 per group.
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Figure 2.13 is a sample trace of twitch tension development when the
gastrocnemius-plantaris-soleus muscle bundle was stimulated. Isometric twitch
tension rose from the initial tension to the maximum tension (staircase) over
60seconds. Twitch tension was then maintained and / or declined gradually until
contraction was stopped at 10minutes. There was no difference in muscle maximum
isometric developed twitch tension at different flows rates (figure 2.14). However
initial and final developed tensions were both directly related to blood flow. That is,
a perfusion rate of 2ml/minute, the developed tension at the end of 10 minutes of
repeated stimulation was still greater than 80% of the peak tension but when
hindlimbs were perfused at 1ml/minute the tension declined to less than 60% of its
peak (figure 2.15).
B
A

C

600
Figure 2.13: Characteristic pattern of series of twitch contractions over a 10minute
period of contraction. A: Initial peak twitch tension at the commencement of sciatic nerve
stimulation. B: Maximum peak twitch tension (PTmax) occurs approximately 60-80
seconds after the initial stimulation of the sciatic nerve. C: Final peak twitch tension. The
fall to point C is heavily dependant on the frequency of stimulation.
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Figure 2.14: Twitch tension developed (grams tension /grams muscle tissue
w.w) in the autoperfused rat hindlimb across 10 minutes of muscle stimulation
(1Hz, 7-12V, 0.05ms) with different flow rates (1, 1.5 and 2ml/minute). N=6
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per group. Mean  SEM.
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Figure 2.15: Percentage of maximum peak twitch tension maintained
(grams tension / gram muscle tissue w.w) in the rat autoperfused hindlimb
after 10 minutes of muscle stimulation (1Hz, 7-12V, 0.05ms) with different
flow rates (1, 1.5 and 2ml/minute). Different letters a,b indicate p<0.05. 1way ANOVA (Bonferroni correction for comparison of group means) N=6
per group. Mean  SEM.
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Oxygen consumption measured at the completion of the 10minute stimulation was
significantly increased compared to resting conditions at all flow rates. The
hindlimbs tended to consume slightly less oxygen during twitch contractions if they
were perfused at a higher flow rate (figure 2.16), and the efficiency index

Oxygen Consumption
(mol/g/min)

(g/g/mol/minute) was greater (figure 2.17) at higher flow rates.
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Figure 2.16: Oxygen consumption (mol/g/minute) at 1, 1.5 and 2ml/minute (from study 1) and
during twitch stimulation at the same three experimental flow rates (1, 1.5 and 2ml/minute).
Different letters a,b indicate p<0.05 within resting conditions *p<0.05 between rest and exercise
(independent of flow). 1-way ANOVA. (Bonferroni correction for comparison of group means)
N=6 per group. Mean  SEM.
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Figure 2.17: Efficiency index (g/g/mol/min) in the autoperfused rat hindlimb after 10 minutes
of muscle twitch stimulation (1Hz, 7-12V, 0.05ms) with different flow rates (1, 1.5 and
2ml/minute). a,b,c p<0.05. (Bonferroni correction for comparison of group means) N=6 per
group. Mean  SEM.
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There was no difference in the concentration of arterial lactate over 120 minutes
irrespective of the experimental conditions. At all flow rates, venous blood lactate
increased significantly above resting conditions (p<0.05) when muscle was
stimulated. High flow rates were associated with a significantly larger venous efflux
of lactate (figure 2.18A). With 90 minutes of perfusion, including three bouts of
twitch contractions, stored glycogen was markedly reduced in all lower hindlimb
muscle groups (figure 2.18B) reflecting the use of this stored substrate as an energy
source for muscle contraction
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Figure 2.18: A: Lactate efflux (mmol/min) from the hindlimb at baseline (flow rate 1ml/minute),
during contraction at flow rates 1,1.5 and 2ml/minute and then recovery 1 and 2 (flow rate
1ml/minute) * p>0.05 1-way ANOVA v baseline (Bonferroni correction for comparison of
means). B: Muscle glycogen concentration in the Red Gastrocnemius (Gas (red)), White
Gastrocnemius (Gas (white)), Mixed Gastrocnemius (Gas (mixed)), soleus and plantaris muscles
of the control and perfused hindlimb. * p<0.05 1-way ANOVA within muscle types. N=6 per
group. Mean  SEM.
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2.6 Discussion
The present study has extended the auto-perfused dog hindlimb into the smaller
laboratory rat. The auto-perfused rat hindlimb showed stability over more than
2hours, which allowed sufficient oxygen delivery to support twitch contraction
bouts. Delivery of oxygen to the muscle core remains a limitation of both in vitro and
in situ studies as previously reported (Bonen et al., 1994). Good staining of the
contracting muscle bundle indicated that blood delivery was good and the lack of
oedema, which would also compromise tissue perfusion suggests a superiority of the
auto-perfusion technique over other perfusates.

Muscle Perfusion
It is appropriate for studies of metabolism that the relative proportion of the perfused
muscle that is contracting is known. Stimulation of the muscles of perfused
hindlimbs via the sciatic nerve, results in 15-30% (Dora et al., 1994; Rolfe et al.,
1999) to 82% (Spriet et al., 1985; Spreit et al., 1986) of the perfused muscle mass
contracting. At this stage there is no clear explanation for such large variations.
Cannulation of the popliteal artery and vein as well as being difficult has not shown
any improvement as co-lateral circulation to the non-contracting upper limb occurs
making lower limb metabolism quantitatively inaccurate (Dora et al., 1994). In the
present study, injection of Evan’s Blue dye, demonstrated that the method of
cannulation and careful ligation, resulted in the investigative blood flow being
mainly restricted to lower leg of the rat. The results indicate that there was minimal
loss to the quadriceps muscle bundles and moderate loss to hamstring group. Sciatic
nerve isolation and stimulation as previously described by (Gorski et al., 1986), and
carried out according to the methods above, resulted in the stimulation of distal
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muscles, namely the gastrocnemius-plantaris-soleus muscle bundle and these
represented 70% of the perfused muscle mass used to calculate oxygen consumption.
Therefore, our method demonstrated an adequate contraction to perfusion ratio.

Hindlimb blood flow
When the rat hindlimb was perfused with its own blood, the flow required to
maintain good oxygenation, perfusion pressure and sustain twitch contractions was
significantly lower than previously used in the in situ preparations (table 2.1). The
flow rates used in these studies are highly variable, ranging from 2-20ml/min, and
differ according to the make up of the perfusate (cell v cell free) and size of the
animal. Perfusion pressure was always low when in situ flow was less than
6ml/minute and was rarely above 80mmHg. The auto-perfusion method achieved
good oxygenation at flow rates similar to the in vivo flow rates in the rat hindlimb
under resting and contracting conditions (Sapirstein et al., 1960). As a consequence
of the very high perfusion rates, tissue oedema and hindlimb swelling are a major
problem with the in situ preparations. The present investigation found no evidence of
foot swelling over 120mintes and therefore concluded that the stability of the autoperfusion is a clear advantage over previous methods.

As indicated in the results from study 1, at 1ml/minute, PO2 fell towards 40mmHg
and resulted in an (a-v)O2 difference of ~5ml/100ml whole blood (or ~25% of
arterial oxygen content). When hindlimb flow was increased to 1.5ml/minute and
2ml/minute in Groups 2 and 3, the PO2 remained higher on the venous side of the
hindlimb and impacted on the (a-v)O2 and oxygen consumption. There are several
possible explanations as to why this occurred, but the results demonstrated that under
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resting conditions in the auto-perfused rat hindlimb, 1ml/minute is substantial blood
flow for the requirement of resting metabolism.

i)

Red blood cell transit time

It has been clearly shown in the pulmonary system, that large cardiac outputs and
resulting drop in red blood cell transit time effects oxygen diffusion and red blood
cell loading and unloading (Powers and Williams, 1987). It is a possibility that in the
current investigation, when the hindlimb flow is increased to 1.5ml/minute and
2ml/minute, red blood cell transit time also drops and unloading of oxygen is limited
at the muscle cell. In resting conditions there are no other stimuli to enhance this
unloading, known as the Bohr effect, which include changes in muscle temperature,
pH, CO2 and 2,3 diphosphoglyceric acid that are all effected by muscle activity
(Rowell and Shepard, 1996).

ii)

Nutrient and non-nutrient vascular pathways

A second possibility is that at higher flow rates, excess blood is passed through the
muscle in vascular beds that are associated with low oxygen consuming tissue. The
possibility, of nutrient and non-nutrient pathways in muscle was first suggested by
(Barlow et al., 1959, 1961). The concept has gained increased attention again in latter
years, with the majority of work carried out in the in situ rat hindlimb perfusion
(mostly cell free) (Clark et al., 2000). If the concept holds true, then with increased
flow, excess blood may transit the low oxygen consuming pathways and result in a
venous admixture that dampens the evidence of oxygen consumption in the muscle
tissue. Our laboratory is currently investigating the concept of nutrient and nonnutrient pathways in skeletal muscle using the contracting auto-perfused hindlimb
developed for this thesis.
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In study 2 of the present investigation, the muscle was stimulated under twitch
conditions for 10minutes at the same flow rates investigated at rest. Once again, in
agreement with the findings in vivo (Sapirstein et al., 1960), 2ml/minute is close to
the highest blood flow required under these conditions of twitch stimulation when
perfused with its own blood. Oxygen consumption during muscle stimulation rose
significantly at all flow rates compared to resting values in study 1. The highest
oxygen consumption was achieved at 1ml/minute, similar to the resting conditions.
However, while there was no difference in maximum twitch tension both final
tension and the efficiency of oxygen use were higher at the end of the exercise bout
conducted while the hindlimb was perfused at 2ml/minute compared to 1ml/minute
and 1.5ml/minute. Therefore, 2ml/minute would appear to be the optimum hindlimb
perfusion rate to support prolonged contraction bouts.

Perfusion Pressure and Vascular Tone
A further advantage of auto-perfusion is the sustained hindlimb perfusion pressure.
The mean values (~100mmHg) at rest were very similar to the systemic values
recorded simultaneously at the carotid artery. This is a good indication of the
presence of vascular tone in the hindlimb and contrasts with the predominance of
perfusion pressure <<80mmHg in situ. The inherent vascular tone would also allow
this method to be used to investigate vascular resistance, and more importantly the
ability to vasodilate from resting perfusion. Present work in our laboratory aims to
investigate the responses of the rat autoperfused hindlimb to a range of vasodilator
drugs such as isoproterenol. This has not been possible in the in situ method that
display very low perfusion pressures (<50mmHg). Hindlimb vasodilatory responses
have been only induced in the presence of vasoconstriction using exogenous agents
such as adrenaline (Ye et al., 1990). It is of further interest to our laboratory
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(although not this thesis) to investigate the potential role of vasodilators in the
nutritive and non-nutritive hypothesis using the auto-perfused rat hindlimb because
the vast majority of work has been carried out in the in situ model. Since the
hypothesis purports to account for control of blood flow to metabolically active
tissue and metabolic vascular control is most likely mediated through local
vasodilation, the auto-perfused hindlimb model may provide more definitive
evidence.

Ventilation
Artificial ventilation was primarily controlled to maintain a high and constant level
of arterial oxygen. In addition to this role, there was also the importance of
maintaining an adequate acid base balance for the entire perfusion period. Changes
in acid base balance can have a strong influence on the oxyhaemoglobin curve and
unloading of oxygen at the muscle (Wasserman, 1994). In animals with induced
hyperventilation, PaO2 and saturation of red blood cells were maintained at
100mmHg and 98% respectively. However, hyperventilation significantly dropped
the PaCO2 and PvCO2 (CO2 was “blown off”) during resting perfusion. A resulting
shift to alkaline conditions will impact on the unloading of oxygen from the red
blood cell at the muscle bed (Rowell and Shepard, 1996). This was demonstrated by
the significant reduction in resting oxygen consumption in the present study thought
to be a shift in the oxyhaemoglobin dissociation curve and enhanced oxygen
binding during hyperventilation. Therefore, in addition to the primary role of
delivering a high level of arterial oxygen, the importance of maintaining an
adequate acid base balance for the entire perfusion period was established.
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Oxygen Consumption
A clear advantage of this new hindlimb perfusion model in the rat is the oxygen
delivery to the muscle tissue and resulting consumption (results compared to table
2.1). The ability to and the advantage of carrying oxygen in the red blood cell is
obvious when results are compared to the cell free perfusate, and still hold true
compared to using perfusate with either human or bovine erythrocytes included.
(Rennie and Holloszy, 1977), have demonstrated that perfusion with aged human
erythrocytes was inadequate to maintain tissue oxygenation both at rest and during
stimulation. The age, fragility, size (90um3) and large volumes required, does not
make human erythrocytes a viable method. Rejuvenated bovine erythrocytes
improve the situation a little in being smaller in size (60um3) and hence do not have
to elongate as much in the capillary, however the system still requires significantly
higher flow rates than experienced in vivo. The increased ability to carry and offload oxygen at the muscle cell (at lower flow rates) has become an important part of
using the autoperfused method to study alterations in oxygen use via dietary
manipulation of n-3 PUFA. In the current thesis, there was a deliberate attempt to
maintain haematocrit at or above 40% in all animals via re-injection of suspended
red cells that had been previously sampled and used for blood analysis. The
importance of carrying oxygen in the red blood cell is highlighted by studies in
heart and skeletal muscle that do not maintain adequate haematocrit (Bergman et
al., 1979; Gorski et al., 1986). In heart when haematocrit was increased from 25%
to 40%, oxygen uptake increased by 60% without any increase in coronary flow
(Bergman et al., 1979). Additionally, in skeletal muscle, when haematocrit was
maintained at 30%, oxygen uptake could not be significantly increased with twitch
contractions above 1Hz. However, when haematocrit was increased to 40%, oxygen

63

consumption was increased in response to isometric tetanus contractions (Gorski et
al., 1986). These studies support the current thesis in perfusing the hindlimb with
the animal’s own blood and the minimum level of red blood cells required.

Tension development
The stimulation parameters used in the hindlimb perfusion model were representative
twitch contractions in the literature (Fitts and Holloszy, 1976; Hood et al., 1986;
Metzger and Fitts, 1987; Hogan et al., 1996; Ameredes et al., 1998). The pattern of
isometric twitch tension development was characteristic of twitch stimulation (15Hz). That is, the tension increase in peak twitch tension to the maximum levels
occurs in the first 60seconds of stimulation and is referred to as the staircase effect
and has been demonstrated in human muscle (Solmic et al. 1968). The potentiation of
isometric twitch tension during the staircase has been linked to the extent of myosin
light chain phosphorylation in skeletal muscle (Klug et al. 1982). The auto-perfusion
(in particular at 1ml/minute) and good oxygen delivery contributed to the sustained
peak twitch tension over three 10minute periods of muscle contraction. In
comparison, the in vitro preparation can result in very rapid fatigue as seen by Ayre
and Hulbert (1996b) and more than often the in situ hindlimb preparation has not
involved muscle contraction (table 2.1). In conclusion, auto-perfused rat hindlimb as
set up in the present investigation has resulted in lower blood flow requirements,
increased vascular responses (resting tone) and improved oxygen delivery and
consumption when compared to alternative hindlimb perfusion methods as reported
in the literature (table 2.1). Importantly, it has been found to be supportive of
repetitive twitch contractions and viable for 2hours or more. This method will play
an integral part of the continuing investigation of n-3 PUFA and their impact on
physiological

function

and
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active

metabolism.

Chapter 3
Dietary effects on skeletal muscle membrane
composition and function
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3.1 Introduction
Dietary fatty acids have been shown to have profound effects on the structural
membrane lipids across a wide variety of excitable tissues including nervous,
cardiac and skeletal muscle. In turn the membrane composition is strongly linked to
a number of alterations in cellular function, including ion flux, respiratory electron
transport, membrane bound enzyme activity, receptor function and eicosanoid
synthesis (Hulbert and Else 1999). Cardiac tissue fatty acid composition in animals
strongly reflects the type of fatty acids in the diet (McLennan et al. 1988; Charnock
et al. 1992; McLennan et al. 1996; Pepe and McLennan 1996). In particular, it
avidly accumulates n-3 PUFA, particularly DHA, well above the circulating levels.
Skeletal muscle shares this property of sensitive membrane fatty acid composition
changes with diet intervention (Charnock et al. 1992; Ayre and Hulbert 1996a) and
more recently it has been shown to also be influenced by training status,
independent of diet (Helge et al. 1999; Helge et al. 2001). There is some evidence
that the uptake of n-3 PUFA may be fibre type specific (Kriketos et al. 1995; Pan et
al. 1995). That is, type I and type IIa are shown to have increased levels of PUFA,
especially n-3 fatty acids, compared with type IIb, and this may be related to the
increased oxidative capacity seen in type I and IIa muscle cells. Additionally,
increased body leanness and insulin sensitivity are associated with increased muscle
oxidative capacity and membrane fatty acid unsaturation (Kriketos et al. 1996).

Increased dietary PUFA have been demonstrated to enhance mechanical
performance of the heart from the marmoset monkey (Charnock et al. 1987;
McLennan et al. 1989) and modulate myocardial oxygen consumption in the rat
(Pepe and McLennan 2002). A link between skeletal muscle phospholipid content
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and function related to oxygen use, is suggested by the effects seen in the heart on
oxygen modulation (Pepe and McLennan 2002) and the observations already made
in relation to membrane fatty acid content and skeletal muscle function (as
mentioned above). Skeletal muscle fatigue is multi-factorial (Westerblad et al.
1991; Fitts and Metzger 1993; Westerblad et al. 1998), giving rise to a number of
possible sites or mechanisms by which specific fatty acid incorporation may affect
function.

The cental theme of this thesis is that skeletal muscle membrane composition will
directly affect muscle function to increase twitch tension fatigue resistance during
physiologically relevant low frequency stimulation. The auto-perfused rat hindlimb
established in Chapter 2 was used to investigate the effects of dietary n-3 PUFA on
skeletal muscle twitch tension. A repeat bout stimulus was chosen to investigate both
short-term twitch tension fatigue during repeated contraction periods (10mins) and
contractile recovery between stimulation bouts.

3.2 Aims and Hypotheses
Specifically, this part of the project aims to;
•

Confirm the difference in skeletal muscle membrane fatty acid
composition between animals fed a diet containing saturated fat (SF),
high safflower oil (n-6) or tuna fish oil (n-3).

•

Determine if there is a difference in skeletal muscle membrane fatty acid
composition between red (high oxidative) and white (high glycolytic)
portions of skeletal muscle after dietary intervention.

•

Compare changes in skeletal muscle membrane fatty acid composition to
those already seen in cardiac tissue.
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•

Investigate the effects of diet on twitch tension development, oxygen
consumption, efficiency of oxygen use (efficiency index) and muscle
metabolism.

•

Investigate the effects of diet on rest-recovery of twitch tension and
oxygen consumption that may impact on twitch tension fatigue
development in the second and subsequent contraction bouts.

It is hypothesised that;
•

The membrane composition of skeletal muscle is influenced by the fatty
acid composition of the diet.

•

There is a similarity between the levels of n-3 PUFA found in skeletal
muscle and those extensively reported for cardiac tissue.

•

Dietary n-3 PUFA will improve the tension development of the
stimulated muscle for a given amount of oxygen consumed.

•

An increased efficiency of oxygen use will be reflected in reduced
twitch tension fatigue and improved contractile recovery.

3.3 Methods
3.3.1 Diet composition
The diets all contained 10% fat by weight. The total levels of polyunsaturation in the
n-6 and n-3 PUFA diets were balanced to allow distinction between specific fatty
acids. Balance of PUFA was achieved by having a 30/70 ratio of the total fat content
derived from safflower oil and olive oil respectively in the n-6 group and a 50/50
ratio of the total fat content derived from tuna fish oil (Clover Corporation) and olive
oil respectively in the n-3 group. All components of the diet were carefully weighed,
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combined and stored at –20oC. The specific composition for the saturated fat (SF),
safflower oil (n-6), and tuna fish oil (n-3) diets are shown in table 3.1. The diet was
based on the American Institute of Nutrition AIN-93M diet (Reeves, 1997) with an
increase in fat from 4% to 10% and an equal reduction in cornstarch. Its ability to
provide physiological outcomes is supported in the literature (McLennan, 2001).
Table 3.1: Diet composition of saturated fat (SF), safflower oil (n-6), and tuna fish
oil (n-3) groups.
Saturated Fat

Safflower Oil

Tuna Fish Oil

Cornflower

60.0

60.0

60.0

Sugar

10.0

10.0

10.0

Casein

9.0

9.0

9.0

Fibre

5.0

5.0

5.0

And Vitamins

1.0

1.0

1.0

Gelatine

5.0

5.0

5.0

Fat

10.0

10.0

10.0

Beef Tallow

10.0

0

0

Olive Oil

0

7.0

5.0

Safflower Oil

0

3.0

0

Tuna Fish Oil

0

0

5.0

Minerals

Values are shown as grams/100g dry weight of whole diet. The total fat was 10% by weight for
each group. The source of total fat is also shown in grams/100g whole diet.

3.3.2 Animals and study design
Eighteen male Wistar rats were used for this part of the study (6 per dietary
intervention). Experiments were assessed and approved by the Animal Ethics
Committee from the University of Wollongong. Experimental animals were housed
two per cage in the University of Wollongong’s animal facility with a room
temperature maintained at 23oC-25oC and a 12hour light-dark cycle.
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Animals were fed a wash-out diet containing olive oil for 14 days to allow for
variable fatty acid composition of commercial rat feed and standardise muscle
membrane fatty acid composition (McLennan, 2001). They were then randomised
into three groups and fed the saturated fat (SF), safflower oil (n-6) or the tuna fish
oil (n-3) diet for 8weeks, ad lib. Fresh food was provided twice per week and the
daily consumption (g) was estimated by weighing the remainder from the previous
feeding. Animal were weighed weekly.
3.3.3 Surgical preparation for muscle stimulation, artificial ventilation and
hindlimb perfusion
Rats were prepared as described in Chapter 2. Rats were anaesthetised (sodium
pentobarbital, 6mg/100g i.p.) throughout all procedures with anaesthesia maintained
by supplementary sodium pentobarbital, (2mg/100g i.p.), as required during the
procedure. Experiments were performed in a heated perspex chamber and animal
body temperature was maintained with the aid of a heating lamp placed above the
rat. The surgical and experimental procedures (including blood and muscle tissue
sampling) were as outlined specifically in Chapter 2 of this thesis. Optimal resting
length of the stimulated gastrocnemius-plantaris-soleus muscle bundle and optimal
voltage were set as described earlier. There was no systemic blood pressure taken at
the carotid artery for this investigation.

3.3.4 Hindlimb perfusion and stimulation protocol
As previously described, all hindlimbs were perfused for 30minutes at 1ml/minute to
allow perfusion pressure to reach steady state (~100mmHg). Based on the results
from Chapter 2, three stimulation bouts (1Hz, 7-12V, 0.05ms, 10minutes) were
delivered to the sciatic nerve separated by 30minutes muscle recovery. The flow rate
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was progressively increased from 1 ml/minute (exercise 1) to 1.5ml/minute (exercise
2) to 2ml/minute (exercise 3) for successive stimulation periods and returned to
1ml/minute during the recovery periods. The twitch stimulation protocol was used to
investigate fatigue during bouts of 10minutes and recovery between bouts.

Prior to the cannulation and perfusion of the stimulated hindlimb, control muscle
samples (from the contralateral leg) were quickly separated, dissected, freeze
clamped with pre-cooled tongs in liquid nitrogen, and stored at –80oC for latter
analysis of muscle glycogen as described previously in Chapter 2. Baseline arterial
and venous blood samples (400l) were drawn after 30minute of the initial perfusion
(flow = 1ml/minute). The flow rate was then maintained at 1m/minute and
stimulation of the gastrocnemius-plantaris-soleus muscle bundle commenced for
10minutes. Arterial and venous samples were collected between the ninth and tenth
minute of the stimulation bout. The blood sample was presented immediately to the
blood gas analyser for measurement of PO2, PCO2, pH, Hct, Na+, K+, and Cl(240l). The remainder was spun down and the plasma removed for later analysis of
blood glucose and blood lactate as previously described in Chapter 2. The red blood
cells were re-suspended in saline (6% dextran) and re-injected into the venous side of
the hindlimb as described in Chapter 2.

At the completion of the third stimulation bout, the muscles of the stimulated
hindlimb were quickly separated, dissected, freeze clamped with pre-cooled tongs in
liquid nitrogen, and stored at –80oC for latter analysis of muscle glycogen as
described previously in Chapter 2. The time line of events (including tissue
sampling) and sampling of tissue are summarised in figure 3.1.
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Name

Re-perfusion

Exercise 1

Recovery 1

Exercise 2

Recovery 2

Exercise 3

Time

30mins

10mins

30mins

10mins

30mins

10mins

Flow

1ml/min

1ml/min

1ml/min

1.5ml/min

1ml/min

2ml/min

Stimulation

1Hz, 7-12V

1Hz, 7-12V

1Hz, 7-12V

Figure 3.1: Time line of events. Flow was delivered in the same order for each hindlimb perfusion.  Arterial blood sample (400l).
blood sample (400l).

Control muscle samples excised and freeze clamped.
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Venous

Stimulated muscle samples excised and freeze clamped.

3.3.5 Skeletal muscle membrane phospholipid fatty acid analysis
At the time of hindlimb perfusion the quadriceps muscle was rapidly extracted. The
red and white portions of the quadriceps were quickly separated and freeze clamped
using pre-cooled tongs, place in liquid nitrogen and finally stored at –80oC for later
analysis.

The method of membrane fatty acid analysis has been described by Pan and Storlien
(1993). The method involves, total lipid extraction, phospholipid separation,
methylation of phospholipid fatty acids and gas chromatography analysis as
described in detail below.

Lipid extraction
All solvents were freshly prepared at the time of analysis and contained 0.01% w/v
butylated hydroxy toluene. Tissues (100-150mg) were weighed on ice and
homogenised in 6ml chloroform:methanol (2:1) with a further 2 x 6ml washes. The
homogenates were transferred to screw cap pyrex tubes and rotated overnight to
separate lipid from protein. The next morning, 2ml H2SO4 1M was added, the
samples shaken then spun at 1000rpm for 10minutes. The bottom layer was
transferred to another screw cap tube and a further 2ml H2SO4 1M added, tubes
shook and spun at 1000rpm for 10minutes once again. The top phase was then taken
off, discarded, being careful not to disturb bottom phase. A small amount of sodium
hydrosulphite was added, tubes shaken, and the solution filtered through glass wool.
Samples could be stored at this stage at –20oC in plain glass tube if required.
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Phospholipid separation
The samples were dried down under nitrogen and redissolved in 5ml hexane. At this
stage the samples were transferred to silica seppack columns (Waters) and washed
with a further 5ml hexane. The phospholipids were then eluted using 3 x 10ml
methanol, dried under nitrogen and combined in 15ml screw cap tubes. It was
possible to store the samples at this stage at –20oC in a plain glass tube if required.

Methylation of phospholipid fatty acids
The eluted phospholipids were dried under nitrogen and 1ml 14% boron trifluoride in
methanol was added. The tubes were capped tightly, vortexed and heated at 85oC for
1hour (heating block). At the completion of 60 minutes the tubes were quickly
cooled and 3ml distilled water added. The methylated fatty acids were then extracted
using 5 x 2ml additions of hexane, which was then dried by adding a small amount of
sodium hydrosulphite, tubes shaken and filtered.

Purification of methylated fatty acids on florisil
The methylated fatty acids were transferred to florisil seppack columns (Waters) and
washed with 5ml hexane. Diethyl Ether (5%) in petroleum spirit (7ml) was used to
elute the purified methylated fatty acids. Finally the samples were concentrated
(100ul) under nitrogen and transferred to auto-sampler vials. The samples could be
stored at this stage at –20oC until gas chromatography analysis.

Gas chromatography analysis
The relative proportions of fatty acids incorporated into the skeletal muscle cell
membranes were analysed using a Shimadzu GC-17A gas chromatograph with 30m
74

x 0.25mm internal diameter capillary column. Individual fatty acids were identified
by comparison with known standards. The running conditions were as follows.
Injector Temperature: 2600C; Detector Temperature: 2600C; Carrier Gas: Ultra-high
purity hydrogen; Column Flow: 1.54ml/min. The temperature program was set at:
Initial: 185oC; Ramp function: 5oC/minute for 15 minutes; Maintain: 260oC for
8minutes; Total run: 23minutes.

3.3.6 Statistical Analysis
Data is expressed as mean  SEM. Data was analysed by one or two-way analysis
of variance (ANOVA) with individual group means compared using Bonferroni’s
post hoc analysis to indicate significant difference.  was set at p<0.05.

3.3.7 Chemicals
All chemicals previously used in this thesis are list in the equivalent section of the
chapter they first appeared. New chemicals relevant to the current chapter include:
Butylated hydroxy toluene (Sigma-Aldrich) was made up to 0.01% w/v in saline.
Analytical grade chloroform (Fluka; Riedel-deHaen) and methanol (Fluka; RiedeldeHaen) were mixed in the ratio of (2:1). Sulphuric acid (H2SO4) (Sigma-Aldrich)
was bought in concentrate and diluted to 1M. Sodium hydrosulphite (SigmaAldrich) was bought as a dry powder and stored appropriately. Analytical grade
hexane (company) was bought and stored appropriately. Boron trifluoride (SigmaAldrich) was bought as (14%) in methanol and stored appropriately at 0-4oC.
Diethyl Ether (Fluka; Riedel-deHaen) was mixed to 5% with in petroleum spirit
(Fluka; Riedel-deHaen).
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3.4 Results
3.4.1 Food consumption and body weight
Data related to food consumption and body weight include animals from all dietary
studies in this thesis (n = 18 per diet group). Food consumption is represented as
grams consumed / 100grams body weight / day.

There was no significant

difference in food consumed between dietary groups throughout the 8 weeks
feeding period (table 3.2). There was no significant difference in body weight
between any dietary groups before or after 8 weeks diet (figure 3.2A). The change
in body weight over the 8 weeks was greatest in the n-6 group and the least in the n3 group (figure 3.2B).

Table 3.2: Food consumption over 8 weeks for saturated fat, safflower oil, and tuna
fish oil groups.

Saturated Fat

Safflower Oil

Tuna Fish Oil

Week 1

7.140.15

7.250.12

7.210.16

Week 2

6.910.18

6.710.15

6.910.15

Week 3

6.770.20

6.560.22

6.580.15

Week 4

6.620.16

6.600.25

6.620.16

Week 5

7.130.23

6.340.20

6.740.16

Week 6

6.820.14

6.510.17

6.490.11

Week 7

6.640.20

6.710.22

6.380.13

Week 8

6.770.17

6.790.22

6.660.14

Weekly Mean

6.850.12

6.680.15

6.700.11

Values displayed as mean  SEM. Food consumption reported as grams food / 100grams body
weight / day.
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Body weight (grams)

A

500

SF
n-6
n-3

480
460
440
420
400
0

1

2

3

4

5

6

7

8

Weeks

Change in Body W eight
(grams)

B
50

SF
n-6
n-3

40
30
20
10
0

1

2

3

4

5

6

7

8

Weeks
Figure 3.2: A: Body weight in grams and B: Change in body weight in grams for saturated
fat (SF), safflower oil (n-6) and tuna fish oil (n-3) from baseline at weekly intervals during 8
weeks feeding. This represents all animals fed and used for hindlimb perfusions in this
thesis. n=18 per diet group. Mean  SEM.
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3.4.2 Skeletal muscle membrane fatty acids
Fish oil feeding resulted in large membrane fatty acid differences when compared to
SF and n-6 groups. Table 3.3 shows that for both red and white portions of skeletal
muscle the n-3 group had significantly lower 18:2n-6c (linoleic acid), 20:3n-6
(linolenic acid), 20:4n-6 (arachidonic acid) and total n-6 (p<0.05) and significantly
higher 20:5n-3 (eicosapentaenoic acid), 22:6n-3 (docosahexaenoic acid) (figure
3.3A), and total n-3 (figure 3.3B) (p<0.05). This was reflected by the significantly
higher n-3/n-6 ration for the n-3 group compared to SF and n-6 (figure 3.3C)
(p<0.05). These results were achieved without any significant changes between
groups in either the total saturated fatty acids or the total polyunsaturated fatty
acids.

There were no significant differences that could be attributed to red or white portion
of muscle for these particular diets. This also included total PUFA, n-3 and n-6.
Although not significant, there were some apparent differences in the fatty acid 16:0
(palmitic acid) between red and white portions of muscle for all groups. In all cases
the red portion of muscle was lower for 16:0 than the white.
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Table 3.3: Skeletal muscle (red and white) fatty acid profiles for SF, n-6 and n-3
groups after 8 weeks diet.

SF

n-6

n-3

Red

White

Red

White

Red

White

14:0

0.250.03

0.260.02

0.160.04

0.180.02

0.270.04

0.240.01

16:0

17.383.76

20.630.72

18.691.95

21.150.52

19.174.21

22.970.83

18:0

11.542.34

11.930.36

13.441.57

12.100.49

12.820.68

11.210.45

18:1n-9 8.642.17

9.601.25

8.861.35

7.420.78

8.290.55

7.260.32

18:2n-6c13.753.04

14.590.32

14.801.58

15.060.19

10.060.67a

9.630.7

20:3n-6 0.880.08

2.651.62

3.242.81

0.750.06

0.510.05

0.500.05

20:4n-6 21.076.11

16.636.89

17.242.29

20.811.47

10.370.960a

9.430.84a

20:5n-3 0.110.07

0.040.03

0

0

1.030.06a

1.110.07a

22:5n-3 1.680.51

2.470.30

1.470.22

1.770.14

1.180.14

1.080.08

22:6n-3 13.033.36

9.981.05

8.930.98

9.100.31

24.360.68a

25.161.06a

SFA

32.811.0

32.303.42

33.430.95

36.261.29

34.421.13

PUFA 43.902.58

44.261.82

45.631.79

45.303.27

47.191.57

46.683.47

 (n-6)
PUFA 35.753.22

33.891.74

35.371.79

36.671.47

20.061.13a

20.530.70a

 (n-3)
PUFA 14.843.12

12.501.18

10.411.17

10.880.36

26.490.75a

27.471.19a

n-3/n-6 0.410.05

0.360.03

0.290.03

0.290.01

1.330.06

1.340.07

Fatty
Acid

29.176.0

Values displayed as mean ± SEM. N=6 per group. * p<0.05 significantly different within groups. a, b, c
p<0.05 significantly different between groups SFA = Sum of saturated fatty acids, PUFA = Sum of
polyunsaturated fatty acids,  (n-6) PUFA= Sum of omega-6 polyunsaturated fatty acids,  (n-3)
PUFA= Sum of omega-3 polyunsaturated fatty acids. n-3 / n-6 ratio.
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A

DHA: Percentage of
Total

30

20

a

a

b
b

b
10

0

Red

b

White

B

Total n-3 PUFA:
Percentage of Total

30

20

a

a

b
b
b

b

Red

White

10

0
C

n-3 / n-6 PUFA Ratio

a

a

1.5

SF
n-6
n-3

1.0

0.5

0.0

b

b

c

Red

c

White

Skeletal Muscle Type
Figure 3.3: Skeletal muscle fatty acid levels for saturated fat (SF), safflower oil
(n-6) and tuna fish oil (n-3) groups after 8 weeks feeding. A: Docosahexaenoic
Acid (DHA) B: Total n-3 PUFA C: n-3/n-6 ratio. Different letters a,b,c indicate
p<0.05 between diets. 1-way ANOVA N= 6 per group. Mean  SEM
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3.4.3 Baseline perfusion
Baseline measures determined after 30minutes of hindlimb perfusion (1ml/minute)
are shown in Table 3.4. Minute ventilation was significantly lower in the n-6 group
compared to both the SF and n-3 groups (p<0.05). This was a function of lower tidal
volume and breathing frequency (p<0.05 v SF) resulting from a significantly lower
body weight in the n-6 group for this particular study (p<0.05).

There were no significant differences in the baseline arterial blood samples. In all
groups PaO2 was sufficient to achieve ~98% oxygen saturation of the red blood cell
and corresponding high content of arterial oxygen supply (~19-20ml/100ml).
Baseline venous samples demonstrated a significant drop in PO2 (p<0.05) and uptake
of oxygen across the resting muscle bundle. Although not significant, the n-3 group
demonstrated a lower (a-v)O2 difference (ml/100ml) and basal oxygen consumption
(mol/g/min) compared to both n-6 and SF groups.

3.4.4 Tension development, oxygen consumption and hindlimb perfusion pressure
Figure 3.4 shows the initial, maximum and final twitch tension development (g/g) of
all groups during 10minutes of exercise 1 (1ml/minute), exercise 2 (1.5ml/minute)
and exercise 3 (2ml/minute). There was a significant decline in initial and maximum
twitch tensions between exercise 1 and exercise 3 independent of diet (p<0.05). The
decline was tended to be smallest in the n-3 group for both initial and maximum
twitch tension (p = 0.07 and 0.09 respectively). There was no significant difference
in the final twitch tension between exercise 1 and exercise 3 independent of diet,
however final twitch tension in the n-3 group was significantly higher compared to
the SF group (p<0.05).
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Table 3.4: Baseline conditions taken after 30minutes perfusion at constant a flow
rate of 1ml/minute.
Variable
Body weight (g)

SF
49127a

n-6
4279b

n-3
47915a

Room temp (oC)

32.90.9

31.60.3

32.40.7

37.00.9

36.70.6

36.00.7

12610b

10214ab

9310a

Respiratory rate (set) (b/min)

684a

621b

672ab

Respiratory depth (set) (ml)

2.60.1a

2.20.1b

2.40.1ab

Minute ventilation (ml/min)

17615a

1366b

1625a

pH

7.530.03

7.50.01

7.550.02

PaO2 (mmHg)

872

904

932

PaCO2 (mmHg)

312

342

332

Hb (grams/100ml)

13.30.3

13.9.0.5

14.30.5

CaO2 (ml/100ml)

18.960.7

19.610.5

19.930.8

[HCO3-] mM

25.81.1 a

32.13.0

29.22.3

[Lactate] mM

2.920.17

2.680.12

2.760.24

pH

7.410.02

7.450.02

7.410.03

PvO2 (mmHg)

402b

433ab

472a

PvCO2 (mmHg)

423

463

484

Hb (grams/100ml)

13.750.5

14.160.4

14.40.5

CvO2 (ml/100ml)

14.381.0

15.630.7

16.530.9

[HCO3 ] mM

26.21.2a

32.82.8b

29.92.5ab

[Lactate] mM

2.620.2

3.660.19

3.120.5

(a-v)O2 (ml/100ml)

4.570.73

3.970.77

3.390.45

VO2 (umol / g/ min)

0.410.07

0.370.07

0.310.04

o

Rectal temp ( C)
Blood Pressure
Hindlimb pressure (mmHg)
Ventilation

Arterial blood gas and metabolite:

Venous blood gas and metabolite:

-

Oxygen Consumption

Values displayed as Mean ± SEM. N=6 per group. Values denoted by different letters (a,b,c)
p<0.05 between groups.
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Figure 3.4: Twitch tension development (grams/gram (ww)) at hindlimb flow rates
1ml/minute (Ex1), 1.5ml/minute (Ex2) and 2ml/minute (Ex3) for SF (saturated fat), n-6
(safflower oil) and n-3 (tuna fish oil) groups. Initial tension (time = 0), maximum tension
(time = ~60seconds) and final tension (time =10mins) are shown. N=6 per group. Values
displayed as Mean  SEM.
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Figure 3.5 shows the percentage recovery of initial, maximum and final twitch
tension in exercise bout 2 and 3 (1.5 and 2ml/minute) compared to exercise bout 1
(1ml/minute). The n-3 group demonstrated a greater recovery of twitch tension in
exercise bout 3 (p<0.05) when compared to SF and n-6 groups. Additionally, when
final twitch tension was expressed as a percentage of either initial or maximum
twitch tension (figure 3.6A and B), in exercise bouts 1, 2 and 3, the n-3 group
demonstrated greater maintenance of tension over the 10minutes. The final twitch
tension relative to maximum twitch tension was significantly different compared to
n-6 and SF groups (p<0.05).

Twitch characteristics including maximum rate of contraction (+dT/dt) and
maximum rate of relaxation (-dT/dt) decreased across exercise 1, 2 and 3
independent of diet (table 3.5). There was no significant difference between diets at
the points of initial, maximum and final twitch tension.

In venous blood sampled after 10minutes contraction, both the PO2 (figure 3.7A) and
resulting oxygen saturation of the red blood cell tended to be higher in the n-3 group
compared to the n-6 and SF. Both parameters in the n-3 group was significantly
different to the SF group by exercise bout 3 (p>0.05). The calculated (a-v)O2
difference (ml/100ml) (figure 3.7B) and oxygen consumption (mol/g/min) (figure
3.8A) were significantly different in the n-3 group compared to the SF group.

As described in Chapter 2, an efficiency index was calculated as the twitch tension
developed relative to muscle mass for a given amount of oxygen consumed

84

(g/g/mol/min). The n-3 group maintained a significantly higher efficiency index
across all exercise bouts compared to both SF and n-6 groups (p<0.05) (figure 3.8B).

A
Percentage Recovery
Ex 2 vs Ex 1

150
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50

0

Initial

Maximum

Final

B
Percentage Recovery
Ex 3 vs Ex 1

150

a
a
100

b
b

a
b

ab

b

b
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n-6
n-3

50

0

Initial

Maximum

Final

Figure 3.5: Percentage recovery for initial, maximum and final twitch tension at flow
rates A: 1.5ml/minute and B: 2ml/minute vs Exercise 1. Different letters a,b indicate
p<0.05 between diets. 1-way ANOVA. (Bonferonni analysis for comparison of
means)N=6 per group. Values displayed as Mean  SEM.
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Exercise 2
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Figure 3.6: Final twitch tension as a percentage of A: Initial twitch tension and
B: Maximum twitch tension at flow rates 1, 1.5 and 2ml/minute (Exercise 1,
Exercise 2 and Exercise 3). Different letters a,b indicate p<0.05 between diets. 1way ANOVA. (Bonferonni analysis for comparison of means) N=6 per group.
Values displayed as Mean  SEM.
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Table 3.5: Maximum rate of contraction and relaxation at the initial, maximum and
final twitch tensions for Exercise 1, 2 and 3.
Variable

SF

n-6

n-3

dT/dt

9877  957

10524  2019

10335 1124

-dT/dt

-7551  909a

-8883  1649a

-7139  766a

dT/dt

11296  682a

14832  3578a

11763  1392a

-dT/dt

-9107  829

-9987  1933

-8522  951

dT/dt

10060  830

9066  2538

9313  1706

-dT/dt

-7895  494

-6250  1076

-6080  1050

dT/dt

7965  781

8484  2811

9282  1059

-dT/dt

-5796  240

-6385  1235

-5708  698

dT/dt

9389  861

10798  2246

9688  1640

-dT/dt

-7566  753

-7862  1485

-7464  989

dT/dt

8338  995

8703  2424

9322  1567

-dT/dt

-7266  862

-6234  1463

-6234  1108

dT/dt

8162  1119

7701  1780

8427  1276

-dT/dt

-5943  816b

-5605  1383b

-5238  698b

dT/dt

8596  1158b

6639  1434b

7364  2360b

-dT/dt

-7594  1191

-6151  1606

-7124  1048

dT/dt

7691  961

8524  2711

9734  1667

-dT/dt

-6333  956

-6195  2108

-6264  952

Exercise 1
Initial

Max

Final

Exercise 2
Initial

Max

Final

Exercise 3
Initial

Max

Final

Values displayed as Mean ± SEM. N=6 per group. Values denoted by different letters (a,b,c) p<0.05
are significantly different within initial, peak, and final, between Exercise 1 and Exercise 3 . dT/dt =
maximum rate of contraction. –dT/dt = maximum rate of relaxation.
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Figure 3.7: A: Venous PO2 and B: Arterial-venous oxygen difference (a-v)O2
at flow rates 1, 1.5 and 2ml/minute (Exercise 1, Exercise 2 and Exercise 3).
Different letters a,b indicate p<0.05 between diets 1-way ANOVA.
(Bonferonni analysis for comparison of means) N= 6 per group. Values
displayed as Mean  SEM.
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Figure 3.8: A: Oxygen consumption (mol/g/min) and B: Efficiency index
(g/g/mol/min) at flow rates 1, 1.5 and 2ml/minute (Exercise 1, Exercise 2 and
Exercise 3). a,b indicates p<0.05 between diet groups. 1-way ANOVA (Bonferonni
analysis for comparison of means). N=6 per group. Values displayed as Mean  SEM.
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Figure 3.9 shows the steady state hindlimb perfusion pressures for SF, n-6 and n-3
groups during exercise 1,2 and 3. As flow increased, so too did perfusion pressure
(p<0.05). Although not significant, the n-6 group showed a trend toward higher
perfusion pressure.

Perfusion Pressure
(mmHg)

200

SF
n-6
n-3

100

0

Exercise 1

Exercise 2

Exercise 3

Figure 3.9: Hindlimb perfusion pressure at flow rates 1, 1.5 and
2ml/minute (Exercise 1, Exercise 2 and Exercise 3). N=6 per group. Values
displayed as Mean  SEM.

3.4.5 Muscle glycogen and blood lactate
The control muscle glycogen levels (plantaris and gastrocnemius) in the
unstimulated hindlimb were significantly lower in the n-6 group compared to both
the SF and n-3 groups (figure 3.10). Both the n-3 and n-6 groups had significantly
decreased levels in all the stimulated muscles sampled (p<0.05). The SF group
decreased in all muscles although only significant in the plantaris (p<0.05). There
was no diet effect on venous blood lactate concentration either during the exercise
bouts or recovery periods. Figure 3.11 A and B, show that in all groups venous
lactate concentration rose significantly from baseline by the end of the exercise
bouts (p<0.05) and decreased significantly in the recovery periods before the next
exercise bout (p<0.05).
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Figure 3.10: Muscle glycogen content (mg/g(ww)) in Medial Gastrocnemius (Gm),
soleus (Sol) and plantaris(Pl) for control and stimulated hindlimbs. #p<0.05 between
dietary groups within control muscle. * p<0.05 within dietary groups compared to
control muscle. N=6 per group. Values displayed as Mean  SEM.
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Figure 3.11: Arterial and venous lactate concentration at baseline A: Compared to
venous lactate concentration at during exercise B: Compared to venous lactate
concentration during recovery 1 and 2. * p<0.05 ANOVA between baseline venous
and either exercise or recovery venous independent of diet. N=6 per group. Values
displayed as Mean  SEM
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3.4.6 Recovery between stimulation bouts
Both arterial and venous blood samples were taken 30minutes after exercise 1 and 2
(flow rate = 1ml/minute). The oxygen consumption at this point was used as an
indicator of recovery. Figure 3.12 shows the calculated oxygen consumption for
recovery period 1 and 2 relative to the original baseline measurements. Both the n-6
and SF groups had higher oxygen consumption compared to their baseline, however
oxygen consumption returned to original baseline levels in the n-3 group. The
difference across recovery periods was significantly different for n-3 compared to SF

Oxygen Consumption
(mol/g/min)

group (p<0.05).
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1.00
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n-6
n-3

b
0.75
b
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b

ab
a
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0.25

0.00

Baseline

Recovery 1

Recovery 2

Figure 3.12: Oxygen consumption (mol/g/min) at baseline and recovery 1
and recovery 2 (following exercise 1 and 2 respectively). Flow rate =
1ml/minute. Different letters a,b indicate p<0.05 between diet groups.
* p<0.05 within SF. 1-way ANOVA. (Bonferonni analysis for comparison of
means) N=6 per group. Values displayed as Mean  SEM
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3.5 Discussion
In the current study we have shown that dietary fatty acid composition will influence
skeletal muscle membrane levels in the rat. The reflection of membrane phospholipid
to the dietary intake has been well documented (Charnock 1982) including heart and
skeletal muscle in the marmoset monkey (Charnock et al. 1992) and more recently
rats and humans (Storlien et al. 1996; Ayre and Hulbert 1996a). In addition, this
study has attempted to match changes in membrane PUFA content to changes in
skeletal muscle function, namely twitch tension. The auto-perfused contracting rat
hindlimb was successfully used to investigate the influence of dietary fatty acids on
isometric developed twitch tension. Both the developed twitch tension and the
oxygen use at the end of the three stimulation bouts of varying flow rate were
effected by 8 weeks dietary manipulation. Hindlimbs from animals fed tuna fish oil
(n-3 group) demonstrated greater fatigue resistance and greater recovery between
contraction periods coupled with a modulated oxygen consumption when compared
to SF group (saturated fat) and n-6 group (safflower oil).

Skeletal muscle membrane fatty acid composition
Large differences in the skeletal muscle membrane fatty acid levels were achieved
with 8 weeks diet of saturated fat, safflower oil or tuna fish oil. There was no strong
indication in the present study that this maybe specific to muscle fibre type as
previously suggested (Kriketos et al. 1995). Although, there was some indication
that the level of 16:0 was decreased in the red fibres compared to the white. There
has been evidence of an inverse relationship between the level of 16:0 and insulin
sensitivity (Vessby et al. 1994). In addition, when low levels of essential fatty acids
were provided (SF group), although not significant, the levels of DHA were
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retained at higher levels in the red muscle compared to the white. That is, the high
oxidative compared to the low oxidative fibres (Kriketos et al. 1995).

The changes in the present investigation, specifically for the long chain fatty acid
DHA, were comparable to those seen in the heart after similar dietary studies
(Charnock et al. 1992; Pepe and McLennan 1996). It has become evident in the heart
that DHA uptake is the primary response to long chain n-3 fatty acids in the diet,
even when high amounts of EPA are present (McLennan et al. 1996). From the
present study it would also seem that DHA is preferentially incorporated in skeletal
muscle. Charnock et al. (1992) demonstrated clearly the remarkably similar fatty
acids profiles between heart and skeletal muscle in the marmoset monkey. Other
tissues in the monkey, such as aortic smooth muscle did not reflect the same level of
incorporated DHA as heart or skeletal muscle. In support of the current study, DHA
levels in skeletal muscle from the marmoset monkey were identical to the levels in
the red and white skeletal muscle of the rat in this study. Additionally, in both the
monkey (Charnock et al. 1992) and the rat (present study), DHA levels were
depressed and arachidonic acid increased significantly in both SF and n-6 groups.
The similarity in levels between heart and skeletal muscle warrant the possibility
that skeletal muscle could be used as an indirect marker to levels in the heart
(Charnock et al. 1992). The use of the biopsy technique in skeletal muscle would
allow for indirect monitoring of changes in the heart of humans.

Skeletal muscle function
There are few studies that have considered skeletal muscle function and dietary
induced changes in membrane composition (Ayre and Hulbert 1996a; Ayre and
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Hulbert 1996b; Ayre and Hulbert 1997). The current investigation is the first study to
investigate skeletal muscle function, namely twitch tension, on the basis of
modulated oxygen consumption, as previously demonstrated in the heart (Pepe and
McLennan 2002), and use a model that allows for near true physiological conditions.

At baseline, there was no effect of diet on resting oxygen consumption of the
perfused hindlimb. This is in agreement with previous work done in heart. Pepe and
McLennan, 2002, demonstrated in isolated rat hearts, during basal conditions, that
the myocardial oxygen consumption from animals fed n-3 diet were not different to
other dietary groups. It seems that during conditions of low oxygen demand, there is
no oxygen modulation, as the required need is satisfactorily met by the supply.
Oxygen modulation and increased efficiency, becomes evident when the
myocardium is put under conditions of increased oxygen demand such as increased
filling pressure or acute myocardial ischaemia and reperfusion (Pepe and McLennan
2002). If the same applies in skeletal muscle, then differences may not been found in
low oxygen demanding situations, such as rest.

When the gastrocnemius-plantaris-soleus muscle bundle was stimulated to twitch,
animals fed the n-3 PUFA diet, displayed greater fatigue resistance during the
10minute contraction periods. The fatigue resistance within contraction periods was
most evident by the third bout. This agrees with the better cardiac contractile
function (Demaison et al. 2000) and mechanical performance seen in the heart
(Charnock et al. 1987; McLennan et al. 1989) that is associated with dietary n-3
PUFA. Despite differences, the stimulation bouts did not depress developed
isometric twitch tension to a great extent (<50%). This indicates that further
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experiments are necessary to evaluate twitch tension fatigue responses between
dietary groups when the muscle is put under greater stress.

Oxygen consumption of the contracting hindlimb was evaluated at the end of the
10minute stimulation period. In addition to altered contractile function, there was
also indication of oxygen modulation, at this specific point. In myocardium,
increased stress results in modulation of oxygen use (Pepe and McLennan 2002),
therefore the current results in skeletal muscle would suggest that low frequency
stimulation also provides stimulus to demonstrate modulated oxygen consumption.
Once again, there is evidence from this study to warrant further investigation of the
direct effects of n-3 PUFA on oxygen use by skeletal muscle. It will be of particular
interest to evaluate oxygen consumption over a range of isometric developed twitch
tension during early contraction and fatigue rather than one single point.

Between contraction periods, hindlimbs were perfused under identical conditions to
the baseline. However, unlike during baseline measures, diet had a significant effect
on recovery oxygen consumption. It is of particular interest, that endurance trained
athletes have greater recovery from bouts of exercise when compared to sedentary
individuals (Hagberg et al. 1980). Oxygen consumption, carbon dioxide production,
minute ventilation and heart rate all show faster adjustment to relative and absolute
exercise levels and recovery from bouts of exercise. Traditionally this was attributed to
lowering of oxygen “debt”. It is now recognised that the process is multi-factorial, and
in fact involves resynthesis of ATP and PCr, resynthesis of blood lactate to muscle
glycogen, restoration of oxygen to blood, tissue fluids and myoglobin, thermogenic
effects of elevated core temperature and epinephrine and norepinephrine, and increased
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circulatory and pulmonary dynamics (see review (Bangsbo and Hellsten 1998)). There
is no direct evidence from the current study to suggest that dietary n-3 PUFA effect any
of the processes mentioned above. However, in addition to reduced oxygen
consumption during recovery, the muscle from animals fed n-3 PUFA also maintained
relative maximum isometric developed twitch tension between stimulation bouts. This
is a secondary indication that recovery was enhanced similar to the effect of endurance
training (Hagberg et al. 1980).

The initial findings, that muscle function in the auto-perfused contracting rat
hindlimb is directly influenced by dietary fatty acid content and resulting membrane
phospholipid changes, is a novel finding. However at this early stage, oxygen
consumption was only calculated at the end of the 10minute stimulation bout. It is of
primary interest to investigate the levels of oxygen use at the start of the contracting
period and establish that these findings hold true at all points of skeletal muscle
twitch tension fatigue. Additionally, it is of interest to establish if these observations
also hold true when the skeletal muscle bundle is put under increased stress. That is,
i) an increased frequency of twitch stimulus that will result in a greater degree of
fatigue (<50% maximum twitch tension) ii) longer duration of stimulation
(30minutes) which will also impact on the degree of twitch tension fatigue and iii)
lower levels of arterial oxygen supply that will result in a mild hypoxic state in the
contracting muscle bundle. It is of primary interest in this thesis to further the
investigation of n-3 PUFA and the likely direct effects on skeletal muscle function
and twitch tension fatigue.
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Chapter 4
Influence of dietary tuna fish oil on skeletal muscle
twitch tension fatigue and oxygen consumption
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4.1 Introduction
The ability to perform work over long periods of time with reduced fatigue has great
benefits across a wide range of activities. Direct application includes improved
performance of daily duties for elderly, those with muscular dystrophy or heart
failure patients through to high level athletic performance. Additionally, it would be
of great benefit if changes in fatigue resistance can be induced through simple dietary
modification. In Chapter 3 of this thesis it was confirmed the fatty acid membrane
composition of skeletal muscle is strongly reflective of the fatty acid composition of
the diet, and remarkably similar to levels reported previously in heart (Charnock et
al. 1992). For the first time, with use of the rat auto-perfused contracting hindlimb,
the change in skeletal muscle membrane composition was associated with possible
modulation of oxygen consumption and function also reported in heart (Pepe and
McLennan 2002). These apparent effects on twitch tension fatigue need to be
quantified and better evaluated with respect to oxygen consumption, metabolism and
closer examination of twitch characteristics.

Skeletal muscle fatigue is best defined as a reduction in the maximum force
generating capacity (Bigland-Ritchie and Woods 1984). In Chapter 3, the direct
effects of n-3 PUFA on skeletal muscle function established differences in twitch
tension fatigue but only considered one single point of twitch tension in
combination with oxygen consumption (time = 10 minutes at flow rates 1, 1.5, and
2ml/minute). The gastrocnemius-plantaris-soleus twitch tension development did
not fall to below 50% of the maximum peak tension. This was an effect of the
duration (10minutes) and frequency (1Hz) of stimulation. Muscle fatigue is highly
influence by duration, intensity and type of contraction (Fitts and Metzger 1993). In
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addition, oxygen consumption increases from the initiation of muscle contraction,
therefore it is warranted that the investigation of the direct effects of n-3 PUFA on
twitch tension fatigue be extended. This will involve more blood sampling for the
calculation of oxygen consumption and allow for a better appreciation of the
influence membrane content has on cellular function.

In order to better study the influence of diet on muscle fatigue, the current study
aimed to enhance the rate and extent of decline in twitch tension. This was achieved
with an increased number of twitch contractions over an extended period of decline
in twitch tension. The pattern of developed tension over 30 minutes is shown in
figure 4.1. The changes reflect disturbances in one or more sites of excitation
contraction coupling described by Bigland-Ritchie, 1984, and may lead to better
understanding of the specific fatigue processes.

B

D

A

E

0

C

30
Time

Figure 4.1: Schematic pattern of series of twitch contractions over a 30minute period of
contraction. A: Initial peak twitch tension at the commencement of sciatic nerve stimulation. B:
Maximum peak twitch tension (PTmax) occurs approximately 60-80 seconds after the initial
stimulation of the sciatic nerve. C: Final peak twitch tension. The fall to point C is dependant
on the frequency of stimulation. D: Time to 80% PTmax E: Time to 50% PTmax

100

The characteristics of twitch contractions during muscle fatigue have been
investigated extensively (Edwards 1981; Fitts 1994; Westerblad et al. 1998) and
include peak tension, rise time, fall time, and contraction duration (figure 4.2) as
well as relative maximum rate of contraction and relaxation. Each of these
parameters are influenced by the total tension development and therefore subjected
to change as the level of fatigue changes. Regardless of the fibre type or stimulating
conditions, the isometric twitch contraction generally shows some or all the
following characteristic changes as fatigue of a muscle cell or bundle increase
(Rowell and Shepard 1996).
i)

A reduced peak tension

ii)

A prolonged contraction duration

iii)

A prolonged rise time and fall time

iv)

A reduced rate of maximum tension development and relaxation

Figure 4.2: Sample trace of a twitch contraction . A: Peak twitch tension (PT). B: Rise time
from 10-90% PT (Rt) (ms). C: Fall time from 10-90% PT (Ft) ms. D: Contraction duration at
50% PT(CD) (ms).
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At this stage of the project, there were additional advantages that allowed for a
more intensive investigation of n-3 PUFA using the rat auto-perfused contracting
hindlimb. These include i). blood gas analyser requiring smaller volumes allowing
more frequent sampling and ii). arterial levels during the experimental period
proving to be constant and needing less frequent sampling .

i) The blood gas analyser (ABL77, Radiometer, Copenhagen) required 25% of the
sample volume previously used in this thesis. In this next stage of investigation
more venous samples were taken over the experimental period without risk of
excessive loss of red blood cells critical for oxygen delivery.

ii) The method development (Chapter 2) and initial dietary investigation (Chapter
3), also established that both in resting and contracting conditions, the arterial level
of oxygenation is maintained across the experimental period. It is then also an
advantage that smaller number of arterial blood samples need be drawn from the
total blood volume thus allowing for more detailed sampling of the venous blood.

It is the primary aim of the current study to investigate the possible direct effects of
n-3 PUFA on twitch tension and twitch characteristics over a greater range of twitch
tension to fatigue (<50% of maximum peak tension). Secondly, to investigate in
more detail the patterns of oxygen consumption over the range of twitch tension.
This may provide confirmation of the results in Chapter 3, and greater
understanding about possible mechanisms by which diet can modulate oxygen
consumption. It is hypothesised that dietary n-3 PUFA will improve oxygen
efficiency and reduce muscle fatigue as previously seen in the heart (Pepe and
McLennan 2002).
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4.2 Aims and Hypotheses
Specifically the aim of this part of the project was to
•

Extend the stimulation protocol used in Chapter 2 and 3. This will involve
increased duration and frequency of stimulation to increase oxygen
demand and cause greater and more rapid twitch tension fatigue.

•

Investigate in closer detail the relationship between twitch tension
development and oxygen consumption over the extended stimulation
period.

•

Determine if there is dietary difference in time taken for twitch tension to
fall to 80% and 50% of the maximum peak twitch tension.

•

Examine the twitch characteristics over the entire range of twitch tension
development and determine any dietary influences.

It is hypothesised that doubling the frequency of muscle twitches will result in;
•

Higher oxygen consumption than those seen in Chapter 3

•

More rapid twitch tension fatigue development.

•

Change in twitch tension characteristics as fatigue progresses.

It is also hypothesised that the n-3 diet will be associated with;
•

A reduction in the rate and extent of twitch tension fatigue.

•

Improved twitch tension development of the stimulated muscle for a
given amount of oxygen consumed.
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4.3 Methods
4.3.1 Diet composition
Three diets were prepared (Saturated Fat: SF, Safflower Oil: n-6 and NuMega Tuna
Fish Oil: n-3) as previously used in Chapter 3 with the specific composition shown
in table 3.1.

4.3.2 Animals and study design
Eighteen male Wistar rats (6 per dietary intervention) were used for this part of the
study. Experiments were assessed and approved by the Animal Ethics Committee
from the University of Wollongong. Experimental animals were housed in the
University of Wollongong’s animal facility with room temperature maintained at
23oC-25oC and a 12hour light-dark cycle. Animals were housed 2 per cage. Animals
were fed a wash out diet containing olive oil for 14 days to standardise muscle
membrane fatty acid composition, allocated to the three dietary trial groups (SF, n6, n-3) for 8 weeks as described in Chapter 3.

4.3.3 Surgical preparation for muscle stimulation, artificial ventilation and
hindlimb perfusion
Rats were prepared as described in Chapter 2. Rats were anaesthetised (sodium
pentobarbital, 6mg/100g i.p.) throughout the all procedures with anaesthesia
maintained by supplementary sodium pentobarbital, (2mg/100g i.p.), as required
during the procedure. Experiments were performed in a heated perspex chamber and
animal body temperature was maintained with the additional aid of a heating lamp
placed above the rat.
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The surgical and experimental procedures (including blood and muscle tissue
sampling) were as outlined specifically in Chapter 2 of this thesis. Optimal resting
length of the stimulated gastrocnemius-plantaris-soleus muscle bundle and optimal
voltage were set as described earlier. There was no systemic blood pressure taken at
the carotid artery for this investigation.

4.3.4 Hindlimb perfusion and stimulation protocol
Prior to the commencement of perfusion, control muscle samples were quickly
separated, dissected, freeze clamped with pre-cooled tongs in liquid nitrogen, and
stored at –80oC for latter analysis of muscle glycogen as described previously in
Chapter 2. The rat hindlimb was prepared for perfusion as described in 2.3.2. All
hindlimbs were perfused for 30minutes at 1ml/minute to allow perfusion pressure to
reach steady state (~100mmHg). Just prior to the stimulation period the hindlimb was
perfused at 2ml/minute. In order to specifically study the fatigue process, stimulation
was conducted at twice the frequency of Chapter 3 (2Hz, 7-12V, 0.05ms) for an
extended duration lasting 30minutes. The higher stimulation frequency hastened
fatigue, making a 50% force decline measurable within 30minutes.

Baseline arterial and venous blood samples (200l) were drawn after 30minute of the
initial perfusion (flow = 1ml/minute). Venous samples were collected throughout the
stimulation bout at the time points 30seconds, 1minute, 2.5minutes, 5minutes, and
then every 5 minutes until 30minutes. The blood sample (80l) was immediately
presented to the blood gas analyser for measurement of PO2, PCO2, pH, Hct, Na+, K+,
and Cl-. The remainder was spun down and the plasma removed for later analysis of
blood glucose and blood lactate as described previously in Chapter 2. The red blood
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cells were re-suspended in saline (6% dextran) and re-injected into the venous side of
the hindlimb as described in Chapter 2.
At the completion of the 30minute stimulation bout, the muscles of the hindlimb
were quickly separated, dissected, freeze clamped with pre-cooled tongs in liquid
nitrogen, and stored at –80oC for later analysis of muscle glycogen as described in
Chapter 2. The time line of events (including tissue sampling) and sampling of tissue
are summarised in figure 4.3.

Analysis of twitch tension and characteristics was performed at the time
corresponding to the blood sampling. Developed tension and other characteristics
were averaged from 10 consecutive contractions. The first derivative of developed
tension was used to determine the maximum rate of developed tension and
relaxation. The area under the twitch curve at the point of initial, maximum and
final tension was also calculated over 10 consecutive contractions and expressed
relative to the peak tension (tension-time index).

4.3.5 Statistical analysis
Data was expressed as meanSEM. Data was analysed by one or two-way analysis
of variance (ANOVA) with individual group means compared using Bonferroni’s
post hoc analysis.  was set at p<0.05.

106





Name

Re-perfusion

Exercise

Time

30mins

30mins

Flow

1ml/min

2ml/min

Stimulation

2Hz, 7-12V

Figure 4.3: Time line of events for long duration (30mins) stimulation.  Arterial blood sample (120l).
and immediately freeze clamped.

Stimulated muscle samples excised and immediately freeze clamped.
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Venous blood sample (120l).

Control muscle samples excised

4.4 Results
4.4.1 Baseline conditions
Control parameters of ventilation, hindlimb perfusion pressure, blood gas and
metabolites recorded after 30minutes of baseline perfusion are presented in table 4.1.
Minute ventilation was slightly higher in the n-6 group compared to the SF and n-3
group. This was simply due to a function of tidal volume that was set according to
the animal body weight.

There were no significant differences in the baseline arterial blood samples. In all
groups the PaO2 was sufficient to achieve ~98% oxygen saturation of the red blood
cell and corresponding high content of arterial oxygen supply (~18-19ml/100ml).
Corresponding venous samples demonstrated a significant drop in PO2 (p<0.05) and
uptake of oxygen across the resting muscle bundle. There was no effect of diet on the
(a-v)O2 difference or the basal oxygen consumption. Additionally, there was no
difference in the baseline measure of blood lactate or glucose on the arterial or
venous sides of the hindlimb.

4.4.2 Tension development, oxygen consumption and hindlimb perfusion pressure
Twitch tension increased from the initial peak tension to the maximum peak tension
within 60-80seonds of the stimulation commencing. Peak developed twitch tension
then declined with time. In all groups the relative twitch tension declined
significantly from its maximum over the 30minutes (figure 4.4) (p<0.05). However,
the n-3 group developed significantly greater maximum twitch tension and sustained
greater twitch tension throughout the 30minutes (p<0.05). Considered as relative
changes (%) from maximum peak tension to final peak tension there was no
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significant difference between the groups, however, the n-3 group tended to sustain a
higher percentage after 30minutes of twitch contraction (SF: 35.33.3; n-6: 34.44.8;
38.76.4). There was no dietary difference in time taken to reach maximum twitch
tension (figure 4.5A) or the time taken to decline to 80% of maximum twitch tension
(figure 4.5B). However, the n-3 group had a slower rate of twitch decline compared
to the SF and n-6 groups, the difference being significantly different from the n-6
group (p<0.05)

The twitch characteristics including rise time, fall time, contraction duration and the
maximum rate of developed tension and relaxation were also affected by time
(p<0.05) (figures 4.6, 4.7, 4.8). However, as in the case of relative twitch tension, the
n-3 group attenuated the changes in twitch characteristics and was significantly
different from both the n-6 and SF groups across the 30minutes of exercise (p<0.05).
There was no significant difference between dietary groups for the relative tension-

Twitch Tension (g/g)

time index (figure 4.9).
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Figure 4.4: Isometric twitch tension (grams/gram (ww)) of the gastrocnemiusplantaris-soleus muscle bundle over 30minutes of stimulation. * p<0.05 for diet **
p<0.05 for time independent of diet: 2-way ANOVA with Bonferroni correction for
group mean difference. N=6 per group. Values displayed as Mean  SEM.
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Table 4.1: Baseline conditions taken after 30minutes perfusion at constant a flow
rate of 1ml/minute.
Variable

SF

n-6

n-3

Body Weight (g)

46528

54435

47234

Hindlimb Pressure (mmHg)

10911

1023

1066

Respiratory Rate (Set) (b/min)

642

632

632

Respiratory Depth (Set) (ml)

2.360.17

2.720.17

2.320.14

Minute Ventilation (ml/min)

15112

17213

14711

Ventilation

Arterial Blood Gas, Electrolyte and Metabolite
pH

7.520.02

7.540.02

7.540.02

PaO2 (mmHg)

943

943

984

PaCO2 (mmHg)

332

352

331

Hb (grams/100ml)

13.00.5

12.40.5

13.20.3

CaO2 (ml/100ml)

18.30.6

18.00.6

18.60.4

[HCO3-] mM

26.951.03

30.011.94

29.01.38

[Lactate] mM

1.740.17

1.640.14

1.710.09

[Glucose] mM

5.870.64

5.750.18

6.10.08

K+
Na+
Venous Blood Gas, Electrolyte and Metabolite
pH

7.450.02

7.440.02

7.420.02

PvO2 (mmHg)

463

472

492

PvCO2 (mmHg)

421

453

402

Hb (grams/100ml)

13.20.4

12.950.44

13.20.3

CvO2 (ml/100ml)

15.190.76

15.030.36

14.960.51

[HCO3-] mM

28.21.3

30.382.07

27.831.69

[Lactate] mM

1.960.13

2.10.14

2.00.11

[Glucose] mM

5.570.56

5.480.74

6.00.84

(a-v) O2 (ml/100ml)

3.140.51

2.950.52

2.960.23

VO2 (mol /g/min)

0.430.07

0.420.06

0.450.06

K

+

Na+
Oxygen Consumption
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Values displayed as Mean ± SEM. N=6 per group. Values denoted by different letters (a,b,c) p<0.05
between groups.
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Figure 4.5: A: Time (seconds) to maximum peak twitch tension. B: Time (seconds) to fall
to 80% of maximum peak twitch tension and time (seconds) to fall to 50% of maximum
peak twitch tension. Different letters a,b indicate p<0.05. 1-way ANOVA (with
Bonferroni correction for comparison of group means). N=6 per group. Values displayed
as Mean  SEM.
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Figure 4.6: A: Relative rise time (10-90%, ms/g tension developed) and B: fall
time (90-10%, ms/gram) of the gastrocnemius-plantaris-soleus muscle bundle over
30minutes of stimulation. * p<0.05 for diet ** p<0.05 for time independent of diet:
2-way ANOVA with Bonferroni correction for group mean difference. N=6 per
group. Values displayed as Mean  SEM.
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Relative Contraction
Duration (ms/g)

1.5

**

SF
n-6
n-3

1.0

*
0.5

0.0
0.5

1

2.5

5

10

15

20

25

30

Time (minutes)
Figure 4.7: Relative contraction duration (50%, ms/g) of the gastrocnemiusplantaris-soleus muscle bundle over 30minutes of stimulation. * p<0.05 for diet
** p<0.05 for time independent of diet: 2-way ANOVA with Bonferroni
correction for group mean difference. N=6 per group. Values displayed as Mean
 SEM.
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Figure 4.8: Maximum rate of contraction (+dT/dt) and relaxation (-dT/dt) of the
gastrocnemius-plantaris-soleus muscle bundle over 30minutes of stimulation. *
p<0.05 for diet ** p<0.05 for time independent of diet: 2-way ANOVA with
Bonferroni correction for group mean difference. N=6 per group. Values displayed as
Mean  SEM.
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Relative Tension-time
Index (g.ms/g)
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10

0

Initial
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30minutes

Figure 4.9: Relative tension-time index at the point of initial, maximum
and 30minutes of contraction. N=6 per group. Values displayed as Mean 
SEM.

Oxygen consumption at intervals measured throughout the muscle stimulation bout
increased with time in all groups (p<0.05 for time). The level of oxygen consumption
was very similar in all dietary groups for the first 5 minutes of twitch contraction.
Beyond this time the oxygen consumption of the n-6 and SF groups stabilised or
even declined while the oxygen consumption of the n-3 group continued to rise
before stabilising after 15minutes (p<0.05 for diet) (figure 4.10A).

The gradual

decline in twitch tension coupled with a gradual increase in the oxygen consumption
resulted in a fall in the efficiency index over time independent of diet (p<0.05). The
greatest fall occurred in the first half of the stimulation period (0-15minute). Despite
the significantly higher oxygen consumption over the 30minute contraction period in
the n-3 group, the efficiency index was significantly higher than both the n-6 and SF
groups (p<0.05) (figure 4.10B) due to the better twitch tension maintenance.
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Figure 4.10: A: Oxygen consumption (mol/gram/minute) and B: Efficiency
Index (g/g/mol/minute) over 30minutes of stimulation. * p<0.05 diet ** p<0.05
time independent of diet: 2-way ANOVA with Bonferroni correction for group
mean difference. N=6 per group. Values displayed as Mean  SEM.
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Hindlimb perfusion pressure recorded continuously during the stimulation period,
rose in all groups immediately after the increase in perfusion rate (table 4.1) (p<0.01)
and was steady within 5minutes. The n-3 group hindlimb pressure was significantly
higher than the n-6 (p<0.05) but not the SF group across the 30minutes of muscle
contraction (figure 4.11).
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Figure 4.11: Hindlimb perfusion pressure at rest and over 30minutes of
stimulation.. *P<0.01 rest v’s contraction independent of diet. **P<0.05 n3 v’s n-6 group. N=6 per group. Values displayed as Mean  SEM

4.4.3 Muscle glycogen, blood lactate and blood glucose
Venous blood lactate concentration rose significantly above (p<0.05) and venous
blood pH level fell significantly below (p<0.05) basal levels during muscle
stimulation. The changes were apparent within the first 60seconds of stimulation
(figure 4.12) and continued to increase before stabilising after 10minutes. The
venous blood lactate concentration was significantly higher and pH lower in the n-3
group during the entire 30minutes of contraction (p<0.05). Once again the difference
became larger after the 10minute time period.
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Figure 4.12: A: Blood lactate concentration (mM) and B: Venous pH over 30minutes
of stimulation. * p<0.05 for diet ** p<0.05 for time independent of diet: 2-way
ANOVA with Bonferroni correction for group mean difference. N=6 per group. Values
displayed as Mean  SEM.

There was no significant arterial-venous difference in blood glucose across the
hindlimb at rest. All levels were within normal physiological range for non-fasted
animals. Any difference was too small to accurately calculate glucose uptake.
Venous blood glucose levels were also taken at the completion of the contraction
period. Although there was a small drop from basal levels there was no significant
difference across time or between groups (figure 4.13A).
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At the completion of the stimulation period muscle glycogen was measured for intramuscular stores and availability of substrate and compared with the contralateral
control muscle. As in the case of blood glucose there was no dietary difference in
either the control muscle or the stimulated muscle. There was an effect of stimulation
(time), independent of diet, as all groups displayed significantly reduced glycogen
levels in the stimulated muscle compared to within animal control muscles (p<0.05)
(figure 4.13B).
Blood Glucose (mmol/L)

A

7
6
5
4
3
2

Glycogen Concentration
(mg/g ww)

B

Pre: Arterial

Pre: Venous

30min Venous

150

SF
n-6
n-3

*

100

50

0

Sol

Pl

Gm

Sol

Pl

Gm

Exercised

Control

Figure 4.13: A: Blood glucose (pre arterial and venous and post venous)
concentration (mM) and B: Glycogen concentration of control and exercised
muscle after 30minutes of stimulation. Soleus (Sol), plantaris (Pl) and medial
gastrocnemius(Gm). * p<0.05 control v exercise independent of diet: 2-way
ANOVA. N=6 per group. Values displayed as Mean  SEM.
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Venous plasma potassium [K+] levels rose from baseline over the 30minutes of
muscle contraction representing a net loss from within the contracting muscle bundle

Venous Plasma [K+] mM

or red cell haemolysis (figure 4.14). There was no effect of diet.
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Figure 4.14: Venous plasma potassium concentration [K+] mM over
30minutes of stimulation. N=6 per group. Values displayed as Mean 
SEM.
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4.5 Discussion
The current study has used the rat auto-perfused contracting hindlimb to
demonstrated for the first time that dietary n-3 PUFA, can modulate both oxygen
consumption and twitch tension fatigue in skeletal muscle. Based on the previous
Chapter (3) that established significant differences in phospholipid content between
dietary groups, these functional changes (oxygen and fatigue) are likely to be related
to membrane composition. This demonstrates that changes in membrane composition
produce effects on oxygen consumption and efficiency in skeletal muscle similar to
those recently established in heart (Pepe and McLennan 2002).

The ability to sustain high isometric twitch tension during repeat stimulation, as seen
in the hindlimb muscle of animals fed n-3 PUFA, is commonly used as an indicator of
fatigue resistance (Fitts and Holloszy 1976) and describes the improved contractile
performance in this group. Twitch tension traditionally described the relationship
between the active cross bridges, however it is now recognised that there are other
factors that contribute to differences in isometric tension, such as Ca2+ transient and
muscle temperature (Fitts and Holloszy 1978).

Severely reduced peak twitch tension (~60%) results in a prolonged contraction
duration and one-half relaxation time (Thompson et al. 1992). Prolonged time for
twitch relaxation occurs during in vivo exercise in humans (Bergstrom and Hultman
1988) and isolated in vitro and in situ muscle preparation (Brust 1964; Mainwood and
Lucier 1972). Reduced twitch tension fatigue in the n-3 PUFA group was associated
with better maintenance of isometric twitch rise time, fall time, contraction duration
and maximum rate of twitch tension development and relaxation which normally
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change with fatigue. The effects of fatigue and diet on twitch characteristics provide
information that may explain the measured differences in twitch tension fatigue.

Ayre and Hulbert (1996b) investigated the effects of specific dietary fat and
incorporation into skeletal muscle membranes. Contractile performance of the
isolated skeletal muscle in vitro only revealed that muscle deficient in essential fatty
acids decreased performance. However these results are difficult to compare to the
current study using the auto-perfused contracting hindlimb. Firstly, as already
discussed in Chapter 2, the oxygen delivery for in vitro work is far from optimal, and
secondly, endurance was only assessed over a time period of 30-60seonds.
Therefore, the current study has contributed to the understanding of n-3 PUFA and
its role in fatigue by assessing function over 30minutes of prolonged isometric twitch
contraction.

In the present study, modulation of twitch tension fatigue when n-3 PUFA is
incorporated into the skeletal muscle membrane seems to result in a more efficient
use of oxygen for cell maintenance, and effectively free up oxygen for use in
generating ATP for contractile purposes. Possible explanations include, change in
substrate preference, alteration of sodium / potassium ATPase activity or cellular
calcium handling. Although no substantial direct evidence has been collected to
support these changes, some indirect evidence (such as twitch characteristics and
blood metabolites) provide stimulus for some suggestions of potential mechanisms.
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1. Substrate difference
In the current study, where muscle from animals fed n-3 PUFA for 8 weeks show
fatigue resistance and increased oxygen efficiency, there was no direct evidence for
changes in substrate use. Measurements of blood glucose (pre and post stimulation)
and muscle glycogen (control v stimulated levels), showed no dietary influence.
However, in implying that there was no change, there are limitations to relying on
absolute levels of substrates in the blood and muscle. It is clearly recognised that it
is more appropriate to measure substrate turnover via stable isotope methods (see
reviews (Rolye et al. 1983; Emken 2001)) when describing changes in substrate use
either during resting or contracting conditions.

Despite this, the n-3 group did demonstrate higher blood lactate levels than both n-6
and SF, particularly as the duration increased above 5minutes. Once again, it is
difficult to conclude a substrate shift towards carbohydrate, as lactate concentration
is influenced by both the production and the clearance from the metabolically active
tissue. However, constant blood flow was maintained in all groups suggesting
increased production of lactate unless there was differential perfusion of the active
muscle and other parallel beds in the different dietary groups (the so called nutritive
and non-nutritive beds) (Clark et al. 2000).

For any given work output, the oxygen consumption of the heart is dependant on
the substrates provided to the heart (Schonekess 1997). Fatty acid oxidation uses
more oxygen to produce each ATP than does glucose (Saddick and Lopaschuck
1991). However, the heart normally uses fatty acids in preference to glucose if both
are available (Taegtmeyer et al. 1980).
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It has been demonstrated that

pharmacological inhibition of fatty acid oxidation or promotion of glucose
oxidation can produce changes in oxygen consumption, cardiac function and
cardiac efficiency (Hutter et al. 1985; Kantor et al. 2000) similar to the effects seen
with fish oil feeding (Pepe and McLennan 2002). The key question is, does skeletal
muscle oxygen consumption respond in the same way as cardiac tissue knowing
that n-3 PUFA are accumulated in the membranes in a similar manner? To date,
fatty acid profile of membrane lipids have been linked to major changes in skeletal
muscle fuel metabolism (Storlien et al. 1991; Pan et al. 1995; Storlien et al. 1995).
Desaturation of skeletal muscle membrane, as occurs in n-3 PUFA feeding, has
been shown to affect insulin sensitivity in rats (Pan, et al., 1993). An increase in
insulin sensitivity increases the ability to of the skeletal muscle cell to take up
glucose. Additionally, in non-trained humans this increase in insulin sensitivity is
also associated with a decrease in intra-muscular triglyceride content (Pan et al.
1997) while fish oil feeding has shown to also decrease serum triglyceride levels
(Phillipson et al. 1985). The n-3 PUFA are linked to even controlling enzymes
critical in energy flux at the gene expression level (Jump et al. 1996). From the
perspective of the whole animal, dietary fish oil may also improve glucose use, at
rest. This is demonstrated when rats fed EPA and DHA show decreased oxidation
of fat and increased carbohydrate oxidation compared to rats fed a saturated fat diet
at rest, in both the fasted and post-prandial state (Rustan et al. 1993). Further
investigation with the use of sophisticated stable isotopes (see reviews (Rolye et al.
1983; Emken 2001)) will be required for evidence of preferred substrate utilisation
during twitch contraction resulting from phospholipid changes.
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2. Sodium / Potassium ATPase Activity
The results from this present experiment confirm a net loss of [K+]. The venous
plasma [K+] rose from baseline through to the end of the 30minute contraction
period. Physiological plasma potassium [K+] levels are normally <2mM. After
excitation in muscle cells, there is a net loss of intracellular potassium [K+] and a net
gain of sodium [Na+] along with chloride and water (Fenn and Cobb 1936). Located
heavily at the sarcolemma, and to a less extent in the t-tubular system (Serjersted
1992), the Na+/K+ pump functions to restore intra and extra cellular levels of sodium
and potassium following the propagation of action potentials. Muscle contractility
relies on the maintenance of these gradients. Modulation of this pump can lead to
increase fatigue resistance.

The Na+/K+ pump activity has been shown to be phospholipid dependant (Kimelberg
and Papahadjopoulos 1974) with activity increasing as saturation decreases (Wheeler
et al. 1975). Respiration rates of isolated soleus muscle are reportedly increased in
rats fed a diet high in polyunsaturated safflower oil. The increased respiration was
partially related to increased Na+/K+ ATPase activity as determined by ouabain
inhibition (Early and Spielman 1995). In the present investigation, there was no
effect of diet on plasma potassium levels following 30minutes of isometric twitch
contraction. It is concluded that although phospholipid composition was altered in
the skeletal muscle, the differences in oxygen consumption and muscle fatigue are
not related to Na+/K+ ATPase activity under these particular conditions. The
membrane hypothesis for skeletal muscle fatigue may be more appropriate with
higher frequencies of stimulation and fatigue that are often non-physiological in
nature (Jones 1996).
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3. Calcium Handling
The dietary differences seen in relative rise time, fall time, and contraction duration
as well as the maximum rate of developed tension and relaxation over the 30minute
contraction period reflect possible calcium handling changes occurring in the muscle
cell that are tightly linked to conditions of low frequency fatigue (Westerblad et al.
1998). Muscle fatigue is known to increase the duration of the calcium transient and
thus prolong the relaxation time (Allen and Westerblad 1989; Westerblad and Allen
1991). Prolonged contraction time and shortening speed are apparent after fatigue in
single motor units as well as whole muscle preparations (Burke et al. 1973; Burke
and Tsairis 1973; Lannergren et al. 1989; Gordon et al. 1990). Therefore, the second
cation pump of interest involved in the excitation contraction coupling process is the
calcium-magnesium ATPase pump. Like all cation pumps, its primary role is to
move positively charged ions against their concentration gradient. Located heavily
on the longitudinal axis of the sarcoplasmic reticulum, specifically it moves free
cellular calcium back into the sarcoplasmic reticulum for storage following
contraction (Fitts 1994). It has been established that the energy cost of calcium reuptake represents 30-50% ATP utilisation under various levels of stimulation
(Dawson et al. 1980). Therefore it becomes a strong possibility that the changes in
oxygen consumption and tension development may be explained by calcium
handling properties of the muscle cell.

Excessive myocardial oxygen consumption that has been associated with conditions of
cellular Ca2+ overload which is also a common underlying factor in arrhythmia
generation (Curtis et al. 1993). Considerable amounts of data show that fish oil has a
marked inhibitory effect on arrhythmia generation (McLennan et al. 1996; Pepe and
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McLennan 1996; Nair et al. 1997). Extensive work by Leaf and coworkers also
suggests that fish oil fatty acids can normalise myocardial cell Ca2+ to prevent Ca2+
overload or even leeching of intracellular Ca2+ after channel blockade (Hallaq et al.
1992). Isolated myocytes treated with long chain PUFA are resistant to ouabain or Bay
K8644 induced Ca2+ influx and the cardio-depressant effects of some Ca2+ channel
blockers. These observations were made using neonatal myocytes in culture and it is
unclear as yet whether they can be applied to adult myocardium in situ as there was
often no clear difference between PUFA in the myocyte system and neonatal Ca2+
handling is not fully developed. More recent work using rat ventricular myocytes has
shown the presence of EPA to reduced [Ca2+]i and calcium overload (O'Neill et al.
2002). Myocardial Ca2+ cycling processes appear as another potential mechanism of
action of fish oil fatty acids in excitable cell function. Any observed difference in the
effect of n-3 fatty acids on cardiac calcium handling may be applicable to skeletal
muscle function considering ischaemia induced injury resembles cell damage following
exhaustive endurance exercise (Hoppeler 1986; Sjostrom et al. 1987) and sarcoplasmic
reticulum function (Ca+ release and re-uptake) is depressed following short high
intensity as well as prolonged exercise (Byrd et al. 1989; Byrd et al. 1989).

In human muscle calcium re-uptake in the sarcoplasmic reticulum has been depressed
to 58% of the pre-exercise value (Golnick et al. 1991) and in frog skeletal muscle (in
vitro) calcium release has been reported to be depressed at the point of exhaustion
(Ward et al. 1998). The evidence suggests that the releasable stores of sarcoplasmic
reticulum calcium are not depleted, rather the rate of release is significantly depressed.
Caffeine, a compound that stimulates the release of calcium from the sarcoplasmic
reticulum, reverses the tension loss of fatigued muscles, particularly late in fatigue

126

(Westerblad and Allen 1991). The depressed release of calcium has been partly
attributed to increased resting intra-cellular calcium concentration (Westerblad and
Allen 1991), metabolism within the triad space including glycogen, ATP, Mg+ and
reactive oxygen species (Favero 1999). The prolonged calcium transient can in part be
explained by the redistribution placing greater load on the re-uptake.

The evidence at this stage for oxygen modulation and twitch tension fatigue resistance
in muscle from animals fed n-3 PUFA, may be as a result of change in substrate
preference or direct modification of calcium handling in the cell. These possibilities
would explain to some degree, the lower oxygen consumption for a given amount of
isometric twitch tension, lower oxygen consumption in periods of recovery, and greater
twitch tension fatigue resistance during and recovery following bouts of contraction. In
addition, possible redistribution of blood flow, as reflected by the hindlimb perfusion
pressure, maybe contributing to the difference in oxygen consumption as a result of
“shunting” between nutrient and non-nutrient vascular beds.

In conclusion, the results from the current study support the hypothesis of increased
oxygen efficiency and function in skeletal muscle from animals fed n-3 PUFA and
support similar evidence from work done in heart (Pepe and McLennan 2002). There
are several possibilities how dietary n-3 PUFA modulate oxygen consumption,
including change in substrate preference or cellular calcium handling. This current
work has provided stimulus to further the investigation of n-3 PUFA and skeletal
muscle fatigue. In particular, establish if providing n-3 PUFA in the diet i). provides
additional fatigue resistance in conditions of low oxygen delivery to the working
muscle, and ii). investigate further the possible mechanisms for oxygen modulation.
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Chapter 5
Role of dietary fatty acids in skeletal muscle twitch
tension fatigue during hypoxia and the effect of
caffeine in the fatigued state
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5.1 Introduction
It was established in Chapter 3 and Chapter 4 that skeletal muscles from animals fed
with n-3 PUFA compared to SF and n-6 PUFA, fatigue less rapidly, and consume
less oxygen for a given amount of isometric twitch tension. These results in skeletal
muscle are similar to those previously seen in the isolated rat heart (Pepe and
McLennan 2002). Hearts from animals fed n-3 PUFA had lower oxygen
consumption for any given volume of cardiac output and external work. In the same
study when hearts were subjected to increased filling pressure or ischaemia /
reperfusion, hearts from animals fed n-3 PUFA used oxygen more efficiently and
reduced the release of markers of ischaemic damage to the myocardium (Pepe and
McLennan 2002). This is in addition to the previously recognised anti-arrhythmic
effects shown by dietary n-3 PUFA, in particular DHA (McLennan et al. 1988;
McLennan et al. 1996; Pepe and McLennan 1996). It is of particular interest that the
n-3 PUFA modulate oxygen consumption and function in the isolated rat heart both
under normal conditions and when the myocardium is put under stress and allowed to
recover. Skeletal muscle may benefit from similar protective actions during times of
stress when demand exceeds supply, either because of excessive demand or
compromised supply. Increased contractile stress during acute hypoxia is commonly
reported as a result of the limited oxygen supply (Katz and Sahlin 1990) possibly in
combination with reported reduction in substrate flux (Timmons et al. 1997;
Timmons et al. 1998).

When oxygen delivery to working skeletal muscle is sufficient, the tension
development will be maintained. If oxygen delivery is lowered or demand increased
then it is expected that force will respond accordingly and fall or be down regulated
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rapidly to a new level (Gladden et al. 1978; Gorman et al. 1988; Barclay 1993;
Hogan et al. 1998). The rapid decline in developed tension when oxygen is limiting
is well established and associated with reduced muscle function without disturbance
in tissue levels of ATP, ADP, PCr and Pi (Hogan et al. 1996). This highlights the
tight coupling of force generation to aerobic re-phosphorylation of ADP and cellular
maintenance. There are occasions when either because of compromised supply or
excessive demand developed muscle tension is severely reduced. These include but
are not limited to acute or chronic exposure to altitude, exercise induced arterial
hypoxemia, and intermittent claudication. It maybe of great advantage in these
conditions, if through dietary modulation, efficient use of oxygen could result in
sustained repetitive tension development over a longer period of time. The first stage
of this investigation focused on the possibility that n-3 PUFA in the diet may
modulate twitch tension fatigue in conditions of low oxygen delivery (compromised
supply), as previously seen in the heart after ischaemia (Pepe and McLennan 2002).

Fatigue-related changes observed earlier (Chapter 4) that were attenuated by n-3
PUFA diet are often related to sarcoplasmic reticulum function (Allen and
Westerblad 1989; Westerblad and Allen 1991). The increased length of time required
for recovery from low frequency fatigue, as used in this study, is one characteristic
that distinguishes it from high frequency fatigue (Jones 1996). In addition,
mechanisms of low frequency fatigue are more complex than the mechanisms of
non-physiological high frequency fatigue (Jones 1996). Low frequency fatigue has
been associated with metabolic, mitochondrial and sarcoplasmic reticulum
alterations, where calcium-release is attributed as a key step involved in the fatigue
process. These changes may be associated with elevated resting intracellular calcium
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in fatigued muscle, amongst a number of other cellular changes such as increased
reactive oxygen species or changes of the metabolism within the triad space
(Westerblad and Allen 1991). In heart, excessive oxygen consumption has been
associated with conditions of cellular Ca2+ overload which is also a common underlying
factor in arrhythmia generation (Curtis et al. 1993). Importantly, considerable data
shows that fish oil has a marked inhibitory effect on arrhythmia generation (McLennan
et al. 1996; Pepe and McLennan 1996; Nair et al. 1997). Recent work with rat
ventricular myocytes investigating calcium-induced calcium-release, showed that in
the presence of the long chain n-3 PUFA, eicosapentaenoic acid, there is indication
of reduced resting [Ca]i in the cell (O'Neill et al. 2002). Additionally, dietary n-3
PUFA modulates both oxygen consumption (Pepe and McLennan 2002) and calcium
handling (Taffet et al. 1993; Pepe et al. 1999; Pepe and McLennan 2002) in the heart
during ischaemia and reperfusion. Therefore, altered myocardial calcium cycling
processes appear as one potential mechanism of action of fish oil fatty acids in excitable
cell function.

Although, skeletal muscle does not mimic the calcium-induced calcium-release in the
heart, it still makes use of the basic properties of calcium release from the
sarcoplasmic reticulum into the cytosol (Favero 1999). N-3 PUFA may also
contribute to calcium handling in skeletal muscle by maintaining lower resting [Ca]i
and consequently more effective release. Caffeine is a methylxanthine derivative that
has ergogenic (work enhancement) effects (Tarnopolsky 1994). Caffeine’s positive
effects on skeletal muscle performance is suggested to be related both to substrate
changes (enhanced fat metabolism) (Costill et al. 1978; Essig et al. 1980; Erickson et
al. 1987) and facilitated neuromuscular function at the level of the sarcoplasmic
reticulum (Weber and Herz 1968; Freyer and Neering 1989; Block et al. 1992). It
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seems that the latter is more appropriate for the explanation of enhanced fatigue
resistance (Tarnopolsky and Cupido 2000) and reversal of the loss of force
production in low frequency fatigued fibres (Edwards 1981).

Skeletal muscle from animals fed n-3 PUFA showed better recovery between
contraction bouts (Chapter 3) and better maintenance of twitch characteristics during
twitch tension fatigue (Chapter 4). In this component of the study caffeine will be
used to explore the return of twitch tension towards peak levels after fatigue is
induced during hypoxia. The recovery of twitch tension may give indirect indication
of the calcium release at the level of the sarcoplasmic reticulum in combination with
myofibrillar calcium sensitivity and maximum calcium activated force.

5.2 Aims and Hypotheses
Specifically, this part of the project aims to
•

Determine the relationship between twitch tension and oxygen
consumption over an extended stimulation period when arterial oxygen
content is lowered.

•

Determine the effect of diet and hypoxia on the rate and extent of muscle
twitch tension fatigue.

•

Examine the influence of n-3 PUFA on caffeine-stimulated twitch tension
fatigue recovery.

It is hypothesised that with lower arterial oxygen content the active oxygen
consumption will be compromised but basal oxygen consumption will not be

132

effected. The compromised oxygen consumption will result in reduced maximum
twitch tension and a greater rate and extent of twitch tension fatigue.
It is further hypothesised that,
•

Dietary n-3 PUFA will increase the efficiency of oxygen used and
decrease the rate and extent of twitch tension fatigue.

•

Caffeine will restore twitch tension development in the fatigued
hindlimb in dose response manner, and

•

Twitch tension will be restored at lower caffeine doses and / or a greater
extent after n-3 PUFA feeding.

5.3 Methods
5.3.1 Diet composition
Three diets were prepared for the investigation (Saturated fat: SF, Safflower oil; n6, Tuna fish oil: n-3) as detailed in Chapter 3 with the specific composition table
3.1.

5.3.2 Animals and study design
Eighteen rats (6 per dietary intervention) were used for this part of the study.
Experiments were assessed and approved by the Animal Ethics Committee from the
University of Wollongong. Experimental animals were housed in the University of
Wollongong’s animal facility with room temperature maintained at 23oC-25oC and
a 12hour light-dark cycle. Animals were housed 2 per cage. Animals were fed a
wash out diet containing olive oil for 14 days to standardise muscle membrane fatty
acid composition, then randomly allocated to the three dietary trial groups (SF, n-6,
n-3) for 8 weeks as described in Chapter 3.
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5.3.3 Surgical preparation for muscle stimulation, artificial ventilation and
hindlimb perfusion
Rats were prepared and anaesthetised as described in Chapter 2. Experiments were
performed in a heated perspex chamber and animal body temperature was
maintained with the additional aid of a heating lamp placed above the rat. The
surgical and experimental procedures (including blood and muscle tissue sampling)
were as outlined specifically in Chapter 2 of this thesis. Optimal resting length of
the stimulated gastrocnemius-plantaris-soleus muscle bundle and optimal voltage
were set as described earlier.

Arterial oxygen content was altered by delivery of a gas with low of oxygen content.
The animal ventilator was connected to the anaesthetised rat as described in Chapter
2. To compromise oxygen delivery to the contracting muscle, the external valve of
the ventilator used to draw air from the room was connected to an airtight sampling
bag filled with a gas mixture containing low oxygen (14%) normal carbon dioxide
(~1%) and nitrogen (85%). The sampling bag volume was large enough to sustain
animal ventilation for a period of 15minutes and was re-filled as required during the
experiment.

5.3.4 Hindlimb perfusion and stimulation protocol
During surgical preparation and prior to the commencement of perfusion, control
muscle samples were quickly separated from the contralateral leg, dissected, freeze
clamped with tongs pre-cooled in liquid nitrogen, and stored at –80oC for latter
analysis of muscle glycogen as described previously in Chapter 2. As previously
described, the left hindlimb was always perfused for 30minutes at 1ml/minute to
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allow perfusion pressure to reach steady state (~100mmHg). Two stimulation bouts
were proposed for each dietary group.

The first stimulation bout was carried out after the completion of the 30minutes
equilibrium perfusion. The aim was to assess twitch tension development under
normal flow and normoxic oxygen delivery conditions (within animals). Flow rate
was increased to 2ml/minute over a 3minute period then the muscle was stimulated 3
minutes via the sciatic nerve (2Hz, 7-12V, 0.05ms). The stimulation duration was
sufficient to achieve maximum peak twitch tension but was kept to minimum to
avoid muscle fatigue and impact on the 30minutes of stimulation to follow. No blood
was drawn during the normoxic stimulation period in order to save red blood cells
and oxygen carrying capacity for the later contraction period. At the completion of
the 3minutes normoxic stimulation period, flow rate was returned to 1ml/minute for a
further 15-20minutes of rest. Baseline normoxic arterial and venous blood samples
(200l) were drawn after 30minute of the initial perfusion (flow = 1ml/minute). The
blood sample (80l) was immediately presented to the blood gas analyser for
measurement of PO2, PCO2, pH, Hct, Na+, K+, and Cl-. The remainder was spun
down and the plasma removed for later analysis of blood glucose and blood lactate as
previously described in Chapter 2. The red blood cells were resuspended in an equal
volume of saline (6% dextran) and injected in to the venous side of the hindlimb as
described in Chapter 2.

The low oxygen gas (14%) was initially presented to the rat while the hindlimb was
perfused at resting flow rates (1ml/minute) and without stimulation. After 5minutes
of low oxygen the hindlimb flow rate was increased to 2ml/minute and 30minutes of
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stimulation commenced. Baseline hypoxic arterial and venous blood samples (200l)
were drawn prior to adjustment of hindlimb blood flow to 2ml/mintute ready for the
commencement of muscle stimulation. Venous samples were collected during the
hypoxic stimulation bout at the time points 30seconds, 1minute, 2.5minutes,
5minutes, and then every 5 minutes until 30minutes (to replicate the time points from
Chapter 4).

After 30minutes of hypoxic contraction, caffeine was administered while both
hypoxia and stimulation continued. Three doses of caffeine (2.5, 5.0 and 10mM in
200l saline room temperature, intra-arterial) were injected at 5minute intervals on
the heart side of the perfusion pump. A venous blood sample (100l) was drawn and
presented to the blood gas analyser to measure PO2 for calculation of oxygen
consumption. The venous sample was taken 60 seconds after the caffeine bolus had
entered the hindlimb. Twitch contractions were monitored continuously. The
effective dose for 25% recovery (ED25) in each hindlimb was calculated using a log
transform for caffeine dose versus recovery from fatigue.

At the completion of the caffeine dose response, the muscles of the hindlimb were
quickly separated, dissected, freeze clamped with tongs pre-cooled in liquid nitrogen,
and stored at –80oC for latter analysis of muscle glycogen as described previously in
Chapter 2. The time line of events (including tissue sampling) and sampling of tissue
are summarised in figure 5.1.
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5.3.5 Statistical analysis
One or two-way analysis of variance (ANOVA) were used to compare means
between dietary groups, between normoxic conditions and hypoxic conditions
within this current study and then between normoxic conditions in Chapter 4 to the
current hypoxic conditions (independent of diet). The Bonferroni’s post hoc
analysis was used to indicate significant difference.  was set at p<0.05.

5.3.6 Chemicals
Caffeine (Sigma, Australia) was prepared in 0.9% NaCl (room temperature) as 0.5M
solution and progressively diluted to the required concentration. Other chemicals as
per Chapters 2, 3 or 4.
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Name

Re-perfusion

Normoxic Ex.

Hypoxic Baseline

Hypoxic Ex.

Time

30mins

3mins

20mins

30mins

Flow

1ml/min

2ml/min

1ml/min

2ml/min

Stimulation

2Hz, 7-12V

2Hz, 7-12V

Figure 5.1: Time line of events for long duration (30mins) stimulation during arterial hypoxia.  Arterial blood sample (120l).
muscle samples excised and immediately freeze clamped.

Stimulated muscle samples excised and immediately freeze clamped.
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Venous blood sample (120l).

Control

5.4 Results
5.4.1 Baseline conditions
Body weights and baseline ventilation, and perfusion pressure, blood gasses and
electrolytes are shown in Table 5.1. In this experimental series, the SF fed animals
had a significantly lower body weight. Aside from body weight, variables were
measured after 30minutes of equilibrium perfusion of the unstimulated hindlimb.
There was no significant difference in steady state hindlimb perfusion pressure.
Minute ventilation was lower in the SF group as function of respiratory depth
calculated based on body weight.

There were no significant differences in the arterial blood samples taken after 30
minutes equilibrium perfusion. Good oxygen saturation of the red blood cells (~98%)
and corresponding high arterial oxygen content (~19-20ml/100ml) was achieved in
all groups. A significant arterio-venous drop in PO2 (p<0.05) indicated uptake of
oxygen across the resting muscle bundle. There was no effect of diet on the resting
oxygen consumption values under basal non-stimulated conditions.

After hypoxic perfusion without muscle contraction (shown in table 5.2), low
availability of oxygen significantly decreased PaO2 (~65-70mmHg), SaO2 (88-90%)
and arterial oxygen supply (~16ml/100ml) in all dietary groups. Under resting
conditions, hypoxia was not associated with changes in either the (a-v)O2 difference
or the resting oxygen consumption and there was no effect of diet on oxygen basal
consumption under conditions of hypoxia.
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Table 5.1: Baseline conditions taken after 30minutes normoxic perfusion at constant
a flow rate of 1ml/minute.
Variable
Body Weight (g)

SF
37022

n-6
41913

n-3
46653

Hindlimb Pressure (mmHg)

11710

1335

1279

Respiratory Rate (Set) (b/min)

583

611

614

Respiratory Depth (Set) (ml)

2.00.3

2.30.1

2.30.3

Minute Ventilation (ml/min)

11720

14010

14120

Ventilation

Arterial Blood Gas, Electrolyte and Metabolite
pH

7.50.02

7.530.01

7.530.03

PaO2 (mmHg)

913

932

974

PaCO2 (mmHg)

373

382

362

Saturation RBC (%)

98.20.2

98.30.1

98.60.2

Hb (grams/100ml)

13.40.5

13.30.3

13.30.8

CaO2 (ml/100ml)

19.50.8

19.50.6

19.20.5

[HCO3 ] mM

37.342.00

42.82.16

30.421.41

K+

1.70.2

1.90.2

1.80.1

1244

1333

1292

-

Na

+

Venous Blood Gas, Electrolyte and Metabolite
pH

7.360.04

7.430.03

7.420.02

PvO2 (mmHg)

453

454

473

PvCO2 (mmHg)

532

532

472

Hb (grams/100ml)

14.10.6

14.10.4

13.80.4

CvO2 (ml/100ml)

15.90.6

15.81.0

15.60.8

[HCO3-] mM

33.162.31

37.92.45

30.01.36

1.90.5

1.90.2

1.90.3

1233

1244

1293

(a-v) O2 (ml/100ml)

3.490.44

3.670.6

3.560.66

VO2 (mol /g/min)

0.280.05

0.290.05

0.310.06

K

+

Na+

Oxygen Consumption

Values displayed as Mean ± SEM. Values denoted by different letters (a,b,c) p<0.05 between
diet groups.
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Table 5.2: Baseline conditions taken during the initial stages of hypoxia (no
contractions) at constant a flow rate of 1ml/minute.
Variable

SF

n-6

n-3

Respiratory Rate (Set) (b/min)

632

641

604

Respiratory Depth (Set) (ml)

2.10.3

2.30.1

2.30.3

Minute Ventilation (ml/min)

13221

1469

13920

Ventilation

Arterial Blood Gas, Electrolyte and Metabolite

vs Normoxia

pH

7.370.01

7.270.04

7.310.02

p<0.001

PaO2 (mmHg)

656

697

723

p<0.001

PaCO2 (mmHg)

421

434

433

p<0.001

Saturation RBC (%)

90.01.5

89.02.1

88.91.3

p<0.001

Hb (grams/100ml)

13.50.6

12.50.4

13.30.2

n.s.

CaO2 (ml/100ml)

16.70.5

16.40.5

17.00.5

p<0.001

[HCO3-] mM

33.221.88

30.643.84

25.122.8

p<0.01

[Lactate] mM

4.60.9

4.30.3

3.80.8

n/a

[Glucose] mM

6.40.4

6.80.4

7.00.4

n/a

K+

1.70.2

2.10.2

1.50.1

n.s.

1252

1312

1333

n.s.

Na

+

Venous Blood Gas, Electrolyte and Metabolite
pH

7.360.04

7.220.07

7.30.01

p<0.01

PvO2 (mmHg)

403

455

413

p=0.2

PvCO2 (mmHg)

572

582

611

p<0.01

Hb (grams/100ml)

13.30.5

13.20.1

13.90.3

n.s.

CvO2 (ml/100ml)

12.80.7

12.70.4

13.40.9

p<0.01

[HCO3 ] mM

33.541.65

28.144.32

29.560.76

n.s.

[Lactate] mM

4.80.3

5.20.8

5.50.8

n/a

[Glucose] mM

6.30.7

5.60.4

5.60.4

n/a

1.60.2

2.21

1.50.2

n.s.

1274

1312

1333

n.s.

(a-v) O2 (ml/100ml)

3.980.45

3.700.81

3.960.9

n.s.

VO2 (umol /g/min)

0.310.04

0.290.06

0.330.08

n.s.

-

K

+

Na+
Oxygen Consumption

Values displayed as Mean ± SEM. Values denoted by different letters (a,b,c) p<0.05 between diet
groups. Comparison to normoxia (table 5.1) within animals, independent of diet n/a = not analysed.
n.s. = not significant.
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5.4.2 Tension development, oxygen consumption, hindlimb perfusion pressure and
metabolites
The effect of hypoxia
The maximum twitch tension developed under normoxic conditions (during 3minutes
stimulation) is shown along with twitch tension developed during 30minutes of
contraction during hypoxia (figure 5.2). The normoxic maximum twitch tension was
highest in the n-3 group and the lowest in the SF group. Hypoxia significantly
reduced maximum peak twitch tension development within animals for each dietary
group. The difference between normoxic and hypoxic twitch tension was not affected

Twitch Tension (g/g)

by diet.

75

#

SF
n-6
n-3

**

60
45
30
15

*

0
-20 0.5

1

2.5

5

10

15

20

25

30

Time (minutes)

Figure 5.2: Isometric twitch tension (g/g (ww)) of the gastrocnemius-plantaris-soleus
muscle bundle over 30minutes of stimulation during arterial hypoxia. # p<0.05
normoxic maximum peak twitch tension in the same animals.

* p<0.05 for diet **

p<0.05 for time independent of diet: 2-way ANOVA with Bonferroni correction for
comparison of group means. N=6 per group. Values displayed as Mean  SEM.

142

During hypoxia, the pattern of twitch tension development over the 30 minutes
followed the same trend as in normoxic conditions of Chapter 4 for all groups and is
shown in figure 5.2. Tension rose in the first 60-80seconds to reach maximum
tension, plateaued, then declined with time to the final tension at 30minutes (p<0.05).
Thirty minutes of hypoxia, compared to normoxia in Chapter 4, reduced relative
peak twitch tension across the entire 30minutes stimulation (figure 5.3A) (p<0.01)
also reflected by reduced area under the twitch curve at the points of initial,
maximum and final developed tension (figure 5.3B). Additionally, hypoxia
significantly increased twitch characteristics including relative rise time (normoxia:
0.240.02 hypoxia: 0.580.04ms/g) (p<0.01), relative fall time (normoxia: 0.460.03
hypoxia: 0.61-.03ms/g)(p<0.01) and relative contraction duration (normoxia:
0.450.03 hypoxia: 2.490.16ms/g)(p<0.01) and reduced maximum rate of
developed tension (normoxia: 7219336 hypoxia: 3272146) (p<0.01) and
relaxation (normoxia: -5154243 hypoxia: -2456103) (p<0.01).

Changes in isometric twitch tension with hypoxia, was associated with significantly
decreased venous pH (normoxia: 7.330.01; hypoxia: 7.170.01), oxygen
consumption (figure 5.4A) and efficiency index (figure 5.4B) and increased venous
lactate during 30minutes stimulation. Hindlimb pressure rose when flow was
increased to 2ml/minute and was 15mmHg higher (although not significant)
compared to normoxic conditions (section 4.).
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Twitch Tension (g/g)

A
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Normoxia
Hypoxia

**
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*
0
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Time (minutes)
B

Tension-time Index
(g.ms)

3000

SF
n-6
n-3

a
ab

2000

b

*

1000

0

Inital

Maximum

30minute

Figure 5.3: A: Isometric twitch tension (g/g) over 30minutes of stimulation during
normoxia and hypoxia * p<0.05 normoxia v hypoxia** p<0.05 time independent of
condition : 2-way ANOVA with Bonferroni correction for comparison of group
means. B: Tension-time index at the point of initial, maximum and final (30minutes)
tension (g.ms) during hypoxia. Different letters a,b indicate p<0.05.
*p<0.05 30minute v initial independent of diet. N=18 per condition. N=6 per diet
group. Values displayed as Mean  SEM.

144
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Figure 5.4: A: Relative oxygen consumption (mol/g/min) B: Efficiency
index (g/gmol/minute) over 30minutes of stimulation during normoxia
and hypoxia. * p<0.05 normoxia v hypoxia** p<0.05 time independent of
condition : N=18 per group. 2-way ANOVA with Bonferroni correction for
comparison of group means. Values displayed as Mean  SEM.
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The effect of diet
The developed twitch tension was higher in the n-3 group compared to both n-6 and
SF groups. The higher tension was also sustained longer in the n-3 group represented
by a significant difference in time to fall to 50% of peak twitch tension compared to
the n-6 group (p<0.05) (figure 5.5). There was no apparent rise in resting tension
during the 30minutes of contraction for any dietary group.

Despite the significant difference in relative twitch tension, all twitch characteristics,
rise time, fall time, contraction duration, and maximum rate of relaxation, except
maximum rate of contraction were effected by polyunsaturation (n-3 and n-6) in the
diet rather than the specific fatty acid (figure 5.6, 5.7, 5.8). The relative area under
the twitch tension curve (tension-time index) at the 30minute time point tension was
greater in the SF group compared to both the n-3 and n-6 groups (figure 5.9).

Oxygen consumption rose significantly (p<0.05) from baseline in all groups at the
commencement of stimulated muscle contractions (figure 5.10A). Oxygen
consumption continued to increase in the n-3 group after both the n-6 and the SF
groups had reached steady state (~5-10minutes). Oxygen consumption in the n-3
group was significantly higher across the entire 30minutes (p<0.05). The efficiency
index (figure 5.10B) fell significantly in all groups over the 30minutes of
contraction. Both n-3 and n-6 groups were significantly higher than the SF group
over the 30minutes of contraction.
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Figure 5.5: A: Time (seconds) to maximum peak twitch tension. B: Time (seconds)
to fall to 80% of peak twitch tension and time (seconds) to fall to 50% of peak twitch
tension during arterial hypoxia. Different letters a,b indicate p<0.05 between diets.
1 way-ANOVA. N=6 per diet group. Values displayed as Mean  SEM.
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Figure 5.6: A: Relative rise time (10-90%, ms/gram) and B: relative fall time (9010%, ms/gram) of the gastrocnemius-plantaris-soleus muscle bundle over
30minutes of stimulation during arterial hypoxia. * p<0.05 diet ** p<0.05 time
independent of diet: 2-way ANOVA with Bonferroni correction for comparison of
group means. N=6 per diet group. Values displayed as Mean  SEM.
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Figure 5.7: Relative contraction duration (50%, ms/gram) of the gastrocnemiusplantaris-soleus muscle bundle over 30minutes of stimulation during arterial hypoxia. *
p<0.05 diet ** p<0.05 time independent of diet: 2-way ANOVA with Bonferroni
correction for comparison of group means. N=6 per diet group.Values displayed as
Mean  SEM.
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Figure 5.8: Maximum rate of contraction (dT/dt) and relaxation (-dT/dt) of the
gastrocnemius-plantaris-soleus muscle bundle over 30minutes of stimulation during arterial
hypoxemia. * p<0.05 diet ** p<0.05 time independent of diet: 2-way ANOVA with
Bonferroni correction for comparison of group means. N=6 per diet group.Values displayed
as Mean  SEM.
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Figure 5.9: Relative tension-time index at the point of initial, maximum
and 30minutes of contraction. *p<0.05 30minutes vs initial independent of
diet. N=6 per diet group. Values displayed as Mean  SEM.
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Figure 5.10: A: Oxygen consumption (mol/g/min) and B: Efficiency index
(g/g/mol/min) over 30minutes of stimulation during arterial hypoxemia. * p<0.05 diet
** p<0.05 time independent of diet: 2-way ANOVA with Bonferroni correction for
comparison of group means. N=6 per diet group.Values displayed as Mean  SEM.
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Hindlimb perfusion pressure recorded continuously during the stimulation period,
rose above baseline levels in all groups (table 5.1) (p<0.01) and was steady within
5minutes. The n-3 and n-6 groups’ hindlimb pressure was significantly higher than
the SF group (p<0.05) across the 30minutes of muscle contraction (figure 5.11).

As a result of twitch contractions and energy requirement, venous blood lactate rose
above baseline over time (p<0.05) and pH significantly fell (p<0.05) (figure 5.12).
The n-3 group had significantly higher lactate and lower pH compared to the SF and
n-6 groups (p<0.05). Additionally, muscle glycogen significantly depleted in the
stimulated hindlimb compared to the control (figure 5.13).

Electrolyte levels of plasma sodium did not change from baseline samples
(30minutes = 1252, 1334, 1313 for SF, n-6 and n-3 respectively). As expected
with muscle contraction, plasma potassium levels did increase over the stimulation
period however, with no effect of diet (data not shown).
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Figure 5.11: Hindlimb perfusion pressure at rest (1ml/minute) and during
30minutes stimulation (2ml/minute). *p<0.01 rest v’s contraction. ** p<0.05 n-3, n6 v’s SF. 2 way ANOVA with Bonferroni correction for comparison of group
means N=6 per diet group.Values displayed as Mean  SEM.
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Figure 5.12: A: Blood lactate concentration (mM) and B: venous pH over 30minutes of
stimulation during arterial hypoxia. * p<0.05 diet ** p<0.05 time independent of diet: 2
way ANOVA with Bonferroni correction for comparison of group means. N=6 per diet
group.Values displayed as Mean  SEM.
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Figure 5.13: A: Blood glucose (pre arterial and venous and post venous)
concentration (mM) and B: Muscle glycogen concentration of control and
exercised muscle after 30minutes of stimulation during arterial hypoxia. Soleus
(Sol), plantaris (Pl) and medial gastrocnemius(Gm). * p<0.05 control v exercise
independent of diet: 2-way ANOVA with Bonferroni correction for comparison of
group means. N=6 per diet group.Values displayed as Mean  SEM.
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5.4.3 The influence of caffeine on recovery
Injection of caffeine increased the fatigued twitch tension (figure 5.14A). By the
highest dose (10mM), all groups had recovered towards their maximum peak twitch
tension. The n-3 group displayed the greatest recovery, attaining levels close to 50%
of the hypoxic non-fatigued muscle (figure 5.14B). The recovery of twitch tension
was significantly greater than both the SF and n-6 groups at the 10mM dose
(p<0.05). The effective dose for 25% recovery (ED25) although not significant was
lower in the n-3 group compared to both SF and n-6 groups (SF: 2.690.36; n-6:
4.281.84; n-3: 1.90.55mM).
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Figure 5.14: A: Twitch tension at 30minutes (fatigue) and at increasing caffeine
dose. B: Percentage recovery to maximum peak twitch tension with increasing
caffeine dose. Different letters a,b indicate p<0.05 between diets 1-way
ANOVA. N=6 per diet group. Values displayed as Mean  SEM.
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Blood samples were only taken after the 10mM caffeine dose. Oxygen consumption
showed no significant difference between dietary groups (figure 5.15A).
Additionally, the efficiency index, showed no significant difference between n-3 and
n-6 dietary groups, however both were significantly different to the SF group
(p<0.05) (figure 5.15B).
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Figure 5.15: A Oxygen consumption (mol/g/min) at 10mM caffeine dose. B:
Efficiency index (g/g/mol/min) at 10mM caffeine dose. * p<0.05 SF v n-3, n6. 1-way ANOVA. N=6 per diet group. Values displayed as Mean  SEM.
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The maximum rate of contraction and relaxation increased with increasing caffeine
dose. Both n-3 and n-6 were significantly different to the SF group for the rate of
relaxation (p<0.05). However, the n-3 group was significantly different to both the
SF and n-6 groups for the maximum rate of contraction (p<0.05)(figure 5.16).
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Figure 5.16: Maximum rate of contraction (+dT/dt) and relaxation (-dT/dt) of the
gastrocnemius-plantaris-soleus muscle bundle during arterial hypoxemia at increasing
caffeine dose. * n-3, n-6 p<0.05 v SF, ** n-3 p<0.05 v SF and n-6. 2 way ANOVA
with Bonferroni correction for comparison of group means N=6 per diet group.Values
displayed as Mean  SEM.
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5.5 Discussion
This present investigation found that acute hypoxia established prior to contraction
reduced twitch tension throughout the stimulation period. When n-3 PUFA was
provided in the diet, muscle function improved and twitch tension fatigue was
reduced compared to SF and n-6 PUFA diets despite similar efficiency index in both
polyunsaturated groups. The effects of hypoxia in the rat auto-perfused contracting
hindlimb, combined with previous knowledge of how skeletal muscle adapts to acute
hypoxia challenge, enables the effect of specific dietary fats to be closely interpreted.
In addition, fish oil seems to protect against low frequency twitch tension fatigue by
possibly modulating the calcium handling ability of the cell. Return to pre-fatigue
tension as a response to caffeine was used as an indicator of calcium release in the
fatigued state. Dietary fish oil augmented the response to caffeine suggesting
amongst a number of possibilities, modulation of resting intracellular calcium levels
and release from the sarcoplasmic reticulum.

The effect of acute hypoxia in the rat auto-perfused contracting hindlimb
When oxygen supply was moderately reduced (~14%), the arterial PO2, and oxygen
content was significantly lowered. Arterial hypoxia is associated with lower driving
pressure of oxygen and presumably lower mean intracellular PO2 (Hogan et al.
1992).

Within animals, independent of diet, the reduced oxygen delivery to the hindlimb
had minimal effect on the resting conditions (significance reported in Table 5.2).
Despite the significantly reduced arterial oxygen content (~16ml/100ml), fixed blood
flow (1ml/minute) and some difference in pH, the venous PO2 was maintain above
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40mmHg and oxygen consumption was not significantly different compared to levels
during normoxia. This would indicate that during resting conditions (normoxic and
hypoxic) the basal demand of the muscle to maintain ATP production through
oxidative phosphorylation was adequately met in the auto-perfused rat hindlimb.

When skeletal muscle is stimulated to isometrically twitch, the oxygen requirement
of the cell is increased. Oxygen consumption increased in the present investigation
by 5-6 fold at peak levels compared to a 7-8 fold increase during normoxic
conditions. Independent of diet, this study has confirmed that skeletal muscle
isometric contractile performance is significantly reduced, including maximum
twitch tension and slower more prolonged contraction. Skeletal muscle force
production has been linked to oxygen availability (Hogan et al. 1994) where hypoxia
significantly reduces muscle power (Stainsby et al. 1990). Metabolically, this study
also demonstrated that blood lactate increased in association with increased muscle
glycogen and glucose breakdown. This is supported in canine hindlimb autoperfusion, where reduced arterial oxygen content (~16ml/100ml), similar to the level
achieved in the current investigation, significantly impacted on metabolic response to
short term (2minute) stimulus, including muscle and blood lactate levels (Hogan and
Welch 1986). Hypoxia enhances glucose uptake in cells and tissue (Ismail-Beigi
1993) and blood lactate production (Stainsby et al. 1990; Knight et al. 1996). In free
living conditions hypoxia also impacts on sensorimotor control to skeletal muscle
and motor unit recruitment (Badier et al. 1994; Bendahan et al. 1998) that could also
play a significant role in the difference in the rate of fatigue. It appears that skeletal
muscle has the ability to reduce or “down regulate” the ATP utilisation of the
contractile sites so as not to significantly disrupt the cell homeostasis (Arthur et al.
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1992). This suggests that there is a tight link between the oxygen availability and the
oxygen utilisation in the skeletal muscle cell.

The decreased contractile performance in the current study may be related to the
potential oxygen sensing ability of skeletal muscle and / or reactive oxygen species
and free radicals generated during hypoxia (Clanton and Klawitter 2001). In skeletal
muscle the ryanodine receptor involved extensively with calcium release, is
stimulated by falling levels of intracellular PO2 (Eu et al. 2000) and potentially
regulates the final developed tension. Alternatively, reactive oxygen species and free
radicals are shown to increase during hypoxia both in isolated cell preparations
(Duranteau et al. 1998) and isolated hearts (Park et al. 1991). Substantial increase in
reactive oxygen species will inhibit skeletal muscle force production, most likely
through global changes that include but are not limited to calcium release, calcium
uptake, or myofilament function (see review (Reid 2001)).

The effect of dietary fat in acute hypoxia and response to a caffeine stimulus
Resting baseline: In the normoxic and hypoxic conditions of the present chapter, n-3
PUFA had no effect on resting oxygen requirements. In parallel, Pepe and McLennan
(2002) found that dietary n-3 PUFA had no effect on basal oxygen consumption of
the heart when arrested by 30mmol/L KCl infusion. The results from both heart and
the present investigation of skeletal muscle during normoxia and moderate hypoxia
suggest that the low oxygen requirements at rest in skeletal muscle or under basal
conditions in heart are satisfactorily met in all dietary groups during both conditions
and suggest that any differences are related to the excitation or contraction process.
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Stimulated muscle contraction: Hypoxia reduced relative twitch tension across
30minutes stimulation in all dietary groups. The fact that relative twitch tension was
higher in the n-3 group and time to 50% of peak tension tended to be longer than the
SF group and significantly longer than the n-6 group indicates some level of twitch
tension fatigue resistance. However, it would seem that the effect under conditions
of moderate arterial hypoxia is related to the level of polyunsaturation rather than
specifically the n-3 PUFA. This effect of polyunsaturation was also apparent for the
efficiency index. An explanation for this effect can be drawn from the original work
by Pepe and McLennan (2002) using isolated heart. When global hypoxia was
induced, the contractile performance and oxygen consumption was severely reduced
all dietary groups. The dietary effect of n-3 PUFA was seen during re-perfusion. In
the context of the current study, hypoxia also reduced twitch contractile performance
in the skeletal muscle. The lack of difference in some indices of fatigue between the
n-3 and n-6 groups may be explained by the level of hypoxia. In theory, if the extent
of hypoxia is severe enough, then no amount of protection by dietary n-3 PUFA will
enable twitch contraction to continue. In fact, this is apparent by 30minutes of
contraction where efficiency index of the three groups were similar.

Previous work with in vitro isolated skeletal muscle, also indicated that there was an
greater contractile performance in both n-3 and n-6 groups when compared to a diet
deficient in essential fatty acids (Ayre and Hulbert 1996b). Fatigue in the isolated
muscle was induced within 60 seconds under low frequency stimulation suggesting
that there was a limitation to oxygen diffusion. The critical muscle thickness for
incubation of rat muscle in vitro has been previously reported (Segal and Faulkner
1985) and re-printed by (Bonen et al. 1994). It is highly possible that the core fibres
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of the extensor digitorum longus and soleus muscles used in the study by Ayre and
Hulbert (1996b) were hypoxic resulted in the lack of difference between the groups.
The difference between all groups under normoxic conditions (Chapter 4) and the
similarity between the n-3 and n-6 groups in the current study provide some stimulus
to investigate the protective effects of each diet when oxygen supply is progressively
reduced. This could take place either via reducing arterial oxygen supply from
normoxic levels to severely hypoxic, or progressively reduced blood flow to the
contracting muscle until there is no differences between any diets (as seen in heart)
(Pepe and McLennan 2002).

Despite most twitch characteristics and efficiency index being similar between the n3 and n-6 groups, there was clearly still greater twitch tension development in the n-3
group, especially early in the stimulation period. One difference was the n-3 group
did display greater maximum rate of developed tension throughout the 30minute
period compared to both SF and n-6 groups. Several possible contractile processes
may contribute to the maximum rate of developed tension and provide evidence to
help describe the differences between the dietary groups. Possible mechanisms for
decreased maximum rate of developed tension include decreased numbers of active
cross bridges (Metzger and Fitts 1987) or a depressed rate of calcium release perhaps
resulting from fewer calcium channels opening (Rousseau and Pinkos 1990).

The second part of this study addressed the possibility that changes in developed
isometric twitch tension between the dietary groups may be a function of calcium
release from the sarcoplasmic reticulum. Caffeine produced recovery of twitch
tension during hypoxia and stimulation induced fatigue which was most evident in
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the n-3 group. Caffeine facilitates neuromuscular function at the level of the
sarcoplasmic reticulum to induced calcium release (Weber and Herz 1968; Freyer
and Neering 1989; Block et al. 1992) and reversal of the loss of force production in
low frequency fatigued fibres (Edwards 1981). In fact, a 10mM dose of caffeine
applied to Xenopus laevis fibre early in a contraction period did not effect either
[Ca2+]i or tension development, yet late in fatigue, increased both (Westerblad and
Allen 1991). This supports the concept that calcium release but not sarcoplasmic
reticulum content is depressed in fatigued skeletal muscle.

Failure of the sarcoplasmic reticulum to release calcium, particularly during low
frequency fatigue can be related to several cellular changes that have occurred in the
fatigue state. These include, i) elevated calcium concentrations ii) alteration in the
metabolic homeostasis within the triad space and modification of iii) reactive oxygen
species that are elevated as a result of high oxygen flux in the muscle (Bruton et al.
1998; Favero 1999). It is beyond the scope of the current thesis to examine this
process experimentally, however, the collective results may be as a result of one or
more of these changes.

There was no apparent rise in the resting tension of the gastrocnemius-plantarissoleus muscle bundle during the 30minutes of contraction. Increased intracellular
calcium levels normally increase the resting tension in the aim of sustaining twitch
tension. Whether, small changes in the intracellular calcium concentration that could
potentially affect calcium release could be measured in our system is debatable. It is
common practice to study these levels of change in isolated cell preparation with
dyes such as aequorin, Fura-2 or Indo-1 that fluoresce in the presence of free calcium
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in combination with image analysis of cell shortening. Additionally, increased
intracellular calcium concentration is buffered by increased levels of mitochondrial
and sarcoplasmic reticulum uptake, therefore, it should not be ruled out that changes
in the calcium release with diet are due to intracellular calcium levels.

The case for increased reactive oxygen species certainly warrants further
investigation. Reactive oxygen species and free radicals are shown to increase during
hypoxia both in isolated cell preparations (Duranteau et al. 1998) and isolated hearts
(Park et al. 1991). This could have detrimental effects on contractile activity in
skeletal muscle. As a paradox to the current results, long chain fatty acids, and
particularly fish oils, are highly oxidisable and susceptible to increased levels of
reactive oxygen species (Hu et al. 1989; Leibovitz et al. 1990). On this basis it seems
that there should be a depressed contractile performance in the n-3 group. However,
the long-term intake of a low amount of n-3 PUFA, may indeed protect from
oxidative damage by up regulating the anti-oxidant system in a similar way exercise
training has shown in various tissues (Wilson and Johnson 2000). Evidence from
liver cells (Avula and Fernandes, 1999), spleen cells (Sen et al., 1997) and
antioxidant gene expression (Takahashi et al., 2002) support an associated positive
effect of dietary fish oil on the antioxidant system and possible protection against
reactive oxygen species generated during exercise.

Additionally, care must be taken in the interpretation of these results. It is recognised
that not only the absolute amount of calcium released from the sarcoplasmic
reticulum impacts on the tension development, but also i) the sensitivity of the
myofibrillar apparatus to calcium and ii) the maximum activated calcium cross
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bridge potential (Westerblad et al. 1991). In fact it has been demonstrated that the
sensitivity of rat papillary muscles to calcium is enhanced in the presence of n-3
PUFA (Awumey and Pehowich, 1995). The possibility of enhanced sensitivity of the
myofibrillar apparatus to calcium in skeletal muscle could mean lower required
calcium release during contraction and reduced energy required for re-uptake. It was
beyond the current study to investigate either of these two mechanisms, however it is
possible that in combination with possible release changes, either or both of these
may also be involved in the dietary differences. In addition, caffeine is also shown
under some circumstances to effect substrate use, blood flow, ion balance, and the
central nervous system (Graham 2001), therefore also limiting the interpretation of
these results to simply improved calcium release.

There also seems to be a paradoxical effect of oxygen efficiency and time to 50%
peak tension. In the current study, the SF group has consumed more oxygen for a
given developed twitch tension across 30minutes compared to both n-3 and n-6
groups, yet time to fall to 50% of maximum peak tension was longer than the n-6
group and not significantly different to the n-3. This result adds to the concept that
oxygen efficiency is only one contributing factor in twitch tension fatigue. The fact
that maximum peak tension in the first 60seconds of stimulation tended to be lower
in the SF group and all three dietary groups fell to the same level by 30minutes
indicates the relative rate of fall in tension tended to be slower in SF group. Also,
within the two PUFA groups the difference in force recovery with 10mM caffeine
was reflected in the difference in oxygen consumption. The saturated fat group with
the least recovery in twitch tension had a disproportionate increase in oxygen
consumption compared to the other groups.
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In heart, excessive oxygen consumption has been associated with conditions of cellular
calcium overload which is also a common underlying factor in arrhythmia generation
(Curtis et al. 1993). Importantly, considerable data shows that fish oil has a marked
inhibitory effect on arrhythmia generation (McLennan et al. 1996; Pepe and McLennan
1996; Nair et al. 1997). Recent work in rat ventricular myocytes investigating
calcium-induced calcium-release, showed that in the presence of the long chain
PUFA, eicosapentaenoic acid, there is indication of reduced [Ca]i or calcium
overload of the cell (O'Neill et al. 2002). Additionally, dietary n-3 PUFA modulate
both oxygen consumption (Pepe and McLennan 2002) and calcium handling (Taffet
et al. 1993; Pepe et al. 1999; Pepe and McLennan 2002) in the heart during
reperfusion.

In addition to contractile changes, there was a distinct fall in the level of absolute
muscle glycogen in the stimulated compared to control muscles while blood glucose,
remained stable in all dietary groups. There are limitations to the use of absolute
substrate levels (blood or intramuscular) for drawing conclusions related to substrate
changes. Despite this, the decrease in muscle glycogen levels in all dietary groups
indicated that there was a high turn-over and use of glucose during contraction. The
increase levels of blood lactate in the n-3 group may also indicate the possibility of
increased glucose / glycogen use to maintain tension. Hypoxia is known as a potent
stimulator of glucose transport and uptake via a similar mechanism to exercisepromoted glucose uptake. This is believed to be independent of insulin with hypoxia
resulting in increased blood (Cartee et al. 1991) and muscle lactate (Green et al.
1992). The mechanism is thought to be similar to the non-insulin dependent uptake
of glucose stimulated by muscle contraction (Behrooz and Ismail-Beigi 1999).
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It is beyond the scope of this investigation to suggest that there may be dietary
differences in substrate preference, however, it is important to recognise that n-3
fatty acids are associated with oxygen modulation in the heart (Pepe and McLennan
2002) similar to pharmacologically-induced changes in substrate preference towards
glucose (Hutter et al. 1985). The shift to glucose in the heart occurs in response to
acute increase in energy demand (Goodwin et al. 1998) and results in improved
coupling of glycolysis with glucose oxidation shown to protect the ischaemic heart
(Kantor et al. 2000). The substrate shift toward the more oxygen efficient glucose has
also been apparent in skeletal muscle from animals fed n-3 PUFA for 6-8 weeks
(Rustan et al. 1993). Similar changes with dietary with n-3 PUFA to glucose
substrate use, although not detectable in the current investigation, would help to
improve twitch tension and contractile function in conditions of low oxygen delivery.

There also seems to be a paradoxical effect of acid-base balance, as reflected by
blood lactate and pH, and isometric twitch tension in the n-3 and n-6 groups in the
present investigation. Generally when a muscle is dynamically stimulated or
voluntarily contracts, the increased blood lactate levels and a fall in pH, are
associated with a decrease in contractile (Stevens 1988) or whole body performance.
However, work done with in vivo preparation may indicate that pH is not a major
contributing factor to skeletal muscle fatigue during isometric contractile
performance. In fact, fatigue may be more tightly associated with increased Pi
(Westerblad and Allen 1996). Studies using isometric stimulation in vivo that have
manipulated pH without disturbing other metabolites, support this concept
(Mainwood and Renaud 1985; Meyer et al. 1991). Therefore, it not unusual that the
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n-3 group, with the highest isometric twitch tension also displayed the highest lactate
and lowest pH.

The results of the present investigation would suggest that at least under conditions
of twitch contractions, dietary n-3 PUFA can attenuate the fall in tension and provide
some level of fatigue resistance when oxygen delivery (supply) is reduced to
working muscle. In addition, there is some indication that in twitch fatigued skeletal
muscle, calcium available for release by a caffeine-induced mechanism, is enhanced
by a diet high in n-3 PUFA. There are several possible explanations in regards to the
lack of difference between the n-3 and n-6 groups for oxygen efficiency yet
improved twitch tension development in the n-3 group. These have been discussed
around the importance of using a model of optimal oxygen delivery to examine
fatigue processes and establish dietary differences and fish oil provides protection
against twitch tension fatigue by enhancing calcium regulated release. The latter may
be a result of improved resting intracellular calcium levels and / or reduced oxidative
stress. This would be in agreement with findings in heart where n-3 fatty acids
modulate arrhythmias by reducing spontaneous calcium spill-over release. Excess
intracellular calcium impairs regulated sarcoplasmic reticulum release and promotes
unregulated spontaneous calcium release. Alternatively, there are possibilities that
substrate preference may be altered towards the efficient use of glucose. These
findings have provided further insight to the role of dietary fatty acids in optimal
physiological performance of skeletal muscle and highlighted where further research
is required.
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Chapter 6
General discussion and conclusions
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6.1 Introduction
The primary aim of this thesis, based on reviewed literature of n-3 PUFA and in
particular previous findings in the heart (Pepe and McLennan 2002), was to
investigate the potential links between dietary fish oil, membrane fatty acids,
modulation of oxygen consumption and skeletal muscle fatigue. The collective
results of this thesis support role of the long chain n-3 PUFA, DHA in cell
membranes, as a requirement for optimal skeletal muscle function. In the rat autoperfused contracting hindlimb, during brief and prolonged more intense bouts of
stimulation, in recovery after bouts of stimulation and during hypoxic conditions, n3 PUFA feeding was associated with enhanced muscle contractile function
indicative of reduced fatigue. Specifically, reduced fatigue in the n-3 PUFA group
during normoxic conditions was associated with maintenance of isometric twitch
rise time, fall time, contraction duration and maximum rate of tension development
and relaxation. The effects of membrane change on these twitch characteristics
provide information that may partly explain the measured differences in twitch
tension fatigue, such as altered calcium release. Of particular interest in regard to
the hypothesis of this thesis, reduced twitch tension fatigue in the n-3 PUFA group
was associated with modulated oxygen consumption during twitch contraction and
recovery. These results complement the original findings in heart (Pepe and
McLennan 2002) and establish the n-3 PUFA DHA in skeletal muscle as an
essential membrane fatty acid for optimal function.

6.2 Direct effect of fish oil on skeletal muscle
The composition of phospholipid in the skeletal muscle membrane was highly
sensitive to the type of fat provided in the diet (Chapter 3). This has been previously
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seen in various other tissues (Charnock 1982) including heart and skeletal muscle in
the marmoset monkey (Charnock et al. 1992) and more recently rats and humans
(Pan and Storlien 1993; Storlien et al. 1996; Ayre and Hulbert 1996a). In both red
and white skeletal muscle, significant changes were found between dietary groups in
the relative levels of polyunsaturated fatty acids. The changes in skeletal muscle,
specifically for the long chain n-3 PUFA DHA, are comparable to those seen in the
heart after similar dietary studies (Charnock et al. 1992; Pepe and McLennan 1996)
which importantly are also linked to reduced myocardial oxygen consumption (Pepe
and McLennan 2002). It has become evident in the heart that phospholipid
incorporation of the 22 carbon fatty acid DHA is the primary response to fish oil or
purified long chain fatty acids in the diet, even when the 20 carbon n-3 PUFA EPA
predominates (McLennan et al. 1996). Taken together with high DHA levels in brain
and retina (Jeffery et al. 2001; Salem et al. 2001) this highlights the requirement for
DHA in membranes of excitable cells for optimal function.

The current changes in skeletal muscle membrane content, and resulting skeletal
muscle function, have been achieved in 8 weeks with a diet that is low in total fat
(10%). More importantly, the fish oil diet is low in the total amount of n-3 PUFA
especially DHA that is linked to functional changes. The low dose of fish oil
required for real physiological effect is highlighted by a number a studies
(Kromhout et al. 1985; Burr et al. 1989; Siscovick et al. 1995) that concluded even
a diet of one to two fish meals per week would be beneficial to reduce the risk of
death from coronary heart disease especially direct heart related effects (Siscovick
et al. 1995). Further studies have also confirmed this (Shekelle et al. 1985; Norell et
al. 1986) and support diet effects seen in this thesis within the 8 week time frame.
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In addition to the time frame, the total level of fat used in the present thesis was
significantly lower than levels used in previous studies that consider the roles of
dietary fat in skeletal muscle performance (Pruett 1970; Phinney et al. 1983;
Lambert et al. 1994; Muoio et al. 1994; Helge et al. 1996; Starling et al. 1997;
Helge et al. 1998; Pitsiladis and Maughan 1999; Helge 2000). The overwhelming
observation from literature involving “fat loading” is that fuel substrate use can be
significantly altered in the favour of fatty acid oxidation without consistent or
significant change in exercise performance. These results may indicate that during
long duration aerobic activity, substrate utilisation is only part of a multifactorial
fatigue process.

The ability to sustain high isometric twitch tension (as consistently observed throughout this thesis in muscle of animals fed n-3 PUFA) is commonly used as an indicator
of fatigue resistance (Fitts and Holloszy 1976) and describes the improved contractile
performance in this group. Twitch tension traditionally describes the relationship
between the active cross bridges, however it is now recognised that there are other
factors that contribute to isometric tension, such as Ca2+ transient and muscle
temperature (Fitts and Holloszy 1978). Reduced twitch tension fatigue in the n-3
PUFA group during normoxic conditions was associated with maintenance of
isometric twitch rise time, fall time, contraction duration and maximum rate of
tension development and relaxation. The effects of diet on these twitch
characteristics provides information that may explain the measured differences in
fatigue. Reduction in peak twitch tension effects contraction duration (Thompson et al.
1992). In vivo (Bergstrom and Hultman 1988), in vitro and in situ (Brust 1964;
Mainwood and Lucier 1972) prolonged time for twitch relaxation occurs as fatigue
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increases. The attenuated decline in twitch characteristics with dietary n-3 PUFA
strengthens the argument for improved skeletal muscle contractile function and
delayed fatigue. In addition, both decline in the maximum rate of force development
and relaxation, also associated with fatigue (Brust 1964; Fitts and Holloszy 1978),
were attenuated in skeletal muscle from animals fed n-3 PUFA in Chapter 4.

This thesis is the first to demonstrate that the direct effect of fish oil on the skeletal
muscle fatigue is related to improved efficiency of oxygen consumption, at least in
normoxic conditions as reflected by the efficiency index. The efficiency index was
defined as the relative isometric twitch tension developed for a given amount of
oxygen consumed. At the outset, the major stimulus for this thesis into the role of
dietary n-3 PUFA in skeletal muscle fatigue as discussed above, was the previously
established role of DHA in cardiac membranes and the increased cardiac oxygen
efficiency and contractile function (Pepe and McLennan 2002) taken together with
similarities between heart and skeletal muscle in n-3 PUFA incorporation. There are
no studies that have considered the relationship between n-3 PUFA and fatigue on
the basis of improved oxygen use. However, despite the use of the rat auto-perfused
contracting hindlimb that provides near physiological conditions, the changes in
twitch tension fatigue and oxygen consumption observed in the current thesis need
to be carefully interpreted based on the fact that fatigue has been assessed using
isometric twitch contractions at this preliminary stage. When isometric force is
developed, the muscle length does not change, therefore fatigue mechanisms
identified on the basis of isometric activity may have limitations relevant to tasks
where isotonic or isokinetic contractions occur (Stevens and Syme 1989).
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Previously, Ayre and Hulbert (1996b) investigated the effect of a high n-6 and high n3 diet (Max EPA oil) diet on isolated muscle function. Some care is required in
interpreting these results based on information already presented in this thesis
regarding in vitro muscle preparations (Chapter 2). No difference could be detected in
twitch tension and resistance to fatigue between n-6 and n-3 diets yet the control diet
deficient in essential fatty acids showed a significantly decreased performance. No
oxygen consumption data was collected. Overall these results indicate that a diet
deficient in essential fatty acids may influence skeletal muscle performance but the
study provides limited information in regards to the roles of specific fatty acids such as
n-6 and n-3 PUFA that the current thesis can be compared against.

As an extension from the isolated muscle preparation (Ayre and Hulbert 1996b)
endurance performance in rats on a running treadmill, was assessed (Ayre and Hulbert
1997), again with no oxygen consumption data collected. The n-6 group had
significantly increased times to fatigue compared to the n-3 group and diet deficient in
essential fatty acids. This latter study does not correspond with authors’ own the
isolated skeletal muscle results (Ayre and Hulbert 1996b) nor do they agree with the
current thesis using the auto-perfused contracting rat hindlimb. We believe that
methodology, including diet composition (high EPA in the previous work versus high
DHA in the current thesis) and determinates of whole body fatigue in the rat may have
influenced the findings.

Investigations in humans have hypothesised that n-3 PUFA supplementation may
improve whole body endurance performance through reduced blood viscosity
increasing skeletal muscle blood flow and hence tissue oxygenation (Terano et al.
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1983; Woodcock et al. 1984). An increase in the peak oxygen consumption was
predicted (Leaf and Rauch 1988a). The increase in whole body peak oxygen
consumption of subjects supplemented with a low dose of n-3 PUFA as originally
found by Leaf and Rauch (1988a) was not evident in two follow up studies
(Oostenburg et al. 1997; Raastad et al. 1997). In fact, data collected by Oostenburg
et al. (1997) using endurance cyclists showed that fish oil supplementation did not
have any measurable effect on red blood cell rheological properties. Additionally, in
our laboratory, we have also confirmed that fish oil supplementation, over an eight
week period, has no effect on the peak oxygen consumption of elite cyclists
(Peoples 1998). It is believed that the original findings of improved maximal
oxygen consumption found by Leaf and Rauch (1988a) may be attributable to the
heterogeneous subject group used. This is not to say that changes in blood viscosity
and improved muscle blood flow are not involved with potential improvements in
skeletal muscle performance, but simply the subject populations have been highly
trained athletes who have developed high levels of oxygen carrying capacity to
working muscle. Additionally, improvements in maximal oxygen consumption
amongst highly trained groups are very small and possibly unable to be measured.

As mentioned, work in our laboratory (Peoples 1998) found no change in the peak
oxygen consumption of cyclists supplemented with fish oil. The result of that study
agrees the previous work in humans (Oostenburg et al. 1997; Raastad et al. 1997).
However, heart rate and rate pressure product were reduced during incremental and
steady state exercise indirectly indicating a reduced myocardial oxygen
consumption (Peoples 1998), in agreement with work in isolated rat hearts (Pepe
and McLennan 2002). In the same study (Peoples 1998) we also found that
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submaximal oxygen consumption over a long duration ride (2hours) set at 55% of
peak workload was significantly reduced after 8 weeks fish oil supplementation.
Despite the different types of muscle contraction (dynamic versus isometric), the
improved use of oxygen in cyclists supplemented with fish oil agree with the
current work using the auto-perfused contracting hindlimb.

The increased efficiency of oxygen use by skeletal muscle from the n-3 group was
not always the result of reduced absolute oxygen consumption of contracting skeletal
muscle. Improved oxygen efficiency in isolated hearts from animals fed n-3 PUFA,
was achieved through reduced oxygen consumption with maintained output (Pepe
and McLennan 2002). The oxygen consumption of the skeletal muscle was
sometimes increased and sometimes reduced, depending on the experimental
conditions. The coupling of oxygen consumption and work done in skeletal muscle is
highly dependant on the contraction intensity. It is clear that with higher levels of
twitch tension maintained in the n-3 group over 30minutes, a corresponding higher
level of oxygen is required to regenerate intracellular ATP from ADP. Nevertheless,
this was always achieved with enhanced efficiency because the consistent and most
predominate effect of fish oil feeding in skeletal muscle has been increased force
development out of proportion to the oxygen consumption.

There are a number of factors that could be responsible for the observed differences
in oxygen use between the 30minute contraction periods of Chapter 4 and 5 and the
repeat bout activity in Chapter 3. These include the frequency and duration of
muscle stimulation, the hindlimb blood flow and the timing of blood sampling. In
Chapter 3, blood was sampled only at the end of the 10minute contraction periods.
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At this point oxygen consumption was slightly lower in the repeat bout activity
independent of diet, reflective of the lower frequency of twitch contraction in that
study. It is hard to identify if there would have been a different scenario early on in
the fatigue process under repeat bout conditions. In this repeat bout scenario, fall in
isometric tension was not as great as the studies described in Chapter 4 and 5.
Additionally, the initial investigation in Chapter 3 involved a study design that
considered the recovery process of the different dietary groups. The rate of recovery
will impact on the oxygen consumption in the next contraction period. It must be
noted that the n-3 group under these conditions returned to near pre contraction
resting oxygen consumption levels between bouts, where as both n-6 and saturated
fat groups sustained much higher recovery oxygen consumption. This may have
impacted on the oxygen consumption during contracting periods in these groups.

In hypoxic conditions, the efficiency index of the n-3 group was different from only
saturated fat. This indicates that the differences between diets for isometric fatigue
may not be completely explained by the efficient use of oxygen. During hypoxia,
equal efficiency was seen between the n-6 and n-3 group yet the muscle from the
animals fed n-6 PUFA fatigued significantly quicker than the n-3 muscle. This
highlights the complexity of fatigue and the many potential mechanisms that
specific dietary fats can modulate during twitch contractions. Hypoxia brings a new
challenge to the contracting muscle including an increased glucose uptake (Stainsby
et al. 1990) and increased muscle and blood lactate compared to equivalent exercise
in normoxic conditions (Katz and Sahlin 1987; Parolin et al. 2000a; Parolin et al.
2000b). The differences in both contractile twitch tension and fatigue rate between
the groups may be a combination of several factors including substrate preference.
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An indication of mechanisms involved may come from the maximum rate of
tension development in Chapter 5. This was the only twitch characteristic in the n-3
group that was significantly different from the n-6 PUFA and SF groups, therefore
may hold the key to explaining the overall difference in twitch tension
development. Commonly, reduced maximum rate of tension development has been
tightly linked to decreased numbers of active cross bridges (Metzger and Fitts 1987)
or a depressed rate of calcium release perhaps resulting from fewer calcium
channels opening (Rousseau and Pinkos 1990). Importantly, the ability of the Ca2+
releasing agent caffeine to reverse muscle fatigue in hypoxia was also enhanced in
the n-3 group, suggesting a link to Ca2+ to be discussed later.

6.3 Possible mechanisms to explain the direct effect of fish oil on skeletal muscle
oxygen consumption and fatigue
It has been well documented that membrane composition is strongly linked to a
number of alterations in cellular function, including ion flux, respiratory electron
chain, membrane bound enzyme activity, receptor function, and eicosanoid
synthesis (Hulbert and Else 1999). As previously mentioned, dietary n-3 PUFA are
also associated with potential antiatherogenic effects on the cardiovascular system
both in man and the animal models (Wiener et al. 1986; Davis et al. 1987), affect
eicosanoid metabolism and function (Fischer et al. 1986), lower blood pressure
(Lorenz et al. 1983), reduce endogenous fibrotic activity (Barcelli et al. 1985),
reduce serum triglycerides, very low density lipoproteins and increase the levels of
high density lipoproteins (Dyerberg et al. 1975; Phillipson et al. 1985). In rat
ventricular myocytes the presence of EPA was shown to reduce [Ca2+]i and calcium
overload (O'Neill et al. 2002) while considerable shows that fish oil has a marked
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inhibitory effect on arrhythmia generation (McLennan et al. 1996; Pepe and
McLennan 1996; Nair et al. 1997). Specifically in skeletal muscle, it has also been
established that increased incorporation of n-3 PUFA and unsaturation of the
membrane can influence function including insulin sensitivity and intramuscular
triglyceride storage (Pan et al. 1997) and resultant substrate preference (Rustan et
al. 1993). This highlights the broad range of effects and importance fish oil has in
optimising physiological function and the potential impact it can have on skeletal
muscle performance. Many of these may have possible influence on contractile
function and fatigue and may contribute to the modulated oxygen consumption.

In Chapter 4 several possible mechanisms were introduced and those that are
relevant will be further discussed here. In addition, the possibility of differences in
calcium release between diets was considered in Chapter 5 with the aid of caffeine,
which is known to stimulate the release of calcium from the sarcoplasmic reticulum.

6.3.1 Calcium Handing
The collective evidence from this thesis would suggest that n-3 PUFA, when
incorporated into the skeletal muscle membranes, provide a protective effect against
twitch tension fatigue (stimulated at low frequency). Low frequency fatigue has been
described by several characteristics that distinguishes it from high frequency fatigue,
including the increased length of time required for recovery (Edwards et al. 1977),
and more complex mechanisms involved beyond the neuromuscular junction (Jones
1996). These include metabolic, mitochondrial and sarcoplasmic reticulum
alterations, where calcium release has been identified as a key step in the fatigue
process. Specifically, the release of calcium from the sarcoplasmic reticulum in the
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fatigued muscle (Favero 1999) may be depressed by increased resting intra-cellular
calcium levels or reactive oxygen species generated during conditions of high
oxygen consumption. This study did not measure sarcoplasmic reticulum calcium
release or reactive oxygen species, however our results give indirect evidence
through the attenuation low frequency fatigue by n-3 PUFA.

Firstly, the dietary differences seen in relative rise time, fall time and contraction
duration as well as the maximum rate of developed tension and relaxation over the
30minute normoxic contraction period (Chapter 4) reflect possible calcium handling
changes occurring in the muscle cell. Muscle fatigue is known to increase the
duration of the calcium transient and thus prolong the relaxation time (Allen and
Westerblad 1989; Westerblad and Allen 1991). Prolonged contraction time and
shortening speed are apparent after fatigue in single motor units as well as whole
muscle preparations (Burke et al. 1973; Burke and Tsairis 1973; Lannergren et al.
1989; Gordon et al. 1990). However there seems to be a paradoxical effect between
isometric tension and twitch characteristics in n-3 and n-6 PUFA groups during hypoxic
conditions. Despite greater isometric twitch development in n-3 skeletal muscle, all
other differences in twitch characteristics mentioned above, except the maximum rate of
force development, were lost compared to the n-6 group. Independent of diet, the
contracting rat hindlimb develops less tension and fatigues more rapidly (although not
significant) with low oxygen delivery. Hypoxia adds a new challenge to the contracting
skeletal muscle, and it has been accepted that muscle will fatigue more rapidly in an
environment of low oxygen availability (Fletcher 1902). The lack of difference in
individual twitch characteristics between n-3 and n-6 groups despite differences in the
time to fall to 50% of peak tension during hypoxic, indicates that the interaction
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between isometric tension and fatty acids in the diet is more complicated than simply
calcium transients and cross-bridge interaction, and may involve other processes, such
as substrate preference that will be discussed further on.

Secondly, recovery was greater n-3 PUFA group under two separate conditions. The
hindlimbs from animals fed fish oil maintained maximal peak twitch tension between
repeat bouts, fatigued less within bouts and had reduced oxygen consumption in the
recovery periods. It is of particular interest, that endurance trained athletes result in
greater recovery from bouts of exercise when compared to sedentary individuals
(Hagberg et al. 1980). In addition, fish oil feeding augmented the response to caffeine
as displayed by a significantly greater recovery of twitch tension in hypoxic fatigued
muscle and a leftward shift of the caffeine dose-response curve (Chapter 5, figure 5.14).

Collectively, these results suggest that incorporation of n-3 PUFA in the skeletal muscle
cell membrane provide protection against the altered cellular calcium handling
processes that are linked with excessive oxygen consumption and low frequency
fatigue. The link between altered calcium handling and n-3 PUFA is also apparent in
the heart. Excessive myocardial oxygen consumption that has been associated with
conditions of cellular Ca2+ overload which is also a common underlying factor in
arrhythmia generation (Curtis et al. 1993). Recent work using rat ventricular myocytes
demonstrate that EPA can reduce [Ca2+]i and calcium overload (DHA was not
tested)(O'Neill et al. 2002) while considerable data show that fish oil has a marked
inhibitory effect on arrhythmia generation (McLennan et al. 1996; Pepe and McLennan
1996; Nair et al. 1997). Moreover, Pepe and McLennan (2002) showed that not only
were dietary differences in arrhythmias attenuated by altering sarcoplasmic reticulum
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Ca2+ release but excess oxygen consumption could be restored to levels similar to those
in the n-3 hearts by inhibiting mitochondrial Ca2+ uptake in isolated hearts. Myocardial
Ca2+ cycling processes appear as potential mechanism of action of fish oil fatty acids in
the heart. Further work needs to be done to confirm the results in this thesis that point
towards improved calcium handling in skeletal muscle with increased membrane DHA.

Alternatively, increased reactive oxygen species and have been suggested to interfere
with the cellular calcium handling (Bruton et al. 1998) and modulated redox alters
calcium release (Salama et al. 1992). This area warrants further investigation.
Measures of reactive oxygen species are shown to increase in rat muscle during in
situ stimulation of the tibialis anterior (Coombes et al. 2001), during hypoxia both in
isolated cell preparations (Duranteau et al. 1998) and isolated hearts (Park et al.
1991) and may play a role in fatigue. As a paradox to the current results, long chain
fatty acids, and particularly fish oils, are highly oxidisable and susceptible to
increased levels of reactive oxygen species (Hu et al. 1989; Leibovitz et al. 1990).
On this basis it seems that there should be a depressed contractile performance in the
n-3 group. However, the long-term intake of a low amount of n-3 PUFA, may indeed
protect from oxidative damaged by up regulating the anti-oxidant system. Evidence
from liver cells (Avula and Fernandes, 1999), spleen cells (Sen et al., 1997) and
antioxidant gene expression (Takahashi et al., 2002) support an associated positive
effect of dietary fish oil on the antioxidant system. This would have great benefit to
exercise and fatigue that are associated with high levels of oxidative stress, including
conditions such as acute hypoxia.

The beneficial actions of dietary fish oil may result from a depressed level of
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circulating and membrane incorporated arachidonic acid (high in both the n-6 and SF
group). Contraction related reactive oxygen species can be suppressed by the
inhibition of phospholipase A2 (PLA2) (Nethery et al. 1999). Increased PLA2
stimulation is likely to increase arachidonic acid levels which in turn increases
electron chain production of reactive oxygen species (Nethery et al. 2000). The
limited supply of available arachidonic acid levels as a result of fish oil feeding could
potentially protect against increased oxidative stress and resultant loss of
performance. Additionally, in cardiac mitochondria, n-3 PUFA modulate calcium
levels (Pepe, 2000) which in turn are responsible for phospholipase A2 activity and
reactive oxygen species as mentioned above. At this stage, the impact of oxidative
stress modulated by fish oil consumption is postulated, however, it provides further
interesting research avenues.

6.3.2 Substrate preference
It was beyond the scope of this thesis to substantially conclude if substrate
preference was different between the dietary groups. However, measures of blood
glucose and lactate or muscle glycogen indicated some possibility that fuel
utilisation is altered. Under normoxic and hypoxic conditions, the n-3 group
demonstrated higher absolute blood lactate levels than both n-6 PUFA and saturated
fat groups, particularly as the duration of contraction passed 5minutes. The
increased levels of blood lactate may indicate increased glucose / glycogen use in
the n-3 PUFA group to maintain twitch tension. Muscle glycogen was always lower
in muscles that had undergone a contraction protocol compared to their
unstimulated controls while blood glucose was stable in all dietary groups. There
are limitations to the use of absolute substrate levels (blood or intramuscular) for
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drawing conclusions related to substrate changes. Despite this, the decrease in
muscle glycogen levels in all dietary groups indicated that there was a high turn
over and use of glucose during the 30minute period. Fatty acid oxidation uses more
oxygen to produce each ATP than does glucose (Saddick and Lopaschuck 1991).
Therefore, glucose is a preferred fuel in situations where oxygen is limiting, such as
hypoxia, and in high intensity exercise. As previously mentioned, hypoxia is a
potent stimulator of glycolysis (Green et al. 1992) and resulting increase of blood
and muscle lactate (Katz and Sahlin 1987; Parolin et al. 2000a; Parolin et al.
2000b).

It is important to recognise that n-3 fatty acids are associated with oxygen
modulation in the heart (Pepe and McLennan 2002) similar to the changes
pharmacologically seen with induced shifts of substrate towards glucose (Hutter et
al. 1985; Kantor et al. 2000). A shift toward the more oxygen efficient glucose has
also been demonstrated in skeletal muscle from animals fed n-3 PUFA for 6-8
weeks (Rustan et al. 1993). To date, fatty acid profile of membrane lipids have been
linked to major changes in skeletal muscle fuel metabolism (Storlien et al. 1991;
Pan et al. 1995; Storlien et al. 1995). Desaturation of skeletal muscle membrane, as
occurs in n-3 PUFA feeding, has been shown to affect insulin sensitivity in rats
(Pan and Storlien 1993). An increase in insulin sensitivity increases the ability of
the skeletal muscle cell to take up glucose. Additionally, in non-trained humans this
increase in insulin sensitivity is associated with a decrease in intra-muscular
triglyceride content (Pan et al. 1997) while fish oil feeding also decreases serum
triglyceride levels (Phillipson et al. 1985; Rustan et al. 1992). The n-3 PUFA are
linked to even controlling enzymes critical in energy flux at the gene expression
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level (Jump et al. 1996). Therefore, evidence that n-3 PUFA is associated with
preferred glucose use and higher blood lactate may indicate why isometric twitch
tension was sustained longer in this group.

The popular theory that high blood lactate levels during hypoxia are a direct result
of reduced oxygen availability (Katz and Sahlin 1990) can be coupled with
evidence that there is reduced metabolic inertia at the start of exercise, which is
particularly evident in hypoxia (Timmons et al. 1997; Timmons et al. 1998). If
aerobic metabolism could proceed at an earlier time point this may reduce the
associated by-products such as blood lactate and reduced cellular pH that is often
linked to fatigue. Interestingly, n-3 PUFA levels in heart have been shown to
reduce mitochondrial calcium overload and resultant calcium dependent pyruvate
dehydrogenase activity (Pepe et al. 1999). Delayed activation of pyruvate
dehydrogenase and enzymes of the citric acid cycle in skeletal muscle would mean
a higher reliance on anaerobic glycolytic pathways in the first few minutes of
contraction.

Infusion

of

di-chloroacetate,

known

to

increase

pyruvate

dehydrogenase activity prior to exercise, reduces lactate accumulation and improves
metabolic inertia (Gibala and Saltin 1999; Howlett et al. 1999).

Fatty acid composition of phospholipids in skeletal muscle membranes has previously
been linked with exercise training (Thomas et al. 1977; Andersson et al. 1998; Helge et
al. 1999; Andersson et al. 2000; Helge et al. 2001). However, only Helge et al. (1999)
and Helge et al. (2001) successfully controlled for diet and found enhanced DHA
incorporation into muscle of a leg that underwent exercise training compared with the
contralateral untrained control leg in the same subject. Although speculative, this
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selective incorporation of long chain n-3 PUFA amongst several other polyunsaturated
fatty acids suggests their relative importance for optimal contractile function.
Alternatively, it may also be related to the preferential oxidation of long chain fatty
acids for energy during contraction with the phospholipids pool being one site of
availability. This is supported by recent work that demonstrates that muscle from
animals fed fish oil has higher content of cytoplasmic fatty acid binding proteins
(FABPc) and muscle tissue fatty acid flux and oxidation is increased similar to the
response of endurance training (Clavel et al. 2002). Increased fatty acid flux is probably
not the explanation for improved performance in this thesis, where twitch contractions
of 10-30minutes, particularly during hypoxia, would rely more heavily on glycolysis.
Additionally, fatigue during this type of contraction stimulus is more closely related to
calcium handling properties particularly calcium release (Westerblad et al. 1998).

6.4 Importance of the rat auto-perfused contracting hindlimb
We have demonstrated that dietary n-3 PUFA, and incorporation of DHA into the
skeletal muscle membranes, reduces fatigue and modulates oxygen consumption in
the rat auto-perfused contracting hindlimb and have discussed a number of
possibilities for the observed differences. It is likely that many of the principle
findings of this thesis would not have been possible with previously used rat
hindlimb models based on Ruderman et al. (1971) or popular isolated skeletal
muscle studies in vitro. The current method was based on successful auto-perfusion
of canine hindlimbs for the study of oxygen consumption and blood flow (Hogan
and Welch 1986; Hogan et al. 1994; Hogan et al. 1996; Hogan et al. 1998; Hogan et
al. 1999). At the outset of this thesis, it was decided that this would be the best way
to investigate the role of specific fatty acids in skeletal muscle oxygen consumption
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and fatigue. Importantly, blood flow was delivered via the skeletal muscle’s own
vascular bed and sciatic nerve was used to stimulate muscle contraction. Blood flow
was selectively controlled, arterial and venous blood samples collected at regular
intervals and oxygen consumption, hindlimb flow rate, and perfusion pressure were
all within normal physiological range for both resting and contracting conditions.
Finally, by extending the auto-perfused canine model into the rat, long term dietary
investigations were simplified and possible.

A significant finding from the method development is that when the rat hindlimb is
perfused with its own blood, the required flow is significantly lower at rest and
during muscle stimulation than previously used in the in situ preparation. Lower
flow requirement is also apparent in heart when using whole blood (Olders et al.
1990). It is obvious that the flow rates used in previous in situ studies are highly
variable, ranging from 2-20ml/min (table 2.1), and differ according to the make up
of the perfusate (cell v cell free) and size of the animal. Our results are in agreement
with a previous study investigating in vivo flow rates to the rat hindlimb under
resting and contracting conditions (Sapirstein et al. 1960). Low flow rates also have
the added advantage that oxygen delivery can be further increased via both
increased flow and oxygen extraction, similar to blood perfused hearts (Olders et al.
1990).

In addition to the lower required hindlimb flow rates, a clear advantage is the
sustained hindlimb perfusion pressure. The mean values at rest were very similar to
the systemic values recorded simultaneously at the carotid artery. This is a good
indication of the presence of vascular tone in the hindlimb. It would also allow this
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method to be used in investigations of vascular resistance, and more importantly the
ability to vasodilate from resting perfusion. Present work in our laboratory aims to
investigate the responses of the auto-perfused rat hindlimb to a range of vasodilator
drugs. This has not been possible in the in situ method that display very low
perfusion pressures (<50mmHg). Hindlimb vasodilatory response has been only
induced in the presence of vasoconstriction using exogenous agents such as
norepinephrine (Ye et al. 1990). The combination of near physiological flow rates
and perfusion pressure were advantageous to eliminating hindlimb swelling and
discolouration in the current preparation unlike reported elsewhere (Bonen et al.
1994) and therefore concluded that the stability of the auto-perfusion is a clear
advantage over previous methods.

Most important, for this new hindlimb auto-perfusion model in the rat and our
dietary investigation, is the optimal oxygen delivery to the muscle tissue and
resulting oxygen consumption (results compared to table 2.1). The advantage of
carrying oxygen in the red blood cell is obvious when results are compared to the
cell free perfusate, and still hold true compared to using perfusate with either human
or bovine erythrocytes (Rennie and Holloszy 1977). The increased ability to carry
and off-load oxygen at the muscle cell (at lower flow rates) has become an
important part of using the auto-perfused method to study alterations in oxygen use
via dietary manipulation of n-3 PUFA. In the current thesis, there was deliberate
attempt to maintain haematocrit at or above 40% in all animals via injection of resuspended red blood cells that had been previously sampled and used for blood
analysis. The importance of carrying oxygen in the red blood cell is highlighted by
studies in heart and skeletal muscle that fail to maintain adequate haematocrit
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leading to impaired oxygen consumption (Bergman et al. 1979; Gorski et al. 1986).
These studies support the current thesis in regards to perfusing the hindlimb with
the animal’s own blood and the minimum level of red blood cells required.

In our method development, maintenance of isometric twitch contraction was
apparent with flow rate as low as 2ml/minute. To date, most metabolic studies using
the in situ rat hindlimb have been carried out under resting conditions (table 2.1).
The ability to study contracting skeletal muscle has not been entirely appropriate
due to the already high flow rates at rest. This is reflected by the total number of
studies that stimulate the muscle to contract compared to the number of studies that
are concerned with resting conditions (table 2.1). Additionally, studies of muscle
fatigue using in vitro organ baths are also not entirely appropriate considering the
oxygen delivery is reliant on diffusion ability that is dependent on sample thickness.
Loss of contractile function and fatigue is rapid even with low frequency
stimulation (Ayre and Hulbert 1996b).

The importance of using the animal’s own blood in perfusion systems is supported
by studies using both heart (Topping and Trimble 1985; Pepe and McLennan 1993)
and liver (Storer et al. 1980). The direct comparison with buffer perfusion systems in
the heart, demonstrate long term stability and maintenance of function when using
whole blood (Duvelleroy et al. 1976; Olders et al. 1990; Pepe and McLennan 1993).
In the study by (Olders et al. 1990) cardiac output was similar between the two
groups over a range of pre-loads and afterloads, although hearts perfused with buffer
required greater coronary flow than blood perfused hearts. During hypoxia, blood
perfused hearts were able to increase the oxygen delivery via increased coronary
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flow and maintain performance, however buffer perfused hearts were already at
maximum coronary flow rates and could not meet oxygen demand with reducing
arterial oxygen content. The direct comparison of buffer to blood perfused hearts, as
detailed above, is supportive of the clear advantages of the auto-perfused rat
hindlimb in this thesis compared to previously used in situ rat hindlimb perfusion
first originally described by Ruderman et al. (1971). In conclusion, the auto-perfused
contracting rat hindlimb in the present thesis as set up and used for the dietary
investigation of n-3 PUFA and muscle function, appears to be appropriate for
assessing oxygen requirement and muscle fatigue when compared to alternative
hindlimb perfusion methods available. The influence of n-3 PUFA on oxygen
consumption and fatigue as demonstrated in this thesis are discussed in detail below
with possible mechanisms that may contribute to the change in efficiency.

6.5 Future directions
The current thesis has demonstrated that long chain n-3 PUFA can have significant
effects on both oxygen consumption and muscle function in the contracting rat autoperfused hindlimb. From the outset, there was limited research (Ayre and Hulbert
1996a; Ayre and Hulbert 1996b; Ayre and Hulbert 1997) considering whether
specific fatty acids, rather than total fat, may effect skeletal muscle function and/or
performance specifically based on significant changes to structural membrane lipids
reflecting diet composition (Charnock et al. 1992; Pan and Storlien 1993). This thesis
has provided the stimulus for further investigation of the role of dietary n-3 PUFA in
optimal cell function. In combination with the beneficial effect on the cardiovascular
system including the direct effects on the heart and vascular properties, the potential
for improved function in skeletal muscle is exciting.
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Extension of the auto-perfused contracting hindlimb
The auto-perfused contracting rat hindlimb was set up to a level that could be used
in this thesis to investigate the effects of specific fatty acids in muscle fatigue. In
Chapter 5 the method was extended using low oxygen gas supply to the rodent
ventilator to alter arterial oxygen content.

This is important both from the

perspective of increased ability to study muscle function under a range of conditions
using the model and additionally to extend the understanding of how dietary fatty
acids can affect metabolism and cellular function. However, there are still several
areas that the method could be further improved to successfully study a wide range
of physiological processes. At this stage, only isometric twitch contractions have
been used and it is of interest to extend this to the use of isometric summated or
tetanic contractions. Alternatively, it would also be advantageous to explore the use
of isotonic contractions that allow for change in muscle and fibre length. Both of
these contraction parameters have different metabolic responses compared to the
twitch contractions currently used.

Further investigation of possible mechanisms
The precise mechanisms that modulated muscle fatigue when n-3 PUFA DHA is
increased in the membranes of skeletal muscle were not extensively investigated in
this particular thesis. There are a number of possibilities that may explain the
improved contractile function and efficiency of oxygen use when fish oil is provided
in the diet. Further studies that may or may not confirm the proposed mechanisms
include i). Adapting the rat hindlimb method to focus more extensively on substrate
use during contraction. This should involve use of in-line oxygen and carbon dioxide
analysers (measuring partial pressure to at least 0.1mmHg) to calculate hindlimb
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respiratory quotient for closer examination of substrate shifts (not possible in the
current thesis), ii). Use of stable isotopes (glucose and fatty acids) to trace substrate
flux and turnover during contraction of the hindlimb, iii) Specific analysis of
intracellular calcium handing. There is abundant literature using single muscle fibre
preparation and sensitive image analysis of fatigue that relates to calcium handling.
The effect of dietary fatty acids (acute and chronic) is yet to be considered and iv).
The concept of nutrient and non-nutrient pathways in skeletal muscle. There was
some evidence in this thesis that the hindlimb pressure was responsive to the
efficiency of oxygen use and indicated redirection of flow or less vasodilation.
Reduced vasodilation in the hindlimb may indicate decreased oxygen requirement as
previously shown in the heart with reduced coronary flow (Pepe and McLennan
2002). At this stage the majority of nutrient and non-nutrient work has been done
using the in situ rat hindlimb method first proposed by Ruderman and co-workers
(1971). This concept of shunted blood flow firstly needs to be confirmed using a
more physiological method. Secondly, the effect of modulated oxygen consumption
with fish feeding needs to establish if there is also a redirection of blood to nonnutrient pathways.

Application of the findings
Many of the studies that involve improved endurance or reduced muscle fatigue are
focussed on athletic performance. This thesis has supplemented the diet of untrained
animals with specific fatty acids and shown greater fatigue resistance associated with
the increased membrane n-3 PUFA DHA. It is more realistic that the observed
changes in muscle fatigue and efficiency may be most applicable to situations where
function is decreased or compromised. Reduced oxygen delivery to either resting or
contracting skeletal muscle can result in premature fatigue in a number of
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pathologies including exercise induced arterial hypoxemia (reduced PaO2) and
intermittent claudication (reduced blood flow). Regardless of the mechanism/s that
may explain fatigue differences, from the results of the current thesis, there is a
possibility, that dietary fatty acids may play a role in such conditions so as to delay
loss of performance.

Cases of exercise induced arterial hypoxemia at sea level in fit healthy subjects of
varying ages are occurring in greater numbers. This is a result of a combination of
increased awareness and testing for the occurrence. The drop in arterial oxygen
saturation of red blood cells during exercise, has been classified as mild (93-95%),
moderate (88-93%) and severe (<88%) (Dempsey and Wagner 1999). Several
hypotheses exist to explain the occurrence, particularly during the latter stages of
increased exercise intensity. These include, excessive alveolar to arterial PO2
difference and inadequate compensatory hyperventilation. A diet rich in PUFA has
already shown to improve the alveolar-arterial oxygen conductance in masters
athletes (Aguilaniu et al. 1995) and reduce exercise induced arterial hypoxemia. The
current study would also suggest that improvements in fatigue resistance may be
obtained at the level of the skeletal muscle itself.

Intermittent claudication is a pathological condition of leg pain and limping caused
by periods of ischaemia lasting ~5minutes at a time and results in a number of
adaptive responses (Clanton and Klawitter 2001). Once again, the direct effects of
n-3 PUFA on fatigue resistance may also alleviate down-regulation of force and
maintain higher quality of life.
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Alternatively, muscle from Type II diabetic rats have reduced function including,
prolonged contraction duration and relaxation, coupled with depressed tetanic tension
and increased fatigue (Cameron et al. 1990). Some limited work has already focused on
supplementation with PUFA (n-3 and n-6) (Cameron et al. 1991), that resulted in
enhanced muscle function, in vivo related to nerve function. Future work, should
consider if there is additional benefit from diet consisting of increased n-3 PUFA DHA,
and whether the fatigue resistance is apparent in the human diabetic.

Focussing on the fact that dietary n-3 PUFA has considerable effects on
cardiovascular function, and there is increasing evidence for additional direct effects
on skeletal muscle contractile performance, there is potential for great improvement
in those with heart failure. It is now recognised that skeletal muscle function is
effected independent of the reduced blood flow and oxygen delivery resulting from
the failed heart (Drexler et al. 1991; Drexler 1992; Drexler et al. 1992; Drexler 1996;
Gomez et al. 1997; Buonocore et al. 1998). The improvements in muscle function
after increased dietary n-3 PUFA in this thesis may be of great benefit to the failing
muscle in the heart failure patient and deserves further work.

Duchenne muscular dystrophy is a genetic disorder characterised by muscle
weakness and appears in young boys. It is recognised that there is a mutation on a
gene that codes for the protein dystrophin (Hoffman et al. 1987). The most
conclusive evidence to explain muscle weakness has come from the experimental
model, mdx mouse (Gillis 1996). Recent work with single mechanically skinned
muscle fibres from the mdx mouse demonstrates a diminished sarcoplasmic
reticulum Ca2+ release in response to caffeine (Plant and Lynch 2002). If there is a
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similar uncoupling of calcium homeostasis in the human Duchenne muscular
dystrophy, and fish oil proves to modulate calcium levels in skeletal muscle as
shown in heart, there may be reason to also improve quality of life in these patients
with dietary supplementation. Finally, the increasing number of aged citizens in our
communities has placed a large demand on the social and economic structure of the
health care system. Loss of function, particularly muscle endurance and strength is one
major area of concern. The role of continual exercise and activity has been identified as
a key part to maintaining function (see review (Vandervoort 1992)). The implication of
dietary fatty acids to promote contractile performance in ageing skeletal muscle and
greater quality of life is also worth considering.

6.7 Final Conclusions
The current thesis has demonstrated that dietary fat, specifically the long chain n-3
PUFA can indeed have significant effects on both oxygen consumption and muscle
function in the contracting rat auto-perfused hindlimb. The results of this thesis agree
with the modulation of oxygen consumption previously established in the isolated rat
heart (Pepe and McLennan 2002). Additionally in the heart, dietary n-3 fatty acid intake
is linked with direct physiological changes such as reduced in vivo and in vitro
arrhythmia vulnerability (McLennan et al. 1988; McLennan et al. 1996; Pepe and
McLennan 1996). The direct effect of the long chain n-3 PUFA on tissue function is
also confirmed in other tissue such as brain and retina (Weisinger et al. 1995; Jeffery et
al. 2001; Salem et al. 2001). Therefore, the results of the present investigation, would
also confirm that dietary n-3 PUFA modulates function of skeletal muscle, namely
through direct effects on phospholipid content, twitch tension development and oxygen
consumption.
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